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SUMMARY
Nowadays there is growing interest in patient-centered healthcare system. A patient-
reported outcome (PRO) is any report on the status of a patient’s health condition,
quality of life, or functional status associated with health care or treatment that
comes directly from the patient, without interpretation of the patient’s response by
a clinician or anyone else. PROs are increasingly used as primary outcome measures
in observational and experimental studies as they inform clinicians and researchers
about the health-status of patients and generate data to facilitate improved care.
In fact, numerous studies have recommended that objective indicators combined
with PROs would be considered a more comprehensive form of outcome evaluation.
PROs are usually obtained using rating scale questionnaires consisting of questions
or items, grouped into one or more subscales, often called dimensions or domains.
There exist some disease-specific questionnaires as well as generic questionnaires
that even can be applied to healthy subjects. Traditionally, PROs are calculated by
assigning rank scores to the patient’s item responses and summing the scores across
a group of items and creating overall scores by dimensions that are usually rescaled.
Therefore, PROs have an integer and bounded nature which typically accumulate
values in one or both edges of the score scale, leading to U, J or inverse J-shaped
distributions which the usual exponential family distributions are not able to fit
properly.
In order to overcome the poor distributional fit provided by the exponential fam-
ily members, the beta-binomial distribution has been proposed in the literature for
analysing PROs, leading to adequate distributional fits. The beta-binomial distri-
bution is defined as a mixture between a binomial and a beta distribution; or in
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other words, as a binomial distribution which probability parameter is random and
follows a beta distribution,
Y |θ ∼ Bin(m, θ) where θ ∼ Beta (α1, α2) ,
where α1, α2 > 0. Conditional and marginal mean and variances of the beta-binomial
distribution can be therefore derived as
E[Y ] = m
α1
α1 + α2
, Var[Y ] = m
α1
α1 + α2
[
1 + (m− 1) 1
α1 + α2 + 1
]
,
E[Y |θ] = mθ, Var[Y |θ] = mθ(1− θ),
where the marginal density function is given by
f(y) =
∫ 1
0
f(y|θ)f(θ)dθ =
(
m
y
)∫ 1
0
θy(1− θ)m−y θ
α1−1(1− θ)α2−1
B(α1, α2)
dθ
=
(
m
y
)
Γ(α1 + y)
Γ(α1)
Γ(α2 +m− y)
Γ(α2)
Γ(α1 + α2)
Γ(α1 + α2 +m)
.
It is straightforward to notice the complexity of the beta-binomial density function,
which does not belong to the exponential family.
When the aim is to assess the relationship of different covariates on PROs, re-
gression analysis is the most useful framework for statistical modelling. Despite of
the appropriate distributional characteristics of the beta-binomial distribution for
PRO analysis, in a regression framework, the fact that beta-binomial distribution
does not belong to the exponential family makes inappropriate the use of classical
regression models, such as generalised linear models (GLMs) or generalised linear
mixed-effects models (GLMMs).
Researchers at the Respiratory Service at Galdakao Hospital in Spain designed
a longitudinal study where the health-status of patients with Chronic Obstructive
Pulmonary Disease (COPD) was repeatedly measured. COPD is a pulmonary dis-
ease, it is one of the major causes of mortality and it is associated with high levels
of disability. In fact, according to estimates from the World Health Organization,
by 2020 it shall become the third most frequent cause of death. The objective of the
COPD Study was to measure the health-status and evolution of COPD patients who
were followed for up to five years. Two different PRO questionnaires were used to
assess the health-status of the patients: a generic, the Short Form-36 Health Survey,
and a pulmonary disease-specific, the St. George’s Respiratory Questionnaire. Ad-
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ditionally, a set of selected time-dependent and independent variables were recoded
in the study and considered as covariates for the model development.
The main goal of this thesis is to propose a beta-binomial regression approach
that could deal with longitudinal and hierarchical data in PROs framework. This
main objective is split into five specific goals: (i) a review and comparison of existing
beta-binomial regression approaches; (ii) the development of a methodology for the
analysis of multilevel or hierarchical beta-binomial data, in particular, longitudinal
data; (iii) the proposal of a multivariate regression model based on the beta-binomial
distribution for analysing jointly the dimensions provided by PRO questionnaires;
(iv) the implementation of the proposed methodology as Open Source Software to
the scientific community and (v) the application of the proposed methodologies to
COPD data providing clinically relevant interpretations.
The first beta-binomial regression approach is developed in a cross-sectional or
independent data context, and it establishes the base for more complex models.
Based on the conditional or marginal interpretation of the beta-binomial distribu-
tion, two different regression approaches have been proposed in the literature. On
the one hand, the marginal approach, denoted as BBreg, consists of a parametriza-
tion of the beta-binomial distribution assuming that α1 = p/φ and α2 = (1− p)/φ,
where 0 < p < 1 and φ > 0. That way, the marginal expectation of the beta-binomial
distribution is defined as E[Y ] = mp and p can be interpreted as a probability param-
eter, while Var[Y ] = mp(1−p)[1+(m−1)φ/(1+φ)] determinates φ as the dispersion
parameter. Therefore, similar to the logistic regression, a logit link function can be
applied to the probability parameter connecting it with the given covariates through
a linear predictor,
Yi ∼ BB(mi, pi, φ),
logit
(
pi
1− pi
)
= x′iβ,
where mi is the maximum number of score (or summed binary variables) for the
ith observation, β are the regression coefficients and xi is the ith row of a full
rank matrix composed by the given covariates, i = 1, . . . , n. Estimation of the
parameters is done via maximum likelihood. On the other hand, the conditional
approach denoted as BBhglm is based on the hierarchical generalised linear models
(HGLMs), where not necessarily Gaussian random effects are included in a linear
predictor of a GLM. Consequently, the model assumes that conditional on some
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beta distributed random effects the outcomes follow a binomial distribution. Hence,
the BBglm applies a logistic regression in the conditioned expectation including the
beta random effects in the linear predictor.
Yi|ui ∼ Bin(mi, pi), where ui ∼ Beta(1/λ, 1/λ),
logit
(
pi
1− pi
)
= x′iβ + logit
(
ui
1− ui
)
,
where β are the regression coefficients of the fixed effects, ui are the random effects,
xi is the ith row of a full rank matrix composed by the given covariates and λ is
the positive parameter of the distribution of the random effects, i = 1, . . . , n. In
this thesis, we show through a real data application and a simulation study that
when the objective is to measure the effect of the covariates in PROs, the marginal
approach offers more adequate results regarding the statistical significance of the
effect and moreover, a convenient interpretation in terms of odds-ratios.
The BBreg model assumes independence among observations, and hence, some
extension is required in order to apply it to correlated or multilevel data, the longi-
tudinal COPD Study for instance. In this thesis, we extend the BBreg approach to
the inclusion of random effects in the linear predictor in a mixed-effects regression
context,
Yi|u ∼ BB(mi, pi, φ), where u ∼ N (0,D),
logit
(
pi
1− pi
)
= x′iβ + z
′
iu,
where β and xi have been defined in the previous formulae, u are the random effects,
zi is the ith row of the design matrix Z that determines the correlation structure
of the data and D is the variance-covariance matrix of the random effects, i =
1, . . . , n. This way, the random effects will account for the correlation that may exist
among the observations. The model is denoted as BBmm. Due to the conditional
beta-binomial distribution, GLMM estimation theory is not directly applicable, and
therefore, we develop a specific estimation and inference process. The marginal
likelihood of the model is approximated by Laplace approximation considering the
joint likelihood and an adjusted term. Nevertheless, we show that the adjusted
term does not carry any information about the fixed effects and consequently, the
approximation can be done by means of the joint likelihood. A delta method based
procedure is proposed for the estimation of the fixed effects and the prediction of the
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random effects. However, in order to estimate the dispersion parameters (i.e., φ from
the beta-binomial distribution and the variance of the random effects), a penalisation
of the likelihood is performed to avoid the bias due to the successive estimation of
fixed and random effects in an iterative algorithm. We compare our proposal with
similar approaches in the literature, such as generalised additive models for location,
scale and shape (GAMLSS). The main difference between GAMLSS and BBmm
approaches lies in the penalisation of the likelihood used in BBmm to estimate the
dispersion parameters. We show through a simulation study that the penalisation
does not only improve the estimation of the dispersion parameters in terms of the
reduction of the bias, but also in the estimates of the rest of the parameters in the
model.
We apply the BBmm approach to the COPD longitudinal study where clinically
relevant and valid results about the evolution of patients with COPD are obtained.
However, either by BBreg or BBmm approaches, each dimension provided by PRO
questionnaires is analysed separately. In general, a PRO may be interpreted as
a multivariate outcome constructed by responses of the same patients that may
have some correlation and hence, we extend the BBmm model to a multivariate
approach. In this thesis, we develop a mixed-effects regression approach, called the
shared random effects model, for the joint analysis of all the dimensions in the same
PRO questionnaires. The model assumes that each individual has the same random
effect across all the dimensions. The implementation of this model under the mixed-
effects beta-binomial framework proposed in this thesis is straightforward and it also
has the advantage that the complexity of the model is not increased by the number
of PRO dimensions. We apply this model in both cross-sectional and longitudinal
COPD data, leading to clinically and statistically relevant results compared to the
individual analysis of each PRO dimension.
We also implement all the methodology proposed in this thesis in an R-package
called PROreg which is available at CRAN. The package includes the regression
models developed in this thesis and other functionalities.
The research of this thesis leads the way for some future work that must be con-
sidered. For instance, we show that the proposed shared random effects model has
some limitations when dealing with longitudinal multivariate data and hence, the use
of different but correlated random effects structures would be of interest for further
research. However, the correlated random effects approach leads to Laplace’s ap-
proximation problems in the marginal likelihood when more than two dimensions are
jointly analysed. Techniques for dealing with the mentioned limitation are discussed
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in the thesis within the beta-binomial framework. Additionally, several proposals
are left as future work: (i) joint modelling of mean and variance components in
BBmm approach, (ii) joint analysis of survival and longitudinal PROs, (iii) testing
of the variance components in the proposed models; and (iv) inclusion of non-linear
covariate effects in BBmm approach.
In conclusion, in this thesis we develop several regression approaches based on
the beta-binomial distribution for the analysis of PROs. Moreover, although the
illustration of the models is only performed in PRO context, they can also be useful
in any U, J or inverse J-shaped discrete and bounded data (due to overdispersion).
In fact, this type of data can appear in different contexts and research fields, such as
Finance (e.g. the estimation of the probability of a claim in an insurance product),
or Biology (e.g. presence/absence of species or bacteria in agricultural experiments).
The implementation of the methodology through the PROreg R-package provides a
useful tool that clinical researchers can use for statistical modelling in a wide variety
of studies in order to draw conclusions from PROs.
LABURPENA
Gaur egun, gero eta ohikoagoa da pazientiearen inguruan oinarritutako osasun sis-
tema, zeinak pazientetik eratorritako behaketak (PEBk) darabiltzan. PEB pazien-
tearengandik zuzenean, inolako medikuren bitartekaritza zein interpretazio gabe,
pazientearen osasun egoeraren, bizi kalitatearen edo gaixotasun zein tratamentu-
arekin lotutako egoera funtzionalaren edozein neurketa da. PEBk oinarrizko be-
haketa modura erabiltzen hasi diren ikerketen kopurua etengabe ari da hasten,
izan ere, PEBek pazienteen osasun egoeraren informazioa isladatzen diete ikertza-
ile zein medikuei eta gaixoen zaintza hobe dezaketen datuak eskaini. Are gehi-
ago, badira, informazio osoagoa lortu nahiean, indikadore objektiboak PEBekin
ustartzearen garrantzia nabarmentzen duten hainbat ikerketa. Orokorrean, PEBk
puntuazio eskaladun inkesten bitartez lortzen dira, zenbait galderaz osatua dau-
denak, galdera horiek taldeka edo dimentsioka multzokatuta egonik. Gaixotasun
zehatzentzat garatutako inkestak zein inkesta orokorrak, populazio osasuntsuan ere
aplika daitezkenak, existitzen dira. Normalean, PEBk pazienteak ihardetsi behar-
reko galderen erantzun posibleak puntuatuz eta puntuazio horiek taldeka batuz
kalkulatzen dira. Ondorioz, paziente bakoitzak neurtu nahi den PEBren puntuazio
zehatz bat lortzen du multzokatze irizpide izan den dimensio bakoitzean. Azkenik,
lortutako puntuazioen eskala eraldatzen da normalean. Beraz, PEBek izaera oso
eta bornatua daukate eta, orokorrean, balioak puntuazio eskalaren alde batetan zein
bietan multzokatzen dituzte, familia exponentzialeko banaketek ondo dohitzerik ez
duten U, J edo alderantzizko J itxurak aurkeztuz.
Familia exponentzialeko kideek daukaten dohikuntza gabezia gainditze aldera,
banaketa beta-binomiala proposatua izan da literaturan PEB analizatzeko, dohikuntza
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egokiak lortuz. Banaketa beta-binomiala, izenak adierazi bezala, banaketa binomial
eta beta banaketa baten arteko nahastura bat da, edo baliokidea dena, zorizko beta
banaketa darraien probabilitate parametrodun binomiala da,
Y |θ ∼ Bin(m, θ) non θ ∼ Beta (α1, α2)
non α1, α2 > 0. Banaketa beta-binomialaren itxaropen baldintzatu eta marginalak
hurrenez-hurren, hurrengo formulak emanak dira,
E[Y ] = m
α1
α1 + α2
, Var[Y ] = m
α1
α1 + α2
[
1 + (m− 1) 1
α1 + α2 + 1
]
,
E[Y |θ] = mθ, Var[Y |θ] = mθ(1− θ),
non dentsitate funtzio marginala
f(y) =
∫ 1
0
f(y|θ)f(θ)dθ =
(
m
y
)∫ 1
0
θy(1− θ)m−y θ
α1−1(1− θ)α2−1
B(α1, α2)
dθ
=
(
m
y
)
Γ(α1 + y)
Γ(α1)
Γ(α2 +m− y)
Γ(α2)
Γ(α1 + α2)
Γ(α1 + α2 +m)
den. Nabaria da banaketa beta-binomialaren dentsitate funtzioaren konplexuta-
sunaz ohartzea, eta bide batez, familia exponentzialaren parte ez dela konturatzea.
Helburua zenbait koaldagaiek PEBetan duten eragina aztertzea eta neurtzea de-
nean, erregresio ereduak eredugintza estatistikoaren herramintarik erabilienetakoa
dira. PEBk dohitzerako orduan banaketa beta-binomialak emaitza oso onak lortzen
baditu ere, familia exponentzialaren parte ez izateak murriztu egin du banaketa hor-
retan oinarritutako erregresioen erabilera. Izan ere, aplikazio praktikoan gehienetan
erabiltzen diren erregresio lineal orokortuek (ELOek) zein erregresio lineal orokortu
mixtoek (ELOMek), menpeko aldagaiaren banaketa familia exponentzialaren parte
izatea suposatzen dute ezinbestean.
Galdakaoko Ospitaleko arnaskatze zerbitzuko ikertzaileek birikietako burtxadura
kroniko gaixotasuna (BBKG) zuten pazienteen osasun egoeraren denboran zehar-
reko neurketak gauzatu zituzten. BBKG birikietako gaixotasun nahiko larria da,
munduko heriotz tasa handienetarikoa duena. Bestalde, ezintasun fisiko zein men-
tal handiekin lotzen den gaixotasuna da. Osasunaren Mundu Erakundearen iritziz,
2020. urterako gaixotasunek eragindako hirugarren heriotza kausa bilakatuko da.
Ikerketa honen helburua BBKG pairatzen duten pazienteen osasun egoera aztertzea
da eta, bost urtetan zehar aztertuak eta neurtuak izan diren pazienteen osasun gara-
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pena neurtzea. Pazienteen osasun egoera neurtzeko bi inkesta ezberdin erabili ziren:
batetik, inkesta generiko bat, Short Form-36 Osasun Inkesta, eta bestetik, biriki-
tako gaixotasunak aztertzeko inkesta espezifiko bat, St George Arnaskatze Inkesta.
Osasunaren egoeraren neurketa hauekin batera, denboran zehar aldakorrak zein es-
tatikoak diren beste zenbait aldagai ere neurtu zituzten, erregresio eredugintzan
koaldagai modura erabiliko direnak.
Tesi honen helburu nagusia denboran zeharreko zein korrelaturiko PEB datuak
aztertzeko banaketa beta-binomialean oinarritutako erregresio eredu bat garatzea
da. Aldi berean, helburu nagusi hau beste bost azpi-helburutan banatzen da: (i) lit-
eraturan ageri diren banaketa beta-binomialean oinarritutako erregresioen berrikuste
eta komparaketa; (ii) banaketa beta-binomialetik eratorritako datu korrelatu zein hi-
erarkikoen, bereziki denporazko datuen, azterketa ahalbidetuko duen eredua garatzea;
(iii) PEBen inkestek eragiten dituzten dimentsio guztiak amankomunean aztertuko
dituen eta banaketa beta-binomialean oinarrituko den eredu multidimentsionala pro-
posatzea; (iv) garaturiko eredu guztiak software askean implementatzea zientzia eta
ikerketa komunitateari baliagarria izan dakizkion; eta, (v) BBKG pairatzen duten
pazienteen ikerketan garaturiko ereduak aplikatzea eta klinikoki esanguratsuak diren
emaitzak ondorioztatzea.
Banaketa beta-binomialean oinarritutako lehen erregresio ereduak neurketen arteko
askatasuna beharrezkoa du eta hurrengo eredu konplexuagoak garatzeko giltzarria
izango da. Banaketa beta-binomialaren ikuspegi marginal edo baldintzatuaren arabera
erregresio eredu ezberdinak gara daitezke. Alde batetik, eredu marginala, BBreg de-
ritzoguna, banaketa beta-binomialaren parametroen eraldaketa batean oinarritzen
da, α1 = p/φ eta α2 = (1 − p)/φ non 0 < p < 1 eta φ > 0. Eraldaketa horre-
tan oinarriturik, banaketaren itxaropen marginala E[Y ] = mp moduan definitzen
da eta ondorioz, p probabilitate parametro modura interpreta daiteke; era berean,
Var[Y ] = mp(1 − p) [1 + (m− 1)φ/(1 + φ)], φ dispertsio parametro moduan zehaz-
tuz. Ondorioz, erregresio logistikoarekin egin antzera, logit funtzio lokailua aplika
dakioke probabilitate parametroari eta ereduan erabili nahi ditugun koaldagaiekin
erlazionatu herrengo ekuazioen bitartez,
Yi ∼ BB(mi, pi, φ),
logit
(
pi
1− pi
)
= x′iβ,
non mi i. neurketak lor dezaken puntuazio kopuru altuena den (edo batutako al-
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gai binario kopurua), β erregresioaren koefizienteak eta xi koaldagaiek definitzen
duten hein osoko X matrizearen i.garren errenkada den, i = 1, . . . , n. Parametroen
estimazioa egiantz handieneko prozedura erabiliz gauzatzen da. Beste alde batetik,
BBhglm deritzogun eredu baldintzatua erregresio linear okortu hierarkikoetan (ELOH)
oinarritzen da non Gaussiarrak ez diren zorizko efektuak ere gaineratu daitezkeen
ELO baten aurresale linealean. Ereduak suposatzen du behaketek beta banaketa
darraiten zorizko efektu batzuek baldintzatutako banaketa binomial bat darraitela.
Ondorioz aldagaiaren itxaropen baldintzatuan erregresio logistiko bat ezarri eta
zorizko beta efektuak gaineratzen ditu aurresale linealean,
Yi|ui ∼ Bin(mi, pi), non ui ∼ Beta(1/λ, 1/λ),
logit
(
pi
1− pi
)
= x′iβ + logit
(
ui
1− ui
)
,
non β efektu finkoak, ui zorizko efektuak, xi koaldagaiek osatutako hein osoko
matrizearen i. errenkada eta λ zorizko efektuen banaketaren parametro positiboa
diren, i = 1, . . . , n. Helburua koaldagaiek PEBn duten eragina aztertzea denean,
tesi honetan erakusten dugu, aplikazio erreal zein simulazio azterketa baten bitartez,
eredu marginalak emaitza hobeak lortzen dituela estimazioaren adierazgarritasun
estatistikoari dagokionez eta, are gehiago, oso interpretazio txukuna eskaintzen duela
odds-ratioen bitartez.
BBreg ereduak behaketen arteko askatasuna bere egiten du eta ondorioz, hedapen
bat beharrezkoa da datu korrelatuak aztertu nahi badira, denboran zeharreko datuak
kasu. Tesi honetan BBreg eredua zorizko efektuen alorretik hedatzen dugu, banaketa
normala darraiten zorizko efektuak ereduaren aurresale linealean txertatuz,
Yi|u ∼ BB(mi, pi, φ), where u ∼ N (0,D),
logit
(
pi
1− pi
)
= x′iβ + z
′
iu,
non u zorizko efektuak, zi datuen korrelazio egitura zehazten duen Z diseinu ma-
trizearen i. errenkada eta D zorizko efektuen bariantza-kobariantza matrizea diren,
i = 1, . . . , n. Hortaz, zorizko efektuek behaketen arteko korrelazioa berenganatuko
dute. Ereduri honi BBmm deritzogu. Baldintzatutako banaketa beta-binomiala dela
eta, ELOMen estimazio teoria ez da kasu honetan aplikagarria eta ondorioz, esti-
mazio eta inferentzia prozedura zehatza garatu dugu. Ereduaren egiantz marginala
Laplacen hurbilketa erabiliz kalkulatzen da egiantz bateratuaren eta penalizazio gai
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baten bitartez. Hala ere, tesi honetan penalizazio gaiak efekto finkoen inguruko
informaziorik eskaintzen ez duela erakusten dugu, beraz, zorizko efektu zein efektu
finkoen estimazioa egiantz bateratua erabiliz egin daitekeela ondorioztatu. Ere-
duko efektuen estimazioa gauzatzeko delta metodoan oinarritutako prozedura bat
garatzen da. Dena den, ereduko dispertsio parametroak (banaketa-beta binomi-
alaren dispertsio parametroa φ eta zorizko efektuen bariantza) estimatzerako ord-
uan, aurrez gauzaturiko zorizko zein efektu finkoen estimazioak sor dezakeen alb-
orapena ekiditeko, egiantz batertuari penalizazio irizpide bat ezartzen zaio. Gure
eredu proposamena literaturan aurki daitezkeen antzeko ereduekin alderatzen dugu,
lokalizazio, eskala eta itxurazko eredu batukor orokortuekin (LEIEBO) bereziki.
Proposaturik BBmm eta LIEEBO ereduen arteko ezberdintasunik nabariena dispert-
sio parametroak estimatzeko orduan egiantz bateratuan gauzatzen den penalizazioan
datza. Simulazio azterketa baten bitartez penalizazioak dispertsio parametroen es-
timazioaren alborapena murrizteaz gain, gainerako parametro guztien estimazioaren
alborapena ere murrizten duela erakusten dugu.
BBmm eredua BBKG pairatzen duten pazienteen luzerazko ikerketan aplikatu
dugu, klinikoki esanguratsuak eta baliagarriak diren emaitzak lortuz. Hala ere, orain
arteko azterketa erreal guztietan, BBreg zein BBmm ereduak erabiliz, PEBk osatzen
dituzten dimentsioak banan-banan analizatu ditugu, haien artean egon litekeen ko-
rrelazioa kontuan hartu gabe. Izan ere, paziente berberek beteriko inkesten er-
antzunetatik sortzen dira dimentsioak, beraz, paziente berberak dimentsio ezberdine-
tan lortutako puntazioen artean korrelazioa egon daitekela pentsatzeak logikoa dirudi.
Hori dela eta, luzerazko datuetarako proposaturiko BBmm eredua analisi multi-
demensionalak gauzatzeko garatu dugu. Tesi honetan, eredu unidimentsionaletik
multidimentsionalerako pausua eredu mixtoak erabiliz garatzen da, partekaturiko
zorizko efektuen ikuspuntutik. Ereduak dimentsio guztiek zorizko efektu amanko-
muna partekatzen dutela suposatzen du eta modu horretan, korrelazio egitura bat
gaineratzen dio ereduari. Eredu honen inplementazioa, estimazio zein inferentzia
aldetik, zuzena da aurretik garaturiko BBmm ereduan oinarrituz. Azterketa multi-
dimentsionalak gauzatzeko litearturan zenbait eredu existitzen diren arren, parteka-
turiko zorizko efektuen ereduaren aukerateka, nagusiki, dimentsioak gehitu ahala
ereduaren konplexutasuna handitzen ez delako egin dugu, eta beraz, garaturiko
egiantz hurbilketa guztiek egokiak izaten jarraitzen dute. Eredua BBKG duten
pazienteen datu basean aplikatu dugu, paziente bakoitzaren lehen neurketa bakarrik
zein denbora zeharreko neurketa guztiak kontsideratuz. Datu errealetarako ered-
uaren aplikazioak emaitza kliniko zein estatistiko baliagarriak eskaintzen ditu.
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Besteak beste, komeni da aipatzea, garaturiko banaketa beta-binomialean oinar-
rituriko eredu guztiak R software estatistikoan, PROreg paketearen bitartez, inple-
mentatu ditugula, dagoeneko CRAN-en erabiligarri dagoena. Paketeak, aipaturiko
ereduez gain, PEBk aztertzerako orduan baliagarriak izan daitezkeen beste zenbait
funtzio ere gaineratzen ditu.
Tesi honetan zehar garaturiko ikerketak etorkizunean aztertuko beharreko zen-
bait alorren azaleratzea eragin du ezinbestean. Adibidez, partekaturiko zorizko
efektuen ereduak, aplikagarritasunari dagokionean, erreztasun ugari eskaintzen ba-
ditu ere, luzerazko datuen azterketa multidimentsionala garatzeko orduan emaitzen
egokitasuna kolokan jarri dezakeen mugak ere badituela erakusten dugu. Mugak
gainditze aldera, irtenbide bat zorizko efektu ezberdin baina korrelatuak dimentsio
bakoitzean aplikatzea da. Hala ere, zorizko efektu korrelatuen eredu honek egiantz
marginalaren integralaren dimentsioa nabarmen handitzen du PEBk osatzeen diz-
tuzten eta aztergai diren dimentsio kopurua handituz gero. Integralaren dimentsioa
areagotzeak hurbilketa tekniken egokitasun eza dakar, BBmm ereduan garaturiko
Laplacen hurbilketarena adibidez. Hala eta guztiz ere, hurbilketen ezegokitasun
hau gaindituko luketen teknika ezberdinen inguruko eztabaida bat ere garatzen da
tesian. Bestalde, zenbait proposamen ere etorkizunean garatzeko aukera moduan
uzten dira: (i) BBmm ereduaren itxaropen eta bariantza parametroen modelizazio
bateratua, (ii) PEBen luzerazko eta biziraupeneko analisi bateratua, (iii) proposat-
uriko ereduen bariantza parametroen estimazioaren inferentzia, eta (iv) koaldagaien
efektu ez linealen gainerapena BBmm ereduan.
Azkenik, borobiltze aldera, tesi honetan PEBk aztertzeko banaketa beta-binomialean
oinarrituriko zeinbait erregresio eredu garatu ditugu. Hala ere, ereduen ilustrazioa
PEBen kontextuan irudikatu badugu ere, U, J edo alderantzizko J itxura duten datu
oso eta bornatuetan ere aplikagarriak izan daitezke. Izan ere, datu mota hau testuin-
guru zein aztergai diren arlo askotan ageri da, Finantzak (aseguru etxeetan beze-
roen produktu eskaera ezberdinen probabilitatea neurtzeko adibidez) eta Biologia
(laboraltza experimentuetan bakteria edo espezie zehatz baten presentzia/absentzia
aztertezko adibidez) hurrenez-hurren. Are gehiago, garaturiko metodologia PROreg
R-paketean inplementatua egoteak herreminta oso erabilgarria eta zuzena eskaintzen
die kliniko zein ikertzaileei beta-binomialean oinarritutako ereduak aplikatu ahal iza-
teko eta bide batez, emaitza erabilgarri zein adierazgarriak ondorioztatzeko euren
ikergaiaren inguruan.
CHAPTER 1
INTRODUCTION TO
PATIENT-REPORTED OUTCOMES
“Deus ez da inorena, bizitza bera ere ez”
Xabier Lete, 1944− 2010
1.1 Patient-reported outcomes
Patient-reported outcome (PRO) measurements are increasingly used as primary
outcome measures in observational and experimental studies, which play an im-
portant role in health care and understanding health outcomes. A PRO is any
report on the status of a patient’s health condition that comes directly from the
patient, without interpretation of the patient’s response by a clinician or anyone
else (US Department of Health and Human Services, 2012). PROs are used to sub-
jectively assess outcomes, such as pain, quality of life or satisfaction with care, that
are difficult or impossible to measure physically without a patient’s evaluation and
whose key questions require patient’s input on the impact of a disease or treatment.
Consequently, PROs inform clinicians and researchers about issues associated with
health-status that are most important to patients and their families (Dobrozsi and
Panepinto, 2015) and generate data to facilitate improved care of the patient. In ad-
dition, PROs have gradually become an important element and a crucial source for
monitoring disease conditions or assessing the effectiveness of treatment, especially
in some health problems such as subjective discomfort and psychological distress
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(Chang, 2007). Therefore, the U.S. Food and Drug Administration (FDA) has rec-
ommended that objective indicators combined with PROs would be considered a
more comprehensive form of outcome evaluation since 2006 (Speight and Barendse,
2010).
PROs are usually obtained using rating scale questionnaires, which are made up
of questions, called items, grouped into one or more subscales, often called dimen-
sions or domains. The patient is presented with a series of related items and is
asked to respond with ordered categories that represent magnitude estimates of his
or her personal experience related to the content of the items. The term instrument
is used to refer to the collection of items and response categories. Traditionally,
PRO instruments have been scored by assigning rank scores to the patient’s item
responses, summing the scores across a group of items and creating overall scores
by dimensions that are usually rescaled.
PROs provide composite scores, one by dimension, from a series of questions
around a central concept to quantify the level of distress or impairment caused by a
patient’s symptoms, disease, or treatment. A variety of PROs has been developed
and validated to assess symptoms (such as nausea and vomiting, insomnia, constipa-
tion, and pain), patient physical, social, and emotional function, and more complex
constructs such as the impact of health on peer relationships. There are generic and
disease-specific questionnaires that can be used to measure these outcomes, as well
as available measures for the use in pediatric and adult patients.
Therefore, PROs are important supplements to traditional medicine as they offer
a new insight of the health-status of patients. Indeed, some decades ago the World
Health Organization (WHO) defined the health as a complete physical, mental and
social welfare, and not only as a disability or lack of disease. In this context a new
concept appeared, the Health-Related Quality of Life (HRQoL). The measurement
of HRQoL provides information about the disease and its impact on the patient in
a standardised, comparable and objective way (Goldsmith, 1972). Indeed, HRQoL
is a general PRO which is being increasingly used as an outcome in clinical trials,
effectiveness research, and research on quality of care (Wilson and Cleary, 1995).
Factors that have facilitated this increased usage include the accumulating evidence
that measures of HRQoL are valid and reliable (McDowell and Newell, 1987), the
publication of several large clinical trials showing that these outcome measures are
responsive to important clinical changes (Croog et al., 1986) and the successful
development and testing of shorter instruments that are easier to understand and
administer (Hunt et al., 1985). Because these measures describe or characterise
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what the patient has experienced as the result of medical care, they are useful and
important supplements to traditional physiological or biological measures of health-
status.
In fact, measuring HRQoL or, PROs in general, can help determine the burden
of preventable disease, injuries, and disabilities, and it can provide valuable new
insights into the relationships between HRQoL and risk factors. Therefore, to study
the relationship of HRQoL with patient and disease characteristics has become one
of the primary aims of many PROs studies. In this framework, regression models are
necessary in order to assess the effect that clinical and socio-demographic variables
have on the HRQoL of individuals.
There exist some well-designed studies that emphasise the utility of PROs (Au
et al., 2010) especially for patients with chronic diseases. For instance, patients
with cancer commonly experience symptoms that lead to impaired physical func-
tion, emotional function and social function resulting in decreased health-status
(Fisch et al., 2012). However, patient symptoms often go undetected during typi-
cal clinic interviews, and therefore, clinicians may underestimate the impact of the
symptoms from interview alone (Buckner et al., 2014). The impact of cancer and
cancer treatment on patient health-status can be systematically quantified by PROs
(Montazeri, 2008). The use of PROs in these populations has identified symptoms
and impairments in patient function. Moreover, cancer patients with better symp-
tom management and better PRO scores live longer with less distress (Montazeri,
2009). PROs generate data that can facilitate better care regardless of diagnosis or
prognosis for patients with cancer or other chronic illnesses.
Once the nature of the PROs has been defined, and the validity of different stud-
ies has been illustrated, this chapter will continue as follows. In the next section,
we introduce some PRO instruments in the form of questionnaires, we describe the
health aspect they assess and introduce some specific characteristics such as the
number of items or number of health dimensions they provide. In Section 1.3 we
describe two PRO studies carried out for measuring different aspects of the health-
status for different disease patients. This data will be used to validate the proposed
methodology throughout this thesis. In Section 1.4 we describe the statistical fea-
tures of PROs which make commonly used modelling techniques inappropriate in
this framework. We focus our attention on the distributional fit of the PROs pro-
vided in each dataset. Finally, in Section 1.5 we describe the structure an objectives
of the thesis.
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1.2 Measuring instruments: Questionnaires
PROs are measured through instruments to assess for instance, the health-status or
HRQoL of patients. Different measuring instruments have been developed in the
literature, most of them in the form of questionnaires, which decompose the health
aspect they evaluate in different dimensions. Some questionnaires can be provided to
patients with different diseases or healthy subjects, and they are considered generic
questionnaires. On the contrary, others are designed for subjects with specific dis-
eases, the so-called specific questionnaires. Each survey contains a different number
of dimensions and decomposes each dimension in a different score scale. In Section
1.3 we are going to present two different PRO studies which contain measurements
provided by patients with different diseases. In the first study patients with Chronic
Obstructive Pulmonary Disease (COPD) were recruited and their health-status was
measured by means of two different questionnaires, one generic and the other pul-
monary diseases specific. The second study is focused on the assessment of dementia
where a specific questionnaire was used to measure the cognitive status of patients.
First, we describe the Short Form-36 (SF-36) Health Survey, a generic question-
naire which is broadly used for different populations. It provides measurements of
the HRQoL of patients in eight dimensions. The scores provided by the SF-36 in
COPD patients will be analysed in Chapter 2 and Chapter 4. Second, we describe
the St. George’s Respiratory Questionnaire (SGRQ), a specific questionnaire for
chronic airflow limitation diseases. It measures the HRQoL and the impact of the
disease in the patients and it provides three different dimensions. The same as the
SF-36, it has also been applied to patients with COPD. Therefore, the HRQoL of pa-
tients with COPD has been assessed by means of two different PRO questionnaires,
one generic and the other disease-specific. The information provided by the SGRQ
will be analysed in Chapter 3 and Chapter 4. Finally, we introduce the Mini Mental
State Examination (MMSE) which was developed for measuring the cognitive status
of individuals. It only provides one dimension that covers seven cognitive aspects.
Outcomes provided by the MMSE will be analysed in Chapter 3.
It is worth mentioning that while the SF-36 is a generic questionnaire, the MMSE
and SGRQ were developed for specific diseases. In fact, each questionnaire analyses
different aspects of the health-status of patients and provides different measures.
Therefore, we consider that the analysis of the cited questionnaires by different
methodologies will provide a global view of PROs and it will furnish the reader with
different techniques to deal with any other PRO.
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1.2.1 Short Form-36 Health Survey
The SF-36 Health Survey was developed within the Medical Outcomes Study (Ware
et al., 1993) and it is one of the most widely used generic instruments. It mea-
sures generic HRQoL concepts, and it provides an objective way to measure HRQoL
from the patients’ point of view by scoring standardised responses to standardised
questions. The validity and reliability of this instrument have been broadly tested
(Stansfeld et al., 1997).
The SF-36 questionnaire has 36 items, with different answer options. It was
constructed to represent eight health dimensions, which are physical functioning
(PF), role physical (RP), bodily pain (BP), general health (GH), vitality (VT), social
functioning (SF), role emotional (RE) and mental health (MH). Each item is assigned
to a unique health dimension. Each of the eight multi-item dimensions contains two
to ten items. The first four dimensions are mainly physical, whereas the last four
measure mental aspects of HRQoL. The standardised scoring system is thoroughly
described by the original authors (Ware et al., 1993). Briefly, each score is calculated
with an algorithm based on the original items assigned to this dimension. For each
dimension, the answers to the items are first recoded and then added in a weighted
sum fashion. The resulting raw scores are then transformed to standardised scale
scores from 0 to 100, where a higher score indicates a better health-status.
In order to provide a better understanding of the construction of the SF-36
Health Survey dimensions, we show in Table 1.1 the number of items related to each
dimension and the number of possible values each dimension can obtain.
Table 1.1: Number of items related to the construction of each SF-36 dimension and
the number of values each dimension can obtain.
Dimension No. of items No. of possible values
Physical functioning 10 21
Role physical 4 5
Bodily pain 2 27
General health 5 39
Vitality 4 21
Social functioning 2 9
Role emotional 3 4
Mental health 5 26
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Consequently, the SF-36 Health Survey generates a profile of HRQoL outcomes
on eight health dimensions. Additionally, the SF-36 includes an item related to
health transition, which is not used in the scoring of the eight health dimensions.
The authors of the SF-36 Health Survey also provide normative scores for each
health dimension. Each SF-36 score is first standardised using the mean and stan-
dard deviations obtained from the general population and then transformed to a
norm-based (mean=50, standard deviation = 10) scoring (Ware et al., 1993). Two
summary measures, one physical and one mental, can be created from the eight
main domains. These two summary scores are generated using the physical and
mental factor score coefficients from the general population, and they are also trans-
formed to norm-based scoring (Ware et al., 1994). However, we have used neither
norm-based scores nor summary scores in this work.
Finally, it is worth mentioning that the SF-36 was rated in 2002 by the British
Medical Journal (Garratt et al., 2002) as the most frequently used PRO of generic
health in the scientific publications.
1.2.2 St. George’s Respiratory Questionnaire
The SGRQ was designed to quantify the impact of chronic airflow limitation on
health and perceived well-being (quality of life), and to be sufficiently sensitive to
respond to changes in disease activity (Jones et al., 1991). The SGRQ can provide
a psychosocial impact profile of these patients that cannot be identified by the tests
of lung function. Clinically, it has been shown to be a valuable tool in quantify-
ing the impact of chronic obstructive airways diseases on the symptom, functional
measures and well-being (Doll et al., 2003; Peruzza et al., 2003) and in evaluating
the effectiveness of health care (Singh et al., 2001). Compared to other chronic
airflow limitation specific questionnaires, it offers standardised measures. In fact,
the absence of suitable sensitive and standardised questionnaires of health and well-
being limits the application and value of quality of life measurements in respiratory
medicine, as if the questionnaire is not standardised between patients, it is difficult
to compare different studies and different study populations (Jones et al., 1992).
The SGRQ consists of 50 items. Principal-component analysis of the responses
to these items supported the partition of the questionnaire into three sections or
dimensions. The first, symptoms, contains items concerned with the level of symp-
tomatology, including frequency of cough, sputum production, wheeze, breathless-
ness, and the duration and frequency of attacks of breathlessness or wheeze. The
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second, activity, is concerned with physical activities that either cause or are limited
by breathlessness. Finally, the last dimension corresponds to the impacts and it
covers such as employment, being in control health, panic, stigmatisation, the need
for medication and its side effects, and expectations for health and disturbance of
daily life. Items specifically relating to the anxiety and depression were not included
in the SGRQ, since many established measures exist for this area of health. Each of
the three dimensions of the questionnaire is scored separately in the range 0 to 100,
zero score indicating no impairment of life quality. Additionally, a summary score
utilising responses to all items is constructed, which is defined as the total SGRQ
score. This score also ranges from 0 to 100, where a lower score means a better
health-status. More details about the construction of the scores can be found at
Quirk and Jones (1990).
1.2.3 Mini Mental Score Examination
The MMSE is a questionnaire that measures the cognitive mental status of patients
(Folstein et al., 1975). The objective of the survey is to offer a brief screening
tool to provide a quantitative assessment of cognitive impairment and to record
cognitive changes over time. The MMSE consists of 11 simple questions grouped
into 7 cognitive domains: orientation to time, orientation to place, registration of
three words, attention and calculation, recall of three words, language and visual
construction. It only requires 5-10 minutes to the administer, which makes it very
practical to use serially and routinely. In fact, it has become one of the most popular
psychometric tests used to quantify global cognitive functioning and cognitive change
in population-based longitudinal studies. It is only based on the cognitive aspects
of mental functions of patients, avoiding questions about mood, abnormal mental
experiences and the form of thinking.
The MMSE is divided into two parts, the first one covers orientation, memory,
and attention, and the second part covers the ability to follow verbal and written
commands. The maximum score number an individual can obtain is 21 in the first
part and 9 in the second, therefore, a possible score of 30 is used to provide a
picture of an individual’s present cognitive performance based on direct observation
of completion of test items, where a higher value means a better cognitive status.
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1.3 Motivating data
1.3.1 COPD Study
Chronic obstructive pulmonary disease is one of the major causes of mortality world-
wide and it is associated with high level of disability (Pauwels and Rabe, 2004).
Some well-designed studies have found a measured prevalence of COPD in Europe
between 4% and 10% of adults, and it is expected to increase over the next years
(Halbert et al., 2003; Buist et al., 2008). According to estimates from the World
Health Organization (WHO), by 2020 it shall become the third most frequent cause
of death, following coronary and cerebrovascular diseases (Murray and Lo´pez, 1997).
COPD is a respiratory system disease with irreversible damage of pulmonary and
bronchial tubes, which represents the state of chronic airflow limitation (Jones and
Higenbottam, 2007). It not only causes physiological discomfort but also has a psy-
chosocial influence on individuals. The clinical assessment of COPD often involves
measurement of lung function parameters (e.g. FEV1) and exacerbation level of a
patient to evaluate the disease progress and the therapeutic effect (Cosio and Agust´ı,
2010). However, the overall impact of COPD on individuals is multi-faceted and not
entirely reflected by these clinical parameters. For this reason, it is now realised that
no single measure can adequately reflect the nature or severity of COPD and it often
needs to be supplemented by other indicators from a patients perspective, such as
those related to PROs or HRQOL. To date, evaluation of the treatment effect has
emphasised the improvement of the quality of life rather than the small gains in
survival rate or physiological indicators (Wiklund, 2004).
Researchers at the Respiratory Service at Galdakao Hospital in Spain designed
the COPD Study, a longitudinal study whose main goal was to measure the health-
status and evolution of patients being treated for COPD. Patients were recruited
at five outpatient respiratory clinics affiliated with the hospital and consecutively
included in the study for one year, starting in January 2003. Patients were eligible
for the study if they had been diagnosed with COPD for at least six months and they
had been receiving medical care at one of the hospital respiratory outpatient facilities
for at least six months. Their COPD had to be stable for six weeks before enrolment.
Patients were followed for up to five years. Two main outcome measurements were
collected: (i) Generic HRQoL was measured using version 1.2 of the SF-36 Health
Survey (see Section 1.2.1), which corresponds to the version 1.4 of the Spanish
version. (ii) Respiratory specific health-status was measured with the SGRQ (see
Section 1.2.2). In addition, a set of selected time independent and time dependent
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variables recoded in the study and considered as covariates for the models were
socio-demographic variables such as gender and age at entry in the cohort, together
with forced expiratory volume in one second in percentile (FEV1%), body mass
index (BMI), dyspnea (measured with the modified scale of the Medical Research
Council, (Mahler et al., 2009)), the 6-minute walking tests (American Thoracic
Society, 2002) and presence of anxiety and depression measured by the Hospital
Anxiety and Depression (HAD) scale (Zigmond and Snaith, 1983) among others.
Esteban et al. (2016) divided the individuals participating in the COPD Study
in some clusters where four subtypes were identified. They conclude that subtypes
A, B, and C, had marked respiratory profiles with a continuum in severity of several
variables, while the fourth, subtype D, had a more systemic profile with intermedi-
ate respiratory disease severity. Subtype A was associated with less dyspnea, better
HRQoL and lower comorbidity, and subtype C with the most severe dyspnea, and
poorer pulmonary function and quality of life, while subtype B was between sub-
types A and C. Subtype D had higher rates of hospitalization the previous year and
comorbidities.
Table 1.2 shows a socio-demographic and clinical summary of the collected time
independent and time dependent exploratory variables. Both discrete and continu-
ous variables are analysed for the different time points. On the one hand, for the
discrete exploratory variables, the number of individuals in each level and the pro-
portion are shown. On the other hand, for the continuous covariates, the mean and
the standard deviation for each time point are displayed. Additionally, Table 1.2
shows the number of individuals that remain in the cohort for different time points.
In terms of the descriptive analysis of the response measurements in the COPD
Study, Table 1.3 shows the mean and standard deviation of the original standardised
scores of the SF-36 and the row scores of the SGRQ. In general terms, it can be
appreciated that the passing of time affects each dimension of both questionnaires
differently. Regarding SF-36 dimensions, Table 1.3 shows that while in some dimen-
sions the mean and standard deviation of the original standardised scores change
considerably as the time goes by (e.g. role physical), there are some others that
hardly change (e.g. physical functioning). Moreover, it can be appreciated that
patients with COPD get the worst results in average in physical dimensions such as
physical functioning, role physical or general health. In addition, it is worth noticing
that the largest variability occurs in role physical and role emotional dimensions. In
fact, these are the dimensions with the lowest number of possible values (see Table
1.1), and hence, the standardisation to the 0-100 scale scatters more the scores than
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Table 1.2: Descriptive analysis of the covariates in the COPD Study.
Time framework
Baseline 1-Year 2-Years 5-Years
No. Individuals n = 543 n = 480 n = 425 n = 324
Discrete variables n (%) n (%) n (%) n (%)
Sex∗
Male 522 (96.13) 459 (95.62) 405 (95.29) 308 (95.06)
Female 21 (3.86) 21 (4.38) 20 (4.71) 16 (4.94)
Cluster∗
A 164 (30.20) 157 (32.70) 148 (34.82) 137 (42.28)
B 195 (35.91) 177 (36.87) 155 (36.47) 114 (35.18)
C 89 (16.39) 71 (14.79) 60 (14.12) 39 (12.04)
D 95 (17.50) 75 (15.64) 62 (14.59) 34 (10.50)
Anxiety
No 459 (84.51) 409 (85.21) 368 (86.59) 265 (81.79)
Yes 84 (15.47) 71 (14.79) 57 (13.41) 59 (18.21)
Depression
No 506 (93.19) 439 (91.46) 389 (91.53) 299 (92.28)
Yes 37 (6.81) 41 (8.54) 36 (8.47) 25 (7.72)
Dyspnea
1 69 (12.71) 85 (17.71) 75 (17.65) 57 (17.59)
2 264 (48.62) 248 (51.67) 188 (44.24) 134 (41.36)
3 166 (30.57) 127 (26.46) 142 (33.41) 100 (30.86)
4-5 44 (8.10) 20 (4.17) 23 (5.41) 33 (10.19)
Continuous variables Mean (SD)
Age at baseline∗ 68.32 (8.32) 67.61 (8.36) 67.42 (8.29) 66.24 (8.36)
FEV1% 55.00 (13.31) 55.21 (16.05) 57.87 (14.66) 54.27 (14.81)
BMI 28.28 (4.43) 28.33 (5.24) 28.10 (4.44) 27.64 (4.79)
Walking Test 408.89 (92.43) 420.56 (117.55) 412.92 (115.28) 397.36 (123.00)
SD: Standard Deviation; BMI: Body Mass Index; FEV1%: Forced Expiratory Volume in one
second in percentile. Symbol ∗ stands for time independent covariates.
in the other dimensions, causing original standardised scores with higher variability.
In terms of the results provided by the SGRQ, apparently, as time goes by there is
no much change neither in the mean nor the standard deviation of the dimensions
for the survivors.
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Table 1.3: Descriptive analysis of PROs provided by the SF-36 and the SGRQ in
the COPD Study.
Time framework
Baseline 1-Year 2-Year 5-Year
No. Individuals n = 543 n = 480 n = 425 n = 324
Dimensions Mean (SD)
Short Form-36
Physical functioning 57.76 (24.38) 58.17 (24.95) 57.79 (24.68) 56.46 (24.96)
Role physical 65.61 (38.92) 60.99 (39.93) 62.65 (40.01) 55.48 (41.16)
Bodily pain 71.09 (29.26) 67.74 (30.33) 69.25 (29.96) 68.58 (29.00)
General health 44.67 (21.93) 43.36 (23.32) 42.28 (22.47) 41.80 (20.92)
Vitality 59.36 (24.96) 58.27 (24.00) 59.64 (23.42) 57.58 (23.88)
Social functioning 81.58 (24.46) 79.92 (25.89) 82.18 (24.14) 77.89 (26.13)
Role emotional 80.17 (35.91) 73.96 (39.42) 76.71 (37.95) 70.37 (41.14)
Mental health 73.42 (22.92) 73.17 (21.86) 73.39 (22.16) 71.63 (23.11)
St. George
Symptoms 44.54 (22.18) 42.48 (22.36) 43.40 (23.25) 44.06 (23.38)
Activity 48.69 (24.94) 45.90 (24.97) 46.89 (24.74) 47.37 (25.35)
Impacts 32.05 (20.89) 30.36 (21.21) 30.23 (20.32) 30.39 (20.89)
SD: Standard Deviation.
1.3.2 Paquid Research Programme
It is well known that increasing longevity and declining fertility rates are shifting
the age distributions of populations toward older age groups in many parts of the
world, including Europe, the United States of America and, in fact, most industri-
alised nations (Anderson et al., 2000). Improved sanitation, medical technology, and
healthcare services, as well as increased individual wealth, have all contributed to
rising life expectancy (WHO, World Health Statistics report, 2017). According to
the United Nations demographics indicator, the relative population of individuals
aged 65 and above will increase rapidly in industrialised countries by an average of
16.8 percent between 2000 and 2020 (Anderson et al., 2000).
As the population grows older, age-related diseases such as dementia will in-
crease, and issues such as providing proper health care and disease treatment will
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come to the forefront. The resulting financial and personal costs might devastate
the world’s economic and healthcare systems, in addition to burdening many fam-
ilies worldwide. Changes in public policies must be implemented to accommodate
financial security, healthcare provision and living arrangements (Chan, 2001).
Dementia is a cognitive disorder that affects the brain and results in failing
memory and personality changes (Martin, 2009). In 2010 there were an estimated
35.6 million people with dementia worldwide. This number will nearly double every
20 years, resulting in an estimated 65.7 million in 2030 and 115.4 million in 2050.
Much of this increase will occur in developing countries. At present, 58 percent
of people with dementia reside in developing countries; by 2050, this figure will
rise to 71 percent. By 2050, individuals aged 60 years and over will account for
22 percent of the worlds population, with four-fifths living in Asia, Latin America
and Africa (Ferri et al., 2005). The incidence of mental and neurological illnesses is
high in Europe too, with nearly 165 million people (38 percent of the population)
suffering from disorders such as depression, anxiety, insomnia or dementia each year
(Wittchen et al., 2011).
The Paquid research program was designed to study the incidence of dementia
and Alzheimer’s disease in elderly people in South-Western France (Letenneur et al.,
1994). Subjects were randomly selected from the electoral rolls of 37 parishes in
Gironde and followed-up over a maximum period of 20 years. Three criteria had
to be met for subjects to be included in the study: (i) to be more than 65 years
by 31 December 1987; (ii) to be living at home at the time of the initial data
collection phase; and (iii) to give their informed consent to participate in the study.
The selection procedure led to the inclusion of 4050 elderly subjects living at home,
which, finally, 2792 agreed to participate in the program. Intellectual functioning
was examined through a series of psychometric tests which were the most sensitive
for following a cognitive decline in elderly individuals. The battery test included the
MMSE questionnaire introduced in Section 1.2.3. Additionally, socio-demographical
variables of the individuals were measured, such as depressive symptomatology and
subjective health measures. More detailed information about the study and the
sample can be found in the original reference (Letenneur et al., 1994).
In this thesis, we have considered a subsample of the Paquid research programme.
The data are publicly available in lcmm R-package (Proust-Lima et al., 2017). The
data consists of 2050 observations over 498 subjects and includes dementia infor-
mation variables, such as dependency level, depressive symptomatology, dementia
status and age at dementia diagnosis and also time independent socio-demographic
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variables such as educational level and age at entry in the cohort.
Table 1.4 shows a descriptive analysis of the outcome and the exploratory co-
variates available in the subsample of the Paquid Study. For discrete covariates, we
show the number of patients and the relative percentage, while for continuous the
mean and standard deviation are displayed.
Several insights can be carried out from Table 1.4. For instance, it can be
appreciated that the number of individuals in the cohort decreases notoriously as
the study goes on. Moreover, as time goes by, the dementia status of patients
worsens considerably and, hence, while the percentage of no dependency in the
initial point was 25.30%, in the end, it decreases to 3.80%. However, as regards to
the MMSE score, apparently, there is not any evolution over time, as means and
standard deviations remain quite constant for all the time points.
1.4 Distributional features
In this section, we present the statistical challenges there exist when trying to fit
PROs. First, we present the exponential family as a very well-known class of models
which include most of the distributions used in practice. However, some special char-
acteristics that PROs usually present make the fit by exponential family distributions
inadequate. Therefore, we will define the beta-binomial distribution, which has been
illustrated in the literature to get satisfactory distributional fits of PROs (Arostegui
et al., 2007). Finally, we fit some exponential family distributions together with the
beta-binomial distribution to the PROs provided in the two datasets presented in
Section 1.3.
1.4.1 The exponential family
The exponential family is a very wide class of models that includes most of the
commonly used distributions in practice. A general p-parameter exponential family
depends on the parameter vector θ = (θ1, . . . , θp) and its log-density is of the form
log f(x|θ) =
p∑
i=1
ηi(θ)Ti(x)−A(θ) + c(x),
for known functions A(θ) and c(x), and ηi(θ) and Ti(x) for each i, i = 1, . . . , p. The
parameters ηi’s are called the natural parameters of the family, and Ti’s the natural
statistics.
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The exponential family includes both discrete and continuous random variables
such as the normal, binomial, Poisson or gamma distributions. However, although
it covers a wide range of distributions, not all the models are included in the expo-
nential family, the Cauchy and the t-distribution for instance.
Example 1.1. Consider the commonly used normal distribution with parameter
vector θ = (µ, σ2), we have that the density function is defined as
f(x|µ, σ2) = 1√
2piσ2
exp
{
−(x− µ)
2
2σ2
}
.
If we rewrite the density function in a exponential form as
log f(x|µ, σ2) = µx
σ2
− x
2
2σ2
− µ
2
2σ2
− 1
2
log(2piσ2),
we realise that the normal distribution defines a two-parameter exponential
family distribution with natural parameters η1 = µ/σ
2 and η2 = −1/(2σ2),
and natural statistics T1(x) = x and T2(x) = x
2.

Example 1.2. For the Poisson model with mean λ we have that the log-density
function is defined as
log f(x|λ) = x log λ− λ− log x!.
Hence, it is straightforward to prove that the Poisson distribution is a one-
parameter exponential family member.

The joint distribution of an independent and identically distributed (iid) sample
from an exponential family also belongs to the exponential family. The previous
statement is very useful when we are developing a model for a group of observa-
tions that are assumed to be drawn from the same distribution. In addition, for
exponential family distributions of the form
log f(x|θ) = θx−A(θ) + c(x), (1.1)
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it is shown that
µ = E[X] = A′(θ)
Var[X] = A′′(θ) =
∂
∂θ
E[X] = A′′
[
A′−1(µ)
]
= v(µ),
(1.2)
where v(·) is the so-called variance function for the mean µ (see McCullagh and
Nelder (1989) for further details). Therefore, A(θ) implies a certain relationship
between the expectation and the variance of the random variable. The displayed re-
lationship between the mean and the variance is very useful in modelling approaches,
as the distribution family is completely defined by knowing the first two moments.
For statistical modelling, it is often adequate to consider a two-parameter model
known as the exponential dispersion model (Jørgensen, 1987). Based on an obser-
vation x the log-likelihood of the scalar parameters θ and φ is of the form
logL(θ, φ) =
xθ −A(θ)
φ
+ c(x, φ), (1.3)
where A(θ) and c(x, φ) are assumed known functions. In this form the parameter
θ is called the canonical parameter and φ the dispersion parameter. Since A(θ)
and c(x, φ) can be anything there are infinitely many submodels in the dispersion
exponential family, though the density must satisfy
∑
x
exp
{
xθ −A(θ)
φ
+ c(x, φ)
}
= 1,
which forces a certain relationship between A(θ) and c(x, φ).
Compared to the more rigid exponential family defined in Equation (1.1), in this
case, the variance is not closely defined by the mean as
Var[X] = φA′′(θ) = φ
∂
∂θ
E[X] = φv(µ).
This is indeed, the biggest advantage of the exponential dispersion model over the
more rigid model in Equation (1.1).
In practise, while A(θ) is explicitly given, c(x, φ) is left implicit in the model.
However, this is not a problem as far as the maximum likelihood estimation (MLE)
of θ is concerned, since the score equation,
S(θ) =
∂
∂θ
logL(θ, φ) =
x−A′(θ)
φ
,
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does not involve the term c(x, φ). However, it does not allow the performance of
a likelihood based estimation of φ or a full-likelihood inference of both parameters.
One option is to estimate φ with the method of moments, although there exist some
other techniques. In this work, we are going to develop a likelihood approximation
approach, usually called as quasi-likelihood (Wedderburn, 1974), which in general is
easy to implement.
First, we need to define some regularity conditions that the density function of
the random variable must satisfy in order to develop the quasi-likelihood theory.
Definition 1.1. Assume that we have Xi, i = 1, . . . , n, iid variables distributed with
density f(x|θ) and let define θˆ and θ0 as the MLE of the parameter vector θ and
the true but unknown parameter value respectively. Then if,
1. θ0 ∈ Int(Ω), where Ω is the parameter space
2. the true but unknown parameter value θ0 is identified, i.e.
θ0 = arg max
θ∈Ω
E log f(Xi|θ)
3. the log-likelihood function
l(θ|x1, . . . , xn) =
n∑
i=1
log f(xi|θ)
is continuous in θ
4. E log f(X1, . . . , Xn|θ) exists
5. the log-likelihood function is such that 1n l(θ|x1, . . . , xn) converges almost surely
to E log f(Xi|θ) uniformly in θ ∈ Ω, i.e.
sup
θ∈Ω
∣∣∣ 1
n
l(θ|x1, . . . , xn)− E log f(Xi|θ)
∣∣∣ <  almost surely for some  > 0
6. the log-likelihood function is twice continuously differentiable in a neighbour-
hood of θ0
7. integration and differential operators are interchangeable
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8. the expected Fisher information matrix
I(θ0) = E
(
−∂
2 log f(X1, . . . , Xn|θ0)
∂θ∂θ′
)
exists and it is non-singular
then, we say that regularity conditions are satisfy.
It is worth mentioning that all the members of the exponential family and com-
monly used distributions satisfy the regularity conditional defined in Definition 1.1
(Pawitan, 2001).
On the one hand, at fixed φ, the MLE of θ, denoted as θˆ, for the observation x
is the solution of the score equation,
S(θˆ) =
∂
∂θ
logL(θ|x, φ)
∣∣∣
θ=θˆ
=
x−A′(θˆ)
φ
= 0,
which implies that A′(θˆ) = x.
On the other hand, under regularity conditions, it can be proved that the MLE
of θ follows a normal distribution,
θˆ ∼ N (θ0, I(θ0)−1),
where in dispersion exponential families it is equivalently to (Pawitan, 2001)
θˆ ∼ N (θ, I(θˆ)−1),
being I(·) the observed Fisher information matrix, defined as
I(θˆ) = − ∂
2
∂θ2
logL(θ|x, φ)
∣∣∣
θ=θˆ
=
A′′(θˆ)
φ
.
Consequently, we have that the asymptotic distribution of the MLE of θ is defined
as
f(θˆ) ≈ (2pi)−1/2I(θˆ)1/2 exp
{
−I(θˆ)
2
(θˆ − θ)2
}
. (1.4)
Moreover, if the likelihood for the x contribution is regular, i.e. the log-likelihood
is well approximated by a quadratic function, we can apply a second order Taylor
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series around the MLE,
logL(θ) ≈ logL(θˆ) + S(θˆ)(θ − θˆ)− 1
2
I(θˆ)(θˆ − θ)2, (1.5)
and get the following approximation of the log-ratio of the likelihoods,
log
L(θ)
L(θˆ)
≈ −1
2
I(θˆ)(θˆ − θ)2. (1.6)
Given Equation (1.4) and Equation (1.6) we obtain that the density function of
the MLE can be approximated by,
f(θˆ) ≈ (2pi)−1/2I(θˆ)1/2L(θ)
L(θˆ)
.
As we only have one observation, the estimation of the mean of the distribution,
µˆ, is equal to the observed unique outcome x. Additionally, from exponential families
(see Equation (1.2)) we have that µ = E[X] = A′(θ), and hence, that µˆ = A′(θˆ).
Therefore, we can conclude that the approximated density function for the single
observation x is defined as
f(x) = f(µˆ) = f(θˆ)
∣∣∣ ∂θˆ
∂µˆ
∣∣∣ = f(θˆ)A′′(θˆ)−1 ≈ (2piφv(x))−1/2 L(θ)
L(θˆ)
(1.7)
where v(x) is the variance function evaluated in the observation x and θˆ is the MLE
of the canonical parameter for the unique observation. Notice that the term c(x, φ)
cancels out in the likelihood ratio term, so we end up with something simpler.
The last term in Equation (1.7) is directly related to the deviance function which
is defined as
D(x, θ) = 2 log
L(θˆ, φ = 1|x)
L(θ, φ = 1|x) = 2
[
xθˆ − xθ −A(θˆ) +A(θ)
]
, (1.8)
where θˆ is the MLE for the single observation x. If we had x1, . . . , xn an iid sample,
the total deviance of the model would be defined as
D =
n∑
i=1
D(xi, θ), (1.9)
where for fixed φ the MLE of θ is the parameter that minimises the total deviance
(Jørgensen, 1997). In fact, although the deviance is useful and necessary to de-
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velop the quasi-likelihood theory, it is commonly used as a goodness-of-fit criteria
to compare nested models.
Finally, we get the expression of the approximation of the log-likelihood of an
exponential dispersion family distribution for a single observation x as
logL(θ, φ|x) ≈ −1
2
log (2piφv(x))− 1
2φ
D(x, θ). (1.10)
Example 1.3 In this example, we consider the binomial dispersion model or,
simply, the binomial distribution with dispersion parameter. First of all, we
rewrite the binomial distribution in an exponential family way. Once the
canonical parameter θ and the A(·) function of the binomial distribution are
identified, we try to extend it to the dispersion model approach and we ap-
proximate the likelihood function with the theory developed above.
Let us assume that the random variable X follows a binomial distribution with
parameters m and p. Then, the density function is defined as
f(X = x|p) =
(
m
x
)
px(1− p)m−x.
Notice that we do not condition the density function on the maximum score
number m as it is usually given as known and, instead, focus our attention on
the probability parameter p.
Equivalently, we can rewrite the log-density of the binomial distribution in an
exponential family way
log f(x|p) = x log p
1− p +m log(1− p) + log
(
m
x
)
,
where we define θ = log [p/(1− p)] as the canonical parameter of the distribu-
tion and A(θ) = −m log(1− p) = m log (1 + eθ).
Notice that the relationships defined in Equation (1.2) are satisfied as follows,
A′(θ) =
∂
∂θ
m log
(
1 + eθ
)
= m
eθ
1 + eθ
= mp = E[X],
A′′(θ) =
∂
∂θ
A′(θ) =
∂
∂θ
m
eθ
1 + eθ
= m
e−θ
(1 + eθ)2
= mp(1− p) = Var[X].
For that canonical parameter and A(·) function we can define the log-likelihood
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of the dispersion model as
logL(θ, φ|x) = xθ −m log(1 + e
θ)
φ
+ c(x, φ), (1.11)
where θ = log [p/(1− p)].
As it was already mentioned, the model defined in Equation (1.11) is enough if
we want to estimate the canonical parameter or, equivalently, the probability
parameter p. However, it allows neither a full likelihood inference of θ (or p)
nor a likelihood based estimation of the dispersion parameter φ. Nevertheless,
we can approximate the log-likelihood of the binomial dispersion model with
the quasi-likelihood approximation defined in Equation (1.10).
First, we know that for a single observation the estimation of the probability
parameter is defined as the ratio between the number of successes and the
number of trials, i.e. pˆ = x/m, hence, we define the deviance of the model as
D(x, θ) = 2
[
x log
x/m
1− x/m − x log
p
1− p +m log
(
1− x
m
)
−m log(1− p)
]
.
Consequently, using Equation (1.10), the approximated log-likelihood of the
binomial dispersion model or binomial distribution with dispersion parameter
is defined as
logL(θ, φ|x) ≈ −1
2
log
(
2piφ
x
m
(
1− x
m
))
− 1
2φ
D(x, θ).
The above formula allows the full-likelihood based estimation of all the pa-
rameters involving the binomial distribution with dispersion parameter. Ad-
ditionally, it also allow for an inference procedure of the parameters.

It has been mentioned that the exponential dispersion model relaxes the rela-
tionship between the mean and the variance, however, in some cases, this accommo-
dation is not enough for the correct distributional fit of the variable. In fact, most
of the PROs include some characteristics that make the fit by exponential family
distributions inefficient (Arostegui et al., 2007). For instance, we consider the SF-36
dimensions provided in the COPD Study (see Section 1.3.1) as an illustration of the
inefficient fit of PROs by exponential family distributions.
22 Chapter 1
Many of PROs studies, in particular, HRQoL studies, perform statistical analysis
assuming that the dimensions provided by the SF-36 follow a normal distribution
(Pal et al., 2017; Sa´nchez-Garc´ıa et al., 2017). Figure 1.1 shows the distribution of
the original standardised SF-36 dimensions of the COPD Study in a cross-sectional
setting, in this case corresponding to the baseline measurements. It evidences that,
on the one hand, the dimensions have different density shapes and, on the other hand,
the weak distributional fit of the normal distribution. In fact, it can be appreciated
that most of the SF-36 dimensions do not show bell-shaped or Gaussian densities,
and instead, they follow skewed distributions which accumulate values in one or
two edges of the distribution scale. Additionally, it is worth mentioning that while
the normal distribution is defined on the real line R, the original standardised SF-36
dimensions are bounded to [0,100]. Moreover, the raw dimensions are constructed by
summing up some item scores and they can only reach a finite number of values (see
Table 1.1). Therefore, although the raw scores are standardised to the 0-100 scale,
they still maintain the integer feature as it can be appreciated in the role emotional
histogram in Figure 1.1, which only can take values equal to 0, 33.33, 66.66 or 100.
This assumption does not match with the continuity of the normal distribution and,
hence, it makes the fit of the original standardised SF-36 dimensions by the normal
distribution quite senseless.
The COPD Study is a specific study that measures specific PROs in an specific
population. However, it has been illustrated in the literature that many PROs mea-
sured in different populations share the previously cited characteristics (Izem et al.,
2014; Arostegui and Nu´n˜ez-Anto´n, 2008). Indeed, the PROs are usually bounded
and tend to accumulate values in one or both sides of the range, which makes them
far from Gaussian or bell-shaped distributions. Additionally, we must also mention
the integer feature of PROs due to the way they are constructed. Therefore, the
number of distributions available in the exponential family that may match with
the cited characteristics reduces considerably. In fact, only two distributions in the
exponential family can be adapted to the features of the PROs, although with some
limitations: (i) the beta distribution; and (ii) the binomial distribution.
The beta distribution is a continuous two parameter exponential family model
which is bounded in the open interval (0, 1). The density function of the beta
distribution is given by
f(x|α1, α2) = x
α1−1(1− x)α1−1
B(α1, α2)
, (1.12)
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Figure 1.1: Histograms of the original standardized SF-36 scores in cross sectional
COPD data. The black lines correspond to the normal distributional fit.
where α1 and α2 are the positive parameters of the distribution and B(α1, α2) is the
beta function defined as
B(α1, α2) =
∫ 1
0
tα1−1(1− t)α2−1dt. (1.13)
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Figure 1.2 shows the different shape the beta distribution can reach depending on
the values of the parameters. It can be appreciated that U, J or inverse J-shapes
can be obtained. Therefore, due to its flexibility, it has been proposed by several
authors in the literature to model PROs (Basu and Manca, 2012; Hunger et al.,
2011). Regarding the distribution domain, PROs must be rescaled to the (0, 1)
interval before they are analysed by the beta distribution. This lead to some floor
and ceiling problems as, for instance, if an individual reaches the maximum score
number, the rescale process will link the score value with 1, but the beta distribution
is not defined in the closed interval. Different techniques have been described in the
literature to overcome this problem (Smithson and Verkuilen, 2006; Verkuilen and
Smithson, 2012). However, the beta distribution has some other limitations that,
from our point of view, do not match with the nature of PROs. First, we have
mentioned that, although PRO scores are assumed continuous, they have an integer
nature and, hence, they do not fit with the continuity of the beta distribution.
Additionally, the rescale to the (0, 1) interval can lead to some loss information
because the value of the maximum score number is ignored. In fact, we need to keep
in mind that PROs are mainly constructed using questionnaires, therefore, the more
questions are performed (the more items are summed up), the better is the outcome
in terms of variability.
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Figure 1.2: Different shapes of the beta distribution for different values of the pa-
rameters.
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The other distribution from the exponential family that could suit with the
nature of PROs is the well-known binomial distribution. It is a bounded integer
distribution and, conversely to the beta distribution, it takes into account the maxi-
mum score number to calculate the variability of the estimates. The problem of the
binomial distribution is the rigidity of its density function that, in general terms,
displays a Gaussian form. Even if a binomial dispersion model is considered, the
dispersion parameter φ only would scale the distribution, but would not change its
shape. Consequently, U, J or inverse J-shaped forms will not be correctly fitted by
the binomial distribution (Najera-Zuloaga et al., 2017). In Section 1.4.3 we will fit
PROs provided in the studies introduced in Section 1.3 by the binomial and bino-
mial with dispersion parameter distributions. It will be shown that the binomial
distribution does not offer a good fit to the data.
We have mentioned in the previous paragraphs the advantages and disadvantages
of the beta and binomial distributions. On the one hand, we have illustrated the
flexibility of the beta distribution but, we have shown its weakness when fitting
the nature of PROs. On the other hand, we have explained that the binomial
distribution suits to the features of PROs, but offers very poor fittings due to its
rigidity. Therefore, we could think of a mixture of both distributions, where the
nature of PROs will be preserved by the binomial distribution, but assume that the
probability parameter follows a beta distribution for accommodating its flexibility
in the model. In fact, the mixture of the binomial and beta distributions is called
the beta-binomial distribution and it has already been proposed in the literature for
fitting PROs (Arostegui et al., 2007).
1.4.2 The beta-binomial distribution
The beta-binomial distribution is defined as a mixture of the binomial and beta
distributions. It consists of a finite sum of Bernoulli variables whose probability
parameter is random and follows a beta distribution.
For instance, consider that we have some binary random variables Yj , j = 1, . . . ,m
where m ∈ N. Assume that conditional on a random variable u the binary vari-
ables are iid from a Bernoulli distribution with parameter u. Additionally, consider
that the random variable u follows a beta distribution with parameters α1 and α2.
Namely, we have that for j = 1, . . . ,m
Yj |u ∼ Ber(u) and u ∼ Beta(α1, α2). (1.14)
26 Chapter 1
The density function of the beta distribution has been introduced in Equation
(1.12) where the first and second order moments are defined as
E[u] = ψ and Var[u] = ψ(1− ψ) φ
1 + φ
, (1.15)
being ψ = α1/(α1 + α2) and φ = 1/(α1 + α2), and hence, 0 < ψ < 1 and φ > 0.
On the contrary, for a binary outcome x the density function of the Bernoulli
distribution with probability parameter u is defined as
f(x|u) = ux(1− u)1−x,
where the first and second order moments are given by
E[X] = u and Var[X] = u(1− u). (1.16)
Therefore, based on the first and second order moments of the beta and Bernoulli
distributions defined in Equation (1.15) and Equation (1.16) respectively, we can
conclude with the marginal moments of the mixed distribution as
E[Yj ] = E [E [Yj |u]] = E [u] = ψ,
Var[Yj ] = Var [E [Yj |u]] + E [Var [Yj |u]] = Var [u] + E [u(1− u)]
= Var [u] + E [u]− E [u2] .
We know from the definition of the variance function that for a random variable u
we have that
Var [u] = E
[
u2
]− E [u]2 ,
and, hence, we have that the marginal variance for each binary variable is defined
as
Var [Yj ] = Var [u] + E [u]−
(
Var [u] + E [u]2
)
= ψ(1− ψ).
Notice that the marginal expectation and variance for each binary outcome corre-
sponds to the Bernoulli distribution with probability parameter ψ. However, due
to the fact that all the binary variables j = 1, . . . ,m are conditioned on the same
random variable, we have that the covariance and correlation within observations
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are defined as
Cov [Yj , Yk] = Cov [E [Yj |u] ,E [Yk|u]] + E [Cov [Yj , Yk|u]]
= Cov [u, u] = Var[u] = ψ(1− ψ) φ
1 + φ
,
Corr [Yj , Yk] =
Cov [Yj , Yk]√
Var [Yj ]
√
Var [Yk]
=
φ
1 + φ
, (1.17)
∀j, k = 1, . . . ,m and j 6= k. Therefore, Equation (1.17) determines the parameter φ
as the dispersion or correlation parameter of the distribution.
If we sum up all the random variables Yj , j = 1, . . . ,m, we define a new variable
as
Y =
m∑
j=1
Yj , (1.18)
which follows the so called beta-binomial distribution.
The marginal density function of the beta-binomial distribution is defined as
f(y) =
∫ 1
0
f(y|u)f(u)du =
∫ 1
0
f
(
m∑
i=1
yi
∣∣∣u) f(u)du
=
∫ 1
0
 mm∑
i=1
yi
 m∏
i=1
f(yi|u)f(u)du
=
(
m
y
)∫ 1
0
uy(1− u)m−y u
α1−1(1− u)α2−1
B(α1, α2)
du
=
(
m
y
)∫ 1
0
uα1+y−1(1− u)α2+m−y−1
B(α1, α2)
=
(
m
y
)
B(α1 + y, α2 +m− y)
B(α1, α2)
.
At this point, we can use the following property of the beta function,
B(x, y) =
Γ(x)Γ(y)
Γ(x+ y)
,
where Γ(·) is the gamma function defined as
Γ(x) =
∫ ∞
0
tx−1e−tdt. (1.19)
Therefore, the marginal density function of the beta-binomial distribution is given
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by
f(y) =
(
m
y
)
Γ(α1 + y)
Γ(α1)
Γ(α2 +m− y)
Γ(α2)
Γ(α1 + α2)
Γ(α1 + α2 +m)
,
or equivalently, using that Γ(x+ 1) = x!, ∀x ∈ N, we obtain
f(y) =
(
m
y
) y−1∏
k=0
(α1 + k)
m−y−1∏
k=0
(α2 + k)
m−1∏
k=0
(α1 + α2 + k)
=
(
m
y
) y−1∏
k=0
(ψ + kφ)
m−y−1∏
k=0
(1− ψ + kφ)
m−1∏
k=0
(1 + kφ)
, (1.20)
where if y = 0, then
y−1∏
k=0
log(φ + kφ) = 1 or equivalently,
y−1∏
k=0
(α1 + k) = 1; and if
y = m, then
m−y−1∏
k=0
log(1− ψ + kφ) = 1, or equivalently,
m−1∏
k=0
(α1 + α2 + k) = 1.
Additionally, the marginal first and second order moments of the beta-binomial
distribution are defined as
E[Y ] = E
[
m∑
i=1
Yi
]
=
m∑
i=1
E[Yi] = mψ,
Var[Y ] = Var
[
m∑
i=1
Yi
]
=
m∑
i=1
Var[Yi] +
∑
j 6=k
Cov[Yj , Yk]
=
m∑
i=1
ψ(1− ψ) +
∑
j 6=k
ψ(1− ψ) φ
1 + φ
(1.21)
= mψ(1− ψ) +m(m− 1)ψ(1− ψ) φ
1 + φ
= mψ(1− ψ)
[
1 + (m− 1) φ
1 + φ
]
.
Notice, that the marginal moments defined in Equation (1.21) correspond to the
binomial distribution with probability parameter ψ and a number of trials m, except
for the variance that includes an additional multiplicative term. In fact, the binomial
distribution is constructed following a similar procedure, however, the summed up
Bernoulli variables are assumed independent. This is, indeed, the reason of the
multiplicative term in the variance of the beta-binomial distribution. The bigger
1.4. Distributional features 29
is the correlation between the binary variables (φ/(1 + φ) >> 0), the larger is the
difference between the variance of the binomial and the beta-binomial distributions.
Finally, it is worth mentioning that when the dispersion or correlation parameter φ
is zero, the beta-binomial distribution reduces to the binomial distribution.
Alternatively, there exits a more direct way of defining a beta-binomial distribu-
tion.
Definition 1.2. The random variable Y follows a beta-binomial distribution, if
conditioned on the beta distributed random variable u, it is drawn from a binomial
distribution with probability parameter u, i.e.
Y ∼ BB(m,ψ, φ) if Y |u ∼ Bin(m,u) and u ∼ Beta(α1, α2)
where ψ = α1/(α1 + α2) and φ = 1/(α1 + α2).
There exist different packages in R to fit a beta-binomial distribution, such as
rmutil, TailRank, emdbook, VGAM and gamlss. Moreover, we have developed our
own functions available in PROreg R-package (see Chapter 5 further details).
In terms of the distributional shape of the beta-binomial distribution, Figure
1.3 shows the different forms it can reach for different parameter values and a fixed
number of summed binary variables, or in a binomial framework, a maximum score
number equal to m = 10. It can be appreciated that the beta-binomial distribution
preserves the characteristics of the binomial distribution that suit with the nature of
PROs (discrete and bounded). Nevertheless, compared to the binomial distribution,
Figure 1.3 displays the flexibility that the introduction of the beta distribution offers.
In fact, if we compare the shapes of the beta-binomial distributions with the shapes of
the beta distributions in Figure 1.2 for the same parameters, we realise that the beta-
binomial distribution is somehow a ‘discretisated’ version of the beta distribution in
the 0-m scale where both maximum and minimum values can be reached.
1.4.3 Distributional fit to the datasets
Once the beta-binomial distribution has been introduced and its suitability for the
accommodation of the nature of PROs has been exposed, we are going to estimate,
as an illustration, the distributional fit of the PROs provided in the studies we have
described in Section 1.3.
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Figure 1.3: Different shapes of the beta-binomial distribution for different values of
the parameters and a fixed number of summed binary observations m = 10.
Short Form-36 Health Survey
In Section 1.4.2 we have introduced the beta-binomial distribution showing its flexi-
bility and shape variety which matches with most of the shapes the SF-36 dimensions
show in the COPD Study (see Figure 1.1). In fact, we have already mentioned that
the beta-binomial distribution has been proposed in the literature for fitting PROs
(Arostegui et al., 2007), in particular, HRQoL dimensions provided by the SF-36.
However, due to the performed standardisation of the raw scores to the [0, 100] in-
terval, recoding of the scores to a binomial form is necessary in order to fit the
beta-binomial distribution to the SF-36 Health Survey scores.
Arostegui et al. (2013) proposed and evaluated a method of recoding continuous
and bounded scores, such as HRQoL scores, to a binomial form. The method was
mainly based on the possible number of values each dimension can obtain, which,
as it has been explained in Section 1.2.1 and showed in Table 1.1, it comes from the
number of items related to the construction of the score in each dimension. Indeed,
the methodology transforms the sorted scale of possible values of each dimension
score to an ordinal scale from 0 to m, i.e. to a discrete and bounded scale. The real
interval [0,100], which is the range of the original standardised scores, is divided into
some subintervals, and then, each subinterval is linked to the value it corresponds
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to in the 0−m order scale, where m+ 1 is the number of intervals. Consequently,
score values within each subinterval are recoded with the value the sub-interval was
linked to in the 0 −m scale. The way the subintervals are constructed is the main
contribution of Arostegui et al. (2013) and the subdivision of the 0 − 100 scale for
each dimension is available in the Appendix of the mentioned work. However, for
the sake of clarity, we give more detailed information about the recoding process in
Appendix A.
Conversely to Figure 1.1 where the original standardised scores are displayed,
Figure 1.4 shows the distribution of the eight recoded SF-36 scores in patients with
COPD at baseline. Additionally, it shows the fit by the beta-binomial distribution,
together with the binomial and binomial dispersion models. Although represented
in different scales, similar shapes can be observed for the original standardised scores
(Figure 1.1) and the recoded scores (Figure 1.4).
Figure 1.4 illustrates that the distributions of the recoded SF-36 scores are, gen-
erally, very skewed, accumulating values at the boundaries. It can be appreciated
that, as it was mentioned in Section 1.4.1, due to the characteristics of PROs, in
particular HRQoL, both the binomial and the dispersion binomial distributions of-
fer a poor fit in most of the recoded scores (e.g. role physical, bodily pain, social
functioning, role emotional and mental health). In fact, as it was mentioned be-
fore, the binomial distribution with dispersion parameter only scales the binomial
density function, but it does not alter its shape. Therefore, if we had performed
a regression model based on this distribution, results would not be reliable as the
binomial distribution does not reflect a good fit to the data. Figure 1.4 also shows
that the scores have different shapes (e.g. bell, U or J-shaped), due to the fact
that in some dimensions people tend to answer more or less extreme than in others.
Consequently, there is an individual within variability in each dimension, that as it
can be appreciated, the beta-binomial distribution is able to accommodate.
Figure 1.5 shows descriptively the distribution of the scores of the eight SF-36
dimensions provided by patients with COPD based on different categorical variables,
such as gender, dyspnea, anxiety, and depression. It allows a description of the effect
of each categorical characteristic in the HRQoL of patients. Each axis of the radar
chart corresponds to a recoded SF-36 dimension. The scales have been standardised
to the interval defined by the length of the axis and divided into three cut points
(25%, 50% and 75%) for a better visualisation of the mean values. In Figure 1.5b we
can appreciate the influence of the dyspnea in the different scores, where lower levels
of dyspnea are associated with higher health-status in all the dimensions. However,
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Figure 1.4: Histograms of the recoded SF-36 scores in cross-sectional COPD data.
The blue and the green lines correspond to the binomial and binomial dispersion fits
respectively. The red line corresponds to the fit by the beta-binomial distribution.
Frequencies are shown at the top of each bar
it can be shown that the mean effect of different dyspnea levels is not equal in all
the dimensions, as the effect in physical functioning is higher than in bodily pain,
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differentiating category effect between physical and mental dimensions. Figure 1.5a
also shows that the mean perception of HRQoL is better in males than in females in
all the dimension, being the mental dimensions where the difference is higher. On
the other hand, Figures 1.5c-1.5d show that, as expected, the anxiety or depression
status worsens in average the health-status of COPD patients in all the dimensions,
the anxiety especially in role emotional and the depression in vitality.
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Figure 1.5: Distribution of the health-status or HRQoL in COPD patients at baseline
based on some categorical variables. Numbers between parenthesis are the maximum
values of the recoded SF-36 scores in each dimension.
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St. George’s Respiratory Questionnaire
The SGRQ has been introduced in Section 1.2.2, where it was mentioned that it
provides three different domains which cover different aspects of the health-status
of the patients with respiratory diseases. In fact, a principal component analysis
was performed on the 50 items of the SGRQ, leading to the decomposition of the
outcome in the following three dimensions: Symptoms, Activity and Impacts. The
resulting three scores were then standardised to the 0−100 scale. Therefore, similar
to the dimensions provided by the SF-36, a recoding process of the SGRQ domains
might be carried out before the beta-binomial distribution is applied.
PROs are used to discriminate differences between patients and evaluate changes
within patients. Unlike most health-status questionnaires, there is evidence that the
SGRQ behaves similarly when used to make comparisons between patients or detect
changes within patients (Jones, 2005). Consequently, the same estimation of the
minimum clinically important difference can be used for both applications. Clinical
thresholds are used most commonly to judge whether a treatment has a clinically
worthwhile effect, or whether it is superior to another treatment. Jones (2002)
showed that the estimate of the SGRQ is consistently around four units, regardless
of the method of estimation and the number of the subjects contributing to the
estimate. Therefore, treatments that produce an improvement of the order of 4
units have found wide acceptance once in use, so it seems reasonable to expect any
new treatment proposed for COPD to produce an advantage over placebo that is
not significantly inferior to a 4 unit difference (Jones, 2005).
We can develop a recoding process of the SGRQ dimensions based on the idea
that a 4 points change in the 0−100 scale can be considered as a clinically significant
change. In fact, we can assume that a change in the health-status only ‘exists’ if 4
units are exceeded in the score and, hence, divide the 0 − 100 scale into 4 length
subintervals recoding the value of each score with the value of the subinterval it
belongs. Table 1.5 shows the recoding of the SGRQ scores based on that criteria.
Consequently, after the recoding has been applied, we get three recoded SGRQ
scores which are integer and take values from 0 to 24, where a higher point, as in the
original scale, means a worse health-status. Figure 1.6 displays the histograms of
the distributions of the original scores (on the left-hand side) and recoded scores (on
the right-hand side) of the SGRQ three dimensions for the patients at baseline. As it
can be appreciated, the recoding process maintains the distributional features of the
scores, which show similar shapes on both sides of the figure. Additionally, Figure
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Table 1.5: Recoding of the SGRQ scores for the three dimensions.
Interval Recoded Interval Recoded
[0, 4) −→ 0 [52, 56) −→ 13
[4, 8) −→ 1 [56, 60) −→ 14
[8, 12) −→ 2 [60, 64) −→ 15
[12, 16) −→ 3 [64, 68) −→ 16
[16, 20) −→ 4 [68, 72) −→ 17
[20, 24) −→ 5 [72, 76) −→ 18
[24, 28) −→ 6 [76, 80) −→ 19
[28, 32) −→ 7 [80, 84) −→ 20
[32, 36) −→ 8 [84, 88) −→ 21
[36, 40) −→ 9 [88, 92) −→ 22
[40, 44) −→ 10 [92, 96) −→ 23
[44, 48) −→ 11 [96, 100] −→ 24
[48, 52) −→ 12
1.6 displays the distributional fit of the scores (symptoms, activity and impacts
domains) by the normal, binomial, binomial with dispersion parameter and beta-
binomial distributions.
First of all, it is worth mentioning that the normal and binomial with dispersion
parameter distributions reach very similar fit shapes conditional on the different
scale and characteristics of the data, which it is assumed continuous in the first one
and integer in the second one. However, it is evidenced that the normal distribution
is not bounded in the 0− 100 range, which leaves distribution tails out of the scale,
especially in the impacts domain. As regards to the fit in the recoded scores, we
can state that the three domains behave quite different and, consequently, different
results are obtained from the fit of the different distributions in each dimension.
First, the symptoms shows a slightly bell-shaped (almost flat) distribution, where
both the binomial with dispersion parameter and the beta-binomial distributions
display similar results. Second, the activity only reaches values in some determined
scores, which complicates the correct fit by any distribution. However, compared
to both binomial distributions, the beta-binomial offers a flatter distribution and,
therefore, accumulates less error in the zero or low frequency scores. Finally, the
impacts scores are accumulated on the left-hand side of the scale, meaning that
there is not much impact of the disease in COPD patients. Similar to the recoded
mental health SF-36 dimension in Figure 1.4, the bell shape of the density function
36 Chapter 1
STGR: Symptoms
D
e
n
s
it
y
0 20 40 60 80 100
0
.0
0
0
.0
1
0
.0
2
0
.0
3
0
.0
4
Normal
Recoded STGR: Symptoms
D
e
n
s
it
y
0 5 10 15 20 25
0
.0
0
0
.0
5
0
.1
0
0
.1
5 Binomial
Binomial Disp.
Beta-Binomial
STGR: Activity
D
e
n
s
it
y
0 20 40 60 80 100
0
.0
0
0
.0
1
0
.0
2
0
.0
3
0
.0
4
Normal
Recoded STGR: Activity
D
e
n
s
it
y
0 5 10 15 20 25
0
.0
0
0
.0
5
0
.1
0
0
.1
5 Binomial
Binomial Disp.
Beta-Binomial
STGR: Impacts
D
e
n
s
it
y
0 20 40 60 80 100
0
.0
0
0
.0
1
0
.0
2
0
.0
3
0
.0
4
Normal
Recoded STGR: Impacts
D
e
n
s
it
y
0 5 10 15 20 25
0
.0
0
0
.0
5
0
.1
0
0
.1
5 Binomial
Binomial Disp.
Beta-Binomial
Figure 1.6: Histograms of the SGRQ scores in the COPD Study at baseline. In the
left-hand side, the original scores are displayed, while on the right-hand side the
recoded scores are shown. The figure offers the fit to the data by the normal (left),
binomial, dispersion binomial and beta-binomial (right) distributions.
of the binomial distributions does not allow an appropriate fit to the data, even
if a dispersion parameter is included. In this domain, it can be easily appreciated
that the beta-binomial distribution offers the most accurate fit. Summarizing, in
one recoded dimension the binomial distribution with dispersion parameter and the
beta-binomial distribution offer very similar results, however, in the other two the
beta-binomial is the most adequate, especially in the Impacts dimension. Therefore,
we propose the use of the beta-binomial distribution as a unified way of analysing
the SGRQ scores in the COPD Study.
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Mini Mental State Examination
In the following lines, we are going to perform the distributional fit to the MMSE
scores in the Paquid Research Programme subsample introduced in Section 1.3.2.
The MMSE offers tools for measuring the cognitive status of patients being evaluated
and, conversely to the SF-36, it only provides a unique score. Moreover, the provided
score is an integer in the 0 − 30 scale, and hence, no recoding process is required
before the beta-binomial distribution is applied.
The Paquid research programme was carried out in a longitudinal framework,
and a maximum of 9 measurements were performed for each individual in the co-
hort. Therefore, in order to show and compare the adequacy of the beta-binomial
distribution in the longitudinal study, we perform different distributional fits on
each of the time points. However, for the sake of clarity, as scores behave similarly
in each time point, Figure 1.7 only displays the distribution of the first four-time
point measurements. In addition, it shows the fit by the beta-binomial and binomial
distributions with and without dispersion parameter.
The main conclusion we obtain from Figure 1.7 is that observations tend to accu-
mulate on the right-hand side of the score scale, meaning that patients have a good
mental status in general. Consequently, it is easy to appreciate that any of the first
four measurements do not follow a Gaussian or bell-shape distribution. In fact, that
is one of the reasons for the poor performance of both binomial distributions, as they
assume a bell-shaped distribution. On the contrary, the beta-binomial distribution
does not display any bell-shaped form, which makes its adjustment more accurate
taking into account the characteristics of the data. Indeed, Figure 1.7 shows that,
in low frequency scores, the beta-binomial distribution gets much better fit than the
binomial distributions. Although, in high frequency scores the fit is not as good as
the previous ones.
We have already shown in Section 1.4.2 that the beta-binomial corresponds to
the binomial distribution when the dispersion parameter φ is equal to zero, meaning
that there is no extra variability or overdispersion. However, Figure 1.7 displays
quite different shapes for each distribution and, therefore, we can conclude that
there exists overdispersion in MMSE scores for the different time points. Therefore,
we propose the use of the beta-binomial distribution to fit MMSE scores.
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Figure 1.7: Histograms of the MMSE score at the first four visits in Paquid subsam-
ple data. The blue and the green lines correspond to the binomial and dispersion bi-
nomial models respectively. The red line corresponds to the fit by the beta-binomial
distribution.
1.5 Objectives of the thesis
This thesis is focused on the development of regression approaches based on the
beta-binomial distribution for the appropriate analysis of PROs in different sce-
narios. In general terms, we can break the objectives of this thesis down in five
main goals. First, in order to detect and quantify the effect of the covariates on
PROs in cross-sectional studies, we will propose a regression model based on the
beta-binomial distribution and we will define a method to make inference in this
context. However, PRO studies are usually carried out over time where patients are
repeatedly measured leading to non-independent data. Therefore, our second ob-
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jective is to extend the cross-sectional beta-binomial regression model to multilevel
data framework, where not only longitudinal studies, but also any kind of correlated
data could be analysed. Due to the fact that that PROs often provide different
dimensions referring to several health aspects, the third objective is to develop a
regression model based on the beta-binomial distribution for the joint analysis of all
the dimensions, i.e. the third objective is to develop a multivariate beta-binomial
regression model. The theoretical development of statistical regression models may
be useless unless a practical tool is provided. Hence, the fourth goal is the imple-
mentation of the regression models as Open Source Software that could be easily
used in clinical research. Finally, the fifth and last objective is the application of the
proposed methodology to COPD data in order to get clinically valid and relevant
results involving the health-status of COPD patients.
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CHAPTER 2
CROSS-SECTIONAL ANALYSIS: A
BETA-BINOMIAL REGRESSION
APPROACH
“The limits of my language means the limits of my world”
Ludwig Wittgenstein, 1889− 1951
The work developed in this chapter has already been accepted in the Statistical Methods
in Medical Research journal and partially presented in the Conference - 31st International
Workshop on Statistical Modelling Conference.
Najera-Zuloaga, J., Lee, D.-J. and Arostegui, I. (2017). Comparison of beta-binomial re-
gression model approaches to analyze health-related quality of life data. Statistical Methods in Med-
ical Research (in press)
31st International Workshop on Statistical Modelling. Comparison of beta-binomial regres-
sion approaches to analyze health-related quality of life data. Najera-Zuloaga, J., Lee, D.-J. and
Arostegui, I. Proceedings volume II. Rennes, July 4 - 8, 2016.
2.1 Introduction
One of the most important goals of PRO studies is the measurement of the effect
that some specific observed variables, such us life habits, disease’s characteristics or
socio-demographical properties, have on the life status of the patients. A variety
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of statistical methods are available to deal with the mentioned objective, however,
due to PROs features referred to in Section 1.4, not all the methodologies would be
appropriate.
Typically, regression models have been developed in the literature to estimate
the relationship between an outcome variable and some given exploratory variables.
In the classical linear models (LMs) the random vector Y = (Y1, . . . , Yn), referred to
as the outcome, is connected to the given covariates by means of a linear regression
Y = Xβ + ,
where X is a full rank matrix which each column corresponds to the measurements
of each exploratory variable, β are the regression coefficients and  is the error
vector. Usually it is assumed that the error term is a vector of iid variables normally
distributed with zero mean and the same variance. This model specification sets up
some conditions on the outcome variable Y , such as continuity, which is not met in all
the real examples. For instance, one may be interested in the relationship between
some covariates and dichotomous or count outcomes, however, the distributional
assumption of LMs may fail in this situations. The extension of classical LMs to
cover non-normal responses is one of the largest success of the statistical inference.
McCullagh and Nelder (1989) developed the well-known generalised linear models
(GLMs) which are based on exponential family distributions, covering a huge range
of real situations.
2.1.1 Generalised linear models
Due to the fact that GLMs are a well-known regression methodology (McCullagh and
Nelder, 1989), in this section, we will shortly introduce and describe them. Unlike the
classical LMs, GLMs do not assume normality of the outcome, and instead, restrict
their assumption to the exponential family distributions. The exponential family,
which has been introduced in Section 1.4.1, covers a wide variety of distributions,
and hence, it makes GLMs useful in a huge range of studies.
In general terms, GLM methodology applies a monotonic function defined in
the real line, which is commonly called the link function, to the expectation of the
outcomes, and then, connects it with the given covariates by a linear predictor. For
instance, assume that y = (y1, . . . , yn)
′ are the observed n independent outcomes
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which follow an exponential family distribution of the following form
f(yi|θi, φ) = exp
{
yiθi −A(θi)
φ
+ c(yi, φ)
}
,
where θi is the canonical parameter of the distribution i = 1, . . . , n and A(·) and
c(·) are known functions. As it was mentioned, GLMs connect the expectation of
the outcomes with the given covariates by means of a link function h(·),
h(µi) = x
′
iβ
where µi = E[Yi], xi is the ith row of a full rank matrixX composed by the covariates
and β are the regression parameters. From exponential family theory (see Section
1.4.1), we know that µi = A
′(θi), and therefore, there exists an implied relationship,
A′(θi) = h−1(x′iβ),
between the canonical parameter and the regression parameters. The choice of h(·)
such that h(µi) = θi, or equivalently θi = xiβ, is called canonical link function.
The use of the canonical link facilitates the estimation and inference procedures,
and consequently, it is usually selected in most of the applications, although any
monotonic function could be used. Notice that the canonical link function depends
on the canonical parameter and, hence, each exponential family distribution has a
different canonical link function.
Therefore, GLM approach only needs two specifications for defining a model,
the distribution from the exponential family and the link function. However, it was
mentioned in Section 1.4.1 that, by fixing the first two moments the distribution
family is completely defined due to the relationships presented in Equation (1.2).
Consequently, a GLM could be specified by the definition of the link function and
the first two moments of the distribution of the outcome.
Following exponential family distribution theory (see Section 1.4.1) the log-
likelihood of a GLM is defined as
logL(β, φ|y) =
n∑
i=1
f(yi|β, φ) =
n∑
i=1
yiθi −A(θi)
φ
+ c(yi, φ), (2.1)
where A′(θi) = h−1(x′iβ) or θi = x
′
iβ if the canonical link function is used and the
dispersion parameter is assumed constant for all the outcomes.
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Regarding the estimation of the regression parameters β, the Iterative Weighted
Least Squares (IWLS) is one of the most widely used approaches (McCullagh and
Nelder, 1989). It extends the Newton-Raphson algorithm to the GLM case, where
an iterative estimating formula is obtained. More details about the construction of
the IWLS procedure are provided in Appendix B.2.
However, in some distribution, such as the binomial, if the dispersion model
defined in Equation (1.3) is considered, then we do not have an explicit formulation
of the density function because c(·) is unknown. In this situations, as well as in the
distributional inference in Section 1.4.1, the estimation of the regression parameters
β remains equal as c(·) do not depend on β, however, it does depend on φ. Therefore,
we are not allowed to perform a likelihood-based estimation of φ, neither a full
inference of β as the second derivatives of the likelihood depend on φ.
In Chapter 1, Section 1.4.1, we have introduced the so-called quasi-likelihood ap-
proximation as a full inference procedure of the parameters in an exponential family
dispersion model. The quasi-likelihood methodology is based on the normalisation
of the density function of the outcomes through a quadratic approximation of the
likelihood, which leads to a deviance approximation. Based on the quasi-likelihood
theory, the MLE of β is the value that minimises the total deviance of the model
defined in Equation (1.9) (Wedderburn, 1974). Additionally, it offers an explicit
formulation of the approximation of the log-likelihood of the model as
logL(β, φ|y) ≈
n∑
i=1
−1
2
log(2piφv(yi))− 1
2φ
D(yi, θi), (2.2)
where A′(θi) = h−1(x′iβ), h(·) is the link function, xi is the ith row of a full rank
matrix X composed by the covariates, v(·) is the variance function of the specific
exponential family member and D(·) is the total deviance of the model defined in
Equation (1.8).
The quasi-likelihood function defined in Equation (2.2) allows a full inference
process in both regression and dispersion parameters of the model.
2.1.2 Beta-binomial regression background
The classical GLMs are a very general regression methodology where a wide variety
of outcomes and covariates can be analysed. In fact, they do not restrict their dis-
tributional assumption to a unique distribution as LMs, and moreover, the possible
use of different link functions enriches the models. However, although the exponen-
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tial family includes most of the distributions that do occur in real studies, there are
some exceptions. Indeed, as it was explained in Chapter 1, the observations’ within-
correlation and overdispersion that most PROs present make the fit by exponential
family distributions inadequate.
The beta-binomial distribution was proposed in 2007 to fit the SF-36 Health
Survey scores (Arostegui et al., 2007). The proposal was mainly motivated be-
cause of the ordinal feature that many of the SF-36 scores exhibit. Furthermore,
they showed that the beta-binomial regression is a good option to detect significant
predictors of SF-36 scores and they provided a nice interpretation of the effect of
explanatory variables on HRQoL when SF-36 is used. The authors also compared
results using multiple linear regression (MLR) and beta-binomial regression for real
and simulated data, showing that performance of the beta-binomial approach was
better or similar than the MLR approach in all the dimensions of the SF-36. Com-
parison of MLR and beta-binomial regression approaches was performed based on
distributional assumptions.
In 2012, Arostegui et al. (2012) generalised the SF-36 results and presented
eight methods of analysis of PROs under different assumptions that lead to dif-
ferent interpretation of the results. The methods were: MLR with least square
and bootstrap estimations, tobit regression, ordinal logistic and probit regressions,
beta-binomial regression, binomial-logistic-normal regression and coarsening. All
methods were applied to scores obtained from two of the health dimensions of the
SF-36 Health Survey. They showed that the beta-binomial regression approach ren-
ders satisfactory results in a broad number of situations, with a very convenient
clinical interpretation of the results.
Therefore, the beta-binomial distribution has been proposed in the literature not
only for fitting the distribution of PROs but also as the given distribution of the
outcomes for performing regression models. However, there are two different ways of
implementing a regression model based on the beta-binomial distribution in the liter-
ature. On the one hand, the marginal beta-binomial regression can be implemented,
which applies a logistic regression in the probability parameter of a beta-binomial
distribution (Forcina and Franconi, 1988). In this setting, estimation is done via
maximum likelihood where the delta algorithm (Jørgensen, 1984) is applied. On the
other hand, the binomial-beta model developed by Lee and Nelder (1996) can be
used as a particular case of the Hierarchical Generalised Linear Models (HGLMs).
In the conditional or HGLM approach beta distributed random effects are included
in the linear predictor of a logistic model to accommodate the overdispersion and
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correlation of PROs. Keeping in mind that there could exist some differences in
the results due to average-specific (marginal) and subject-specific (conditional) ap-
proaches respectively, it would be reasonable if both methodologies may result in
similar conclusions. Nevertheless, none of the existing literature in the analysis of
PRO data has performed a comparison of both approaches in terms of adequacy
and regression parameter interpretation context. Therefore, in order to clarify dif-
ferences between both approaches and find out the optimal methodology in terms
of the estimation of covariate effect, in this chapter we carry out a deep comparison
study between both models in both real and simulated data.
The rest of the chapter is organised as follows. Section 2.2 presents a description
of both methodological approaches to perform a regression model based on the beta-
binomial distribution. The application to COPD Study is carried out in Section
2.3 where the defined models result on different parameter and standard deviation
estimates, that lead to different conclusions regarding the effect of the covariates
in the HRQoL of patients with COPD. Consequently, Section 2.4 is focused on a
simulation study that provides comparisons of the approaches in controlled scenarios.
Finally, in Section 2.5, we provide a brief discussion of the obtained results, as well
as some general conclusions and recommendations.
2.2 Beta-binomial regression approaches
It was described in Section 1.4.2 that the beta-binomial consists of a mixture between
a beta and a binomial distribution. Therefore, as it was explained, there exits two
ways of defining the distribution model: (i) the marginal; and (ii) the conditional.
In the marginal model we integrate out the beta distributed random variable, and
get a closed-form equation for the density function. In the conditional approach we
do not perform any integration and, instead, the model is left in a conditional form.
Each of the model definitions leads to a different regression approach. This section
is focused on the description of both methodologies where, apart from the definition,
the estimation procedure is broadly discussed.
2.2.1 Marginal approach
The first approach, which we denote as BBreg, is based on a marginal regression
model approach. BBreg assumes that the observed outcomes are drawn from a
beta-binomial distribution and applies a logistic regression model in the marginal
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expectation. Therefore, it does not consider the beta-binomial as a mixture, and
instead, it is focused on the marginal distribution where beta effects are integrated
out in the density function. BBreg model definition is similar to GLMs as a link
function is applied to the expectation of the outcomes before linking it with a linear
predictor consisting of the covariates. However, there is a crucial difference: the
beta-binomial distribution does not belong to the exponential family. Consequently,
GLM inference procedure cannot be directly applied as it is developed based on
some properties that exclusively exponential family distributions satisfy.
Let Y = (Y1, . . . , Yn)
′ be a set of idd random variables where each Yi follows a
beta-binomial distribution with parameters pi and φ and a maximum score number
equal to mi, i = 1, . . . , n. Namely, we have that
Yi ∼ BB(mi, pi, φ), i = 1, . . . , n,
where
E[Yi] = mipi and Var[Yi] = mipi(1− pi)
[
1 + (mi − 1) φ
1 + φ
]
. (2.3)
Notice that we assume that the dispersion parameter φ is equal for all the random
variables associated with each observation. In fact, in PRO context, φ measures
the dimension within correlation for the binary responses of the same individual.
Therefore, it is logical to think that the correlation depends on the specific dimension
and hence, that remains equal for all the patients.
Based on the binomial distribution, Equation (2.3) offers a straightforward in-
terpretation of the beta-binomial distribution parameters. In fact, this can be very
useful in the medical framework as it allows the interpretation of the regression pa-
rameters’ effect based on the meaning of the modelled distribution parameter. On
the one hand, as it can be appreciated, the mean corresponds to the binomial mean,
and hence, similar to the binomial distribution, pi can be interpreted as the probabil-
ity parameter of obtaining one success or one point in PRO framework. On the other
hand, the second order moment adds a multiplicative term to the binomial variance
allowing for overdispersion. Indeed, φ was defined as the correlation parameter be-
tween the binary outcomes in Section 1.4.2 and therefore, we can conclude that the
overdispersion of the data is generated by the intraclass correlation of the summed
up Bernoulli (binary) outcomes. Notice that when φ = 0, the model corresponds
to the binomial case. On the whole, the beta-binomial distribution can be inter-
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preted as a binomial distribution where intraclass correlation and overdispersion are
measured.
Due to the easy and useful interpretation of the distribution parameters, and
in order to simplify the notation, from now on we will consider pi the probability
parameter of the beta-binomial distribution, φ as the dispersion parameter and mi as
the maximum score number. The main objective of PRO studies is the measurement
of the effect that some covariates may have on the expected PRO being analysed.
In other words, studies are interested in modelling the mean as a function of the
covariates. Therefore, we will only connect or relate the probability parameter as a
function of the covariates, letting φ as a constant.
Assume that we have y = (y1, . . . , yn)
′ a set of observations. Following Forcina
and Franconi (1988), we can connect the probability parameter of the beta-binomial
distribution with a linear predictor consisting of some given covariates X1, . . . , Xp
by means of a logit link function as
log
pi
1− pi = ηi = x
′
iβ,
where ηi is the linear predictor that corresponds to the ith observation, β is the
(p+ 1)× 1 vector of regression parameters and xi the ith row of a full rank design
matrix X composed by the given covariates, i = 1, . . . , n.
The log-likelihood of the described model is defined as
logL(β, φ|y) =
n∑
i=1
log f(yi|β, φ)
=
n∑
i=1
log

(
mi
yi
) Γ( 1
φ
)
Γ
(
1
φ
+mi
) Γ
(
pi
φ
+ yi
)
Γ
(
pi
φ
) Γ
(
1− pi
φ
+mi − yi
)
Γ
(
1− pi
φ
)
 ,
where β is included in the equation through the relationship given by
pi =
ex
′
iβ
1 + ex
′
iβ
, (2.4)
and Γ(·) is the gamma function defined in Equation (1.19).
As done in Equation (1.20), if we use that Γ(x + 1) = xΓ(x) for all x ∈ R and
Γ(0) = 1, we obtain a new expression of the beta-binomial density function, and
hence, of the likelihood, which is easier to manipulate. Therefore, the log-likelihood
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of the marginal beta-binomial regression model can be simplified as
logL(β, φ|y) =
n∑
i=1
[
log
(
mi
yi
)
+
yi−1∑
k=0
log(pi + kφ) +
mi−yi−1∑
k=0
log(1− pi + kφ)
−
mi∑
k=0
log(1 + kφ)
]
, (2.5)
where if yi = 0 then,
yi−1∑
k=0
log(pi + kφ) = 0; and if yi = mi then,
mi−yi−1∑
k=0
log(1− pi +
kφ) = 0.
In order to get the MLE of β we perform the first order derivative of the log-
likelihood, which leads to the next score equation
S(β) =
∂
∂β
logL(β, φ|y) =
[
∂
∂p
logL(β, φ|y)
]
∂p
∂β
= ξ′SX (2.6)
where S = diag (p1(1− p1), . . . , pn(1− pn)) and ξ = (ξ1, . . . , ξn)′ being
ξi =
yi−1∑
k=0
1
pi + kφ
−
mi−yi−1∑
k=0
1
1− pi + kφ, (2.7)
(see Appendix D.2, Equation (D.1) and Equation (D.2) for further details).
Given that Equation (2.6) has no explicit solution, iterative algorithms are used
to solve Equation (2.6). The Newton-Raphson algorithm is one of the most used
procedures for solving score equations. It consists of a quadratic approximation of
the function to be solved which leads to a iterative estimation of the root based on
the approximation through the ratio between the value of the function and the value
of the derivative (see Appendix B.1). When dealing with estimation in regression
models, we try to maximise the likelihood, or equivalently, solve the derivative of the
log-likelihood function. Therefore, approximating ratio consists of the division be-
tween the first and second order derivatives of the log-likelihood function which may
have a tendency to be unstable for many reasons. One reason is that the negative
of the second derivative of the log-likelihood, or equivalently, the observed Fisher
information I(β), may be negative unless β is already very close to the MLE βˆ. In
fact, I(βˆ) determines the sharpness of the peak in the likelihood function around its
maximum, and consequently, it must be positive-defined. However, occasionally the
I(β) term is also used where β is arbitrary, but this can be inadequate as it may
not be positive-defined. Moreover, apart from negativity, there could be additional
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problems as I(β) can be singular and not invertible or it can have both negative and
positive eigenvalues. In order to correct the estimation procedure, the Fisher’s scor-
ing algorithm is used. This method is defined as a Newton-Raphson algorithm where
the matrix of second derivatives is replaced by its expectation, I(β) = E [I(β)], i.e,
the Fisher expected information matrix. Indeed, I(β) is always non-negative, and
even strictly positive in regular cases.
In GLMs, due to exponential family properties, if a canonical link function is
used, the Fisher observed information matrix is equivalent to the expected infor-
mation matrix as ∂2θi/∂β∂β
′ = 0 (see Appendix B.2). Therefore, in these model
approaches, the Newton-Raphson algorithm is accurate and stable. However, we
have mentioned before that the beta-binomial distribution does not belong to the
exponential family, and therefore, Newton-Raphson or GLM estimation procedure
cannot be applied directly. Moreover, due to the complexity of the beta-binomial
distribution, I(β) is very hard to calculate and approximation procedures must be
used. Therefore, in this work, we have developed a modification of the Newton-
Raphson estimating procedure based on the delta algorithm (Jørgensen, 1984).
Basically, the delta algorithm generalises Fisher’s scoring method, and it is de-
rived from a modification of the Newton-Raphson algorithm where the matrix of the
second derivatives is replaced by an approximation of the form
− ∂
2L
∂β∂β′
≈ T (β)′K(µ)T (β), (2.8)
where K(µ) is a suitable n× n symmetric positive-defined matrix called the weight
matrix, T (β) is the n× p matrix ∂µ/∂β and µ is an intermediate parameter vector
of length n× 1, being n the number of observations.
There are several options for the election of the weight matrix in the delta algo-
rithm. In fact, we have that the negative second derivative of the log-likelihood is
defined as
− ∂
2L
∂β∂β′
= T (β)′I(µ)T (β)−
n∑
i=1
∂2µi
∂β∂β′
u(µi), (2.9)
where u(µ) = ∂L/∂µ. Hence, we choose K(µ) close to I(µ). But as the second
term in Equation (2.9) is ignored in the approximation, this term must be small in
absolute value if the delta algorithm is to have a reasonable rate of convergence.
Jørgensen (1984) showed that the delta algorithm is expected to work well only for
models which are nearly linear or fit the data well (Jørgensen, 1984).
For additive log-likelihood models, I(µ) and I(µ) are diagonal, so we take K(µ)
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diagonal and denote by K(µi) the ith diagonal element. The election of K(µi) equal
to the expected information weight
I(µi) = E
[
−∂
2 logL
∂µ2i
]
simplifies the delta algorithm to the Fisher’s scoring method. Moreover, whereas
other choices of K(µi) depend on the particular parametrisation of µ, the expected
information weight is invariant to reparametrisation of µ (Jørgensen, 1984). Addi-
tionally, as we have mentioned before, the expected weights are always positive for
any regular model.
In the BBreg approach the intermediate parameter µ corresponds to the prob-
ability parameter p and therefore, the second derivative of the log-likelihood with
respect to the regression parameters can be approximated using expected informa-
tion weights, as
∂2 logL
∂β∂β′
≈ E
[
−∂p
′
∂β
∂ logL
∂pp′
∂p
∂β
]
= X ′SE[V ]SX (2.10)
where S and ξ = (ξ1, . . . , ξn)
′ have been previously defined in Equation (2.7) and
V = diag(v1, . . . , vn) being
vi = −∂ξi
∂pi
=
yi−1∑
k=0
1
(pi + kφ)2
+
mi−yi−1∑
k=0
1
(1− pi + kφ)2 , (2.11)
(see Appendix D.2, Equation (D.1) and Equation (D.3) for further details).
Consequently, the estimation equation for the MLE of β is defined as
βˆ
(r+1)
= βˆ
(r) −
{
−∂p
′
∂β
E
[
∂2
∂p∂p′
logL(β, φ|y)
]
∂p
∂β
}−1 [
∂
∂β
logL(β, φ|y)
]′
= βˆ
(r)
+
{
(SX)′E [V ] (SX)
}−1
X ′Sξ
= βˆ
(r)
+
{
X ′SE[V ]SX
}−1
X ′Sξ,
and after some simple calculations it leads to
βˆ
(r+1)
= (X ′SE [V ]SX)−1X ′SE [V ]Sν,
where ν = Xβ(r) + (SE [V ])−1ξ, and the previous matrices are evaluated at βˆ(r).
However, due to the complexity of the beta-binomial density function and, espe-
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cially, the vi terms i = 1, . . . , n, the computation of E[V ] is intractable. Therefore,
it is necessary to replace E[V ] with V and use the observed weights instead. This
adjustment will usually increase the rate of convergence, though the algorithm may
be less stable if the starting points are far from the maximum (Jørgensen, 1984).
However, Forcina and Franconi (1988) tested the algorithm and convergence was
always obtained in two to four iterations.
Therefore, we get the MLE of β by the iterative use of the following equation
βˆ
(r+1)
= (X ′SV SX)−1X ′SV Sν, (2.12)
where ν = Xβ(r) + (SV )−1ξ, and the previous matrices are evaluated at βˆ
(r)
.
The estimates of β are functions of φ. Hence, if we replace β with βˆ or, equiv-
alently, p with pˆ, in the log-likelihood function, we obtain the profile log-likelihood
with respect to φ (see Appendix D.2, Equation (D.4)). This function is easy to com-
pute, and simple numerical methods are available to locate the maximum φˆ (Forcina
and Franconi, 1988).
2.2.2 Conditional approach
The second approach considers the beta-binomial distribution as a mixture and,
unlike the BBreg approach, it models the probability parameter of the conditional
binomial distribution. In fact, it performs a logistic regression in the probability
parameter of the conditional binomial distribution but includes specific beta dis-
tributed random effects in the linear predictor to accommodate both the overdis-
persion and observations within correlation. Therefore, compared to the previous
marginal approach, the conditional model is constructed in a mixed-effects frame-
work.
Generalised linear mixed models (GLMMs) are a very widely used methodology
in different frameworks, as they allow the inclusion, in addition to the usual fixed
effects, one or more random effects in the linear predictor of GLMs (McCulloch and
Searle, 2001). However, the distribution of the random effects is better decided by
the properties of the data or the purposes of inference. Therefore, although the nor-
mal distribution is convenient for specifying correlations in the data, the use of other
distributions for the random effects greatly enriches these class of models. Lee and
Nelder (1996) extended GLMMs to hierarchical GLMs (HGLMs), in which the dis-
tribution of random components is extended to conjugates of arbitrary distributions
from the exponential family.
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On the one hand, the HGLMs are defined as, the response vector Y , conditioned
on some given random components u, follows an exponential family distribution
satisfying that
E[Y |u] = µ and Var[Y |u] = λV (µ),
and the linear predictor takes the form
η = g(µ) = Xβ +Zv,
where v = l(u), the random effects, are the transformation of the random com-
ponents u through the scale, and β are the fixed effects. On the other hand, the
random components u follow a distribution conjugate to an exponential family of
distributions with parameter ϕ where
E[ui] = ψc and Var[ui] = ϕVc(ψc),
for i = 1, . . . , q, and q is the number of random effects.
In Bayesian probability theory, a prior distribution is considered conjugate to
another distribution (likelihood) if the posterior distribution through the Bayes the-
orem belongs to the same family of distributions. For instance, we have shown that
the beta-binomial distribution consists of a conditional response following a bino-
mial distribution whose probability parameter is assumed random and drawn from
a beta distribution. Indeed, we assume that the observation y is drawn from a beta-
binomial distribution, if conditional on the random parameter u, u ∼ Beta(α1, α2),
it follows a binomial distribution with probability parameter u. The posterior dis-
tribution of the model is defined as
f(u|α1, α2, y) = f(y|u)f(u|α1, α2)
f(y|α1, α2)
=
(
m
y
)
uy(1− u)m−yuα1−1(1− u)α2−1B(α1, α2)−1∫ 1
0
(
m
y
)
uy(1− u)m−yuα1−1(1− u)α2−1B(α1, α2)−1du
=
uy+α1−1(1− u)m−y+α2−1∫ 1
0 u
y+α1−1(1− u)m−y+α2−1du
=
uy+α1−1(1− u)m−y+α2−1
B(y + α1,m− y + α2)
∼ Beta(y + α1,m− y + α2),
which follows a beta distribution of parameters y + α1 and m − y + α2, being B(·)
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the beta function defined in Equation (1.13). Therefore, we have shown that the
binomial and beta are conjugate distributions. Hence, we can consider the beta-
binomial model as a special case of HGLMs, and define it as
Yi|ui ∼ Bin(mi, pi) and ui ∼ Beta(α1, α2),
where pi is connected to ui by a linear predictor i = 1, . . . , n, being n the number
of observations.
In fact, when we construct a HGLM we must choose l(·) the scale on which
the random effects occur linearly in the linear predictor, that is called the weak
canonical scale (Lee et al., 2006). This weak canonical scale allows the model to
maintain invariance of inference with respect to equivalent modelling approaches.
The linear predictor of the binomial-beta regression model is defined as
ηi = logit(pi) = x
′
iβ + vi, (2.13)
where x′i is the ith row of a full rank design matrix X composed by the given
covariates, β are the fixed effects and vi = l(ui) = logit(ui) is the random effect
attributed to observation i, i = 1, . . . , n. Therefore, in the binomial-beta HGLM,
the scale of the random effects corresponds to the logit transformation. Note that the
model in Equation (2.13) is the binomial-beta HGLM, which we denote as BBhglm.
Constraints must be specified in either the random or fixed part of the model
to maintain the structure of the model. Lee and Nelder (2001) proposed to impose
constraints in the random part of the model, fixing ψc, the expectation of the random
components ui i = 1, . . . , n, equal to the value that the scale transforms to zero.
Namely, in BBhglm they imposed,
E[ui] = ψc = 1/2. (2.14)
The restriction in Equation (2.14) leads to a strict relationship between the param-
eters of the distribution of the random effects,
E[ui] =
α1
α1 + α2
=
1
2
=⇒ α1 = α2,
and hence, it is assumed that the random components satisfy ui ∼ Beta(1/α, 1/α),
where α > 0 (Lee et al., 2006). This assumption fixes the dispersion parameter of
the beta distribution as ϕ = α/2.
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In HGLMs, especially in the BBhglm, the computation of the marginal likelihood
is not straightforward, and moreover, it is totally uninformative about the random
effects v. Consequently, Lee and Nelder (1996) proposed the so-called h-likelihood
(or hierarchical-likelihood) as an approach to perform inference in HGLMs.
Let y = (y1, . . . , yn)
′ be a set of the observed outcomes. The h-likelihood of any
HGLM is defined by
h = h(β,v, λ, α|y) = log f(y|β,v, λ) + log f(v|α), (2.15)
where the first term is the conditional log-likelihood of the response and the second
term is the log-likelihood corresponding to the random effects in the linear predic-
tor. In the BBhglm the first term corresponds to the binomial density function,
while the second term corresponds to the beta density function through the logit
transformation. Consequently, the h-likelihood in BBhglm is given by
h(β,u, α|y) = log f(y|β,u, λ) + log
[
f
(
l−1(v)|α) ∂l−1(v)
∂v
]
= log f(y|β,u, λ) + log [f(u|α)l−1(v) (1− l−1(v))]
=
n∑
i=1
yiθi −mi log
(
1 + eθi
)
λ
+ c(yi, λ)
+ log
[
u
1/α−1
i (1− ui)1/α−1
B(1/α, 1/α)
ui(1− ui)
]
=
n∑
i=1
yi log
pi
1−pi +mi log (1− pi)
λ
+
1
α
log (ui(1− ui)) + d(yi, λ, α)
=
n∑
i=1
yi log
pi
1−pi +mi log (1− pi)
λ
1
2 log
ui
1−ui + log(1− ui)
α/2
+ d(yi, λ, α)
=
n∑
i=1
yi log
pi
1−pi +mi log (1− pi)
λ
+
ψc log
ui
1−ui + log(1− ui)
ϕ
+ d(yi, λ, α)
where d(yi, λ, α) = c(yi, λ)− log B(1/α, 1/α).
In fact, conjugacy allows to consider log f(v|α) as the log-likelihood of quasi-data
ψ = 1nψc, where 1n is a vector of 1s with length n, with quasi-fixed parameters ui,
satisfying the relationship E[ψi] = ui and Var[ψi] = ϕV (ui), i = 1, . . . , n. Therefore,
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the estimation of HGLMs can be seen as an augmented GLM with the response
variable ya = (y
′,ψ′)′, where
E[Y ] = µ, E[ψ] = u,
Var[Y ] = λV (µ), Var[ψ] = ϕV (u).
Moreover, the augmented linear predictor is defined as
ηa = (η
′,η′c)
′ = Tω,
where η = g(µ) = Xβ+Zv is the linear predictor of the original model, ηc = l(u) =
v is the augmented linear predictor, ω = (β′,v′)′ are fixed unknown parameters and
quasi-parameters and T is the augmented model matrix which is defined as
T =
(
X Z
0 I
)
.
I the dispersion parameters λ and α are fixed, based on the augmented GLM
approach, we can compute the IWLS algorithm to estimate ω, and consequently β
and v. Therefore, the estimating equations are defined as
T ′ΣaT ωˆ = T ′Σ−1a za
where, on the one hand, the augmented adjusted dependent variable za = (z
′, z′c)′
consists of
zi = ηi + (yi − µi)(∂ηi/∂µi) and zci = vi + (ψc − ui)(∂vi/∂ui).
And on the other hand, the prior weight J −1 is defined as
J =
[
Λ 0
0 A
]
,
where Λ = diag(λi) and A = diag(αi), and the weight function
W a =
[
W 0
0 W c
]
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is defined as
W = (∂µ/∂η)2V (µ)−1 and W c = (∂u/∂v)2V (u)−1,
which leads to the overall weight function Σ−1a defined as
Σa = JW−1 =
[
Σ 0
0 Σc
]
=
[
ΛW−1 0
0 AW−1c
]
.
However, for the estimation of the dispersion parameters λ and α, the MLE
may be substantially biased owing to the estimation of β (Lee and Nelder, 1996).
Therefore, a modification of the h-likelihood must be applied in order to obtain a
consistent estimation of the dispersion parameters. Let us consider the following
function which consists of a likelihood function l and a parameter α,
pα(l) =
{
l − 1
2
log
[
det
(
1
2
D(l, α)/pi
)]} ∣∣∣
α=αˆ
,
where D(l, α) = −∂2l/∂α2 and αˆ solves ∂l/∂α = 0. The defined pα(l) is a profile
likelihood that eliminates nuisance effects α from l. In fact, D(l, α) is called the
adjusted term for such elimination. On the one hand, Cox and Reid (1987) showed
that for fixed effects β the use of pβ(l) is equivalent to conditioning the likelihood
on βˆ. On the other hand, Lee and Nelder (2001) proved that the use of pv(l) for
the random effects is equivalent to integrating them out.
Therefore, for the estimation of the dispersion parameters, Lee and Nelder (1996)
proposed to use the adjusted profile h-likelihood
pω(h) =
{
h− 1
2
log
[
det
(
1
2
D(h,ω)/pi
)]} ∣∣∣
ω=ωˆ
,
where h is the h-likelihood defined in Equation (2.15), D(h,ω) corresponds to the
Hessian matrix of the HGLM and ω corresponds to the fixed parameters of the aug-
mented model. Iterative use of ∂pω(h)/∂λ and ∂pω(h)/∂ϕ (or ∂pω(h)/∂α) leads to
the maximum adjusted profile h-likelihood estimations of the dispersion parameters.
2.3 Application to the Short Form-36
In this section we will analyse data from the COPD Study in order to conclude
with remarkable relationships between the HRQoL of patients and clinical and
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socio-demographical variables listed in Section 1.3.1. It has been stated that re-
gression models based on the beta-binomial distribution are appropriate candidates
for analysing PRO data and, in particular, HRQoL provided by the SF-36 Health
Survey (Arostegui et al., 2012). However, we have mentioned in the previous section
that there are two different approaches, the marginal (BBreg) and the conditional
(BBhglm), for implementing that type of model. Therefore, we are going to make
use of both regression approaches to analyse data from the COPD Study and, that
way, we will not only look for relationships between the HRQoL and covariates, but
also check the performance of both methodologies in real data application.
In terms of statistical packages and software, on the one hand, we have imple-
mented the BBreg approach in the R-package PROreg available at CRAN, https://
cran.r-project.org/web/packages/PROreg/index.html. Further discussion about
the specific function that performs the BBreg approach is provided in Chapter 5.
On the other hand, the BBhglm approach is implemented in the hglm R-package
(Ronnegard et al., 2010) also available at CRAN.
The eight dimensions of the SF-36 Health Survey were the response variables
and clinical and sociodemographic variables listed in Table 1.2 were considered as
independent variables. Separated models were performed for each of the health di-
mension of the SF-36 and exclusively data from the first visit to the outpatient clinic
was considered. For variables selection, we retained in the model those covariates
whose influence in HRQoL was statistically significant (p-value< 0.05) in at least
one of the modelling approaches. For simplicity, clarity and brevity of exposition,
we only show results for three of the eight health dimensions of the SF-36. The
selected three dimensions (physical functioning, mental health and role emotional)
illustrate different shapes of the distribution (see Figure 1.4) and a wide range of
maximum number of scores (m), from 4 to 20.
Tables 2.1-2.3 provide the results obtained from the analysis of the mentioned
SF-36 dimensions in the COPD Study by both beta-binomial regression approaches.
Estimates of the regression coefficients, their standard deviations and test of sig-
nificance associated with the BBreg and the BBhglm modelling approaches for the
selected three health dimensions of the SF-36 Health Survey are displayed. We also
show the estimates in logarithmic scale of the dispersion parameter of each approach,
α for BBhglm and φ for BBreg.
Real data application leads to several conclusions and interpretation. As regards
to the effects of the covariates in the SF-36 dimensions, it can be appreciated that
while in physical functioning dimension both algorithms lead to similar estimates,
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Table 2.1: Effect of explanatory variables in the physical functioning dimension
measured by both regression approaches based on the beta-binomial distribution.
BBhglm BBreg
Physical functioning βˆ SD(βˆ) p-value βˆ SD(βˆ) p-value
Dyspnea
Mild -0.616 0.111 <0.001 -0.580 0.112 <0.001
Moderate -1.339 0.122 <0.001 -1.281 0.120 <0.001
Severe -2.317 0.178 <0.001 -2.207 0.176 <0.001
Depression
Yes -0.541 0.139 <0.001 -0.544 0.130 <0.001
Anxiety
Yes -0.416 0.096 <0.001 -0.404 0.090 <0.001
Sex
Female 0.469 0.167 0.005 0.461 0.155 0.003
FEV1% 0.007 0.003 0.011 0.006 0.002 0.012
BMI -0.019 0.007 0.011 -0.018 0.007 0.009
Age 0.013 0.004 0.002 0.012 0.004 0.002
Walking Test 0.004 10−4 <0.001 0.004 10−4 <0.001
log(α) -2.656 0.084 − − − −
log(φ) − − − -2.826 0.115 −
SD: Standard Deviation; BMI: Body Mass Index; FEV1%: Forced Expiratory Volume in one
second in percentile.
in mental health and, especially, in role emotional dimension regression parameter
estimates and statistical significances are completely different. For example, for role
emotional dimension, on the one hand, the estimation of the coefficient correspond-
ing to anxiety is −6.145 in BBhglm approach and −1.649 in BBreg, being both
statistically significant in the model. On the other hand, the p-value corresponding
to the estimate of moderate dyspnea is statistically significant in BBreg approach
(< 0.001), but not in BBhglm (0.434).
Due to the fact that the logit link function is used in both methodologies, the
interpretation of the regression coefficients β in both approaches is equivalent to
the log odds-ratio in a binomial logistic regression model. For instance, the coeffi-
cient of depression in the physical functioning model for BBreg approach is −0.544,
which means that based on this model the presence of depression increases by
1/ exp(−0.544) = 1.72 the odds of having a smaller physical functioning score.
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Table 2.2: Effect of explanatory variables in the mental health dimension measured
by both regression approaches based on the beta-binomial distribution.
BBhglm BBreg
Mental health βˆ SD(βˆ) p-value βˆ SD(βˆ) p-value
Dyspnea
Mild -0.353 0.234 0.134∗ -0.294 0.141 0.037
Moderate -0.853 0.246 <0.001 -0.704 0.145 <0.001
Severe -1.132 0.320 <0.001 -0.961 0.181 <0.001
Anxiety
Yes -1.480 0.204 <0.001 -1.290 0.108 <0.001
Depression
Yes -0.966 0.298 0.002 -0.853 0.157 <0.001
log(α) -0.7647 0.069 − − − −
log(φ) − − − -2.263 0.115 −
SD: Standard Deviation. Symbol ∗ stands for regression coefficients that are not statistically
significant.
Table 2.3: Effect of explanatory variables in the role emotional dimension measured
by both regression approaches based on the beta-binomial distribution.
BBhglm BBreg
Role emotional βˆ SD(βˆ) p-value βˆ SD(βˆ) p-value
Anxiety
Yes -6.145 2.062 0.003 -1.649 0.226 <0.001
Dyspnea
Mild -2.600 5.229 0.619∗ -0.614 0.418 0.142∗
Moderate -3.981 5.080 0.434∗ -1.379 0.413 <0.001
Severe -5.603 5.496 0.309∗ -2.048 0.467 <0.001
log(α) 2.735 0.095 − − − −
log(φ) − − − 0.668 0.150 −
SD: Standard Deviation. Symbol ∗ stands for regression coefficients that are not statistically
significant.
Therefore, at first sight, it seems that both regression approaches lead to com-
pletely different conclusions about the effect of the covariates in the HRQoL of pa-
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tients with COPD. However, care must be required when comparing marginal and
conditional models. In fact, although the interpretation of the parameters is made
in the same way, it is worth noticing that they refer to different measurements. For
instance, the BBreg approach should be interpreted in terms of a marginal response,
and hence, conclusions should be taken in terms of population. Indeed, the linear
predictor of BBreg approach is constructed based on the marginal expectation of
the outcome variable,
logit (E [Yi]) = logit (pmi ) = x′iβ.
On the contrary, the linear predictor of the BBhglm approach depends on the con-
ditional mean,
logit (E [Yi|ui]) = logit (pci ) = x′iβ + vi.
We denote pm and pc to refer to the marginal and conditional means respectively,
where E[pc] = pm. Therefore, the conditional BBhglm approach describes individual
responses, and consequently, interpretation of the parameters is done holding the
value of the random effect (a particular value that corresponds to each individual).
Due to the fact that the logit and the expectation operator do not commute (i.e.
E [logit (pci )] 6= logit (E [pci ]) = logit (pmi )), it has been shown that each approach is
modelling a different measurement, and hence, we cannot compare them directly.
However, there are still some features shown in the real data application that should
be explained. First of all, as mentioned before, due to the model definition, we know
that regression coefficients estimates through marginal and conditional models may
differ. However, differences seem to be larger than expected. Moreover, we know that
if a covariate does not affect the individuals, it has no effect on populations; however,
the real data application does not show the same. In fact, it can be appreciated
in Table 2.3 that the effect of the mild dyspnea is statistically significant in the
marginal approach, but not in the conditional approach, which does not make sense
with the previous statement. Furthermore, standard deviations of the estimates are
completely different in both approaches, which could tell that one of the models is
over or under estimating the variances.
Figure 2.1 shows the distribution of the analysed three SF-36 dimensions and
the model-fit by the BBhglm approach. It can be appreciated the subject-specific
feature of the approach, where the inclusion of a beta random effect per individual
accommodates the dispersion of the fitted values. Therefore, it is shown that the
distribution of the fitted values corresponds to the observed distribution of the re-
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sponses, especially in role emotional dimensions, where results tended to be more
misleading (see Table 2.3). Consequently, Figure 2.1 shows that, apparently, the
BBhglm approach is correct, at least concerning fitted values, and that it is fitting
the relationship between the HRQoL of the patients and covariates adequately.
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Figure 2.1: Observed distribution and fitted distribution by the BBhglm approach
of the analysed SF-36 scores.
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In general, we have explained that due to the model specification we cannot
compare estimates from both approaches directly. However, from our point of view,
there are some issues, such as statistical significance and over/under inflation of the
variance, that must be addressed in order to conclude with the most appropriate
approach to measure the effect of the covariates in PROs, for instance, the HRQoL
of patients with COPD. It seems that as the dispersion parameter increases, both
approaches conclude in more different results. Therefore, in the next section, we
focus on the comparison of the two methodological approaches through a complete
simulation study which is divided in different scenarios depending on the value of
the dispersion parameter.
2.4 Simulation study
In this section we perform a simulation study to compare the adequacy in terms of
parameters estimation, standard deviation and significance of both beta-binomial
regression modelling approaches in PROs framework.
In terms of the software implementation, the R-packages described in Section 2.3
have been used in order to perform the simulation study, i.e. PROreg for BBreg
approach and hglm for BBhglm.
2.4.1 Scenarios set up
First of all, we set up some controlled scenarios defining specific values for the
parameters of the model. Different scenarios correspond to different situations that
can occur in real practise.
Given the recoded 8 health dimensions provided by the SF-36, we consider three
groups based on the maximum score m, i.e.: few (3 and 4), standard (8, 9 and 10)
and large (19 and 20) (see Figure 1.4). Consequently, in order to generalise the
results, the simulation study has been also divided into three scenarios considering a
maximum score of 4, 10 and 20. Finally, we have generated 500 random realizations
of 100 observations of a dependent variable Y assuming a beta-binomial distribution
with fixed probability and dispersion parameters.
In order to understand the behaviour of the methodologies in PROs framework,
we are going to focus the simulation exercise on a regression approach with a single
continuous covariate. The probability parameter of the beta-binomial distribution
has been calculated as shown in Equation (2.4) for a fixed value of β0 and β1 equal
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to 1 and −0.3 respectively, and a fixed covariate X simulated assuming a normal
distribution with mean 3 and standard deviation equal to 2.
0 2 4 6 8 10
(a) Binomial (φ = 0)
0 2 4 6 8 10
(b) Bell-shaped (φ = 0.01)
0 2 4 6 8 10
(c) Flat-shaped (φ = 0.5)
0 2 4 6 8 10
(d) U-shaped (φ = 2)
Figure 2.2: Distribution of the beta-binomial distribution for p = 0.5, m = 10 and
different values of φ.
The value of the dispersion parameter φ defines different scenarios (the shape
of the beta distribution), as for a fixed probability parameter the shape of the
distribution changes considerably for different values of φ. Values greater than 0.5
provides U-shaped distributions, values lower than 0.5 bell-shaped and a value equal
to 0.5 flat-shaped. Figure 2.2 illustrates possible scenarios showing how the shape of
the beta-binomial distribution changes for a fixed probability parameter equal to 0.5
considering the values φ = 0.01 (see Figure 2.2b), φ = 0.5 (see Figure 2.2c) and φ = 2
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(see Figure 2.2d) for the dispersion parameter. If there is no overdispersion, φ = 0,
it corresponds to the usual binomial distribution (see Figure 2.2a). Hence, when the
value of the dispersion parameter becomes greater the distribution is further from
the mean value and the observations are accumulated at both extremes of the scale.
2.4.2 Results
As it was mentioned before, the main objective of most PROs analysis is focused on
the estimation of the effect that some previously measured variables may have on the
health-status of some population. Therefore, regression models are applied to the
data where the interest lies in the estimation and interpretation of the regression
coefficients β. It was detailed in Section 2.4.1 that, for the sake of clarity, the
regression model performed in this simulation study only consists of a covariate, and
hence, two regression parameters are included in the linear predictor: the intercept
(β0) and the slope (β1). Consequently, although some details about the estimation of
the intercept are provided, the objective of the simulation study lies in the correct
measurement of the slope, the regression coefficient that multiplies the simulated
covariate in the linear predictor.
In order to compare the performance of both beta-binomial regression approaches,
the marginal (BBreg) and the conditional (BBhglm), Tables 2.4-2.6 include the em-
pirical mean and expected mean square error (EMS) of the estimates of the intercept
coefficient (β0). In addition, Tables 2.4-2.6 also show a deeper comparison analysis
of the slope (β1) where, apart from the mean and EMS, the empirical standard de-
viation (ESD) and the average standard deviation (ASD) of the estimates are shown
together with the coverage probability of the 95% Wald confidence intervals for the
estimates of the slope (β1 = −0.3) and the percentage the simulated covariate effect
is statistically significant in each model (PCSS). Moreover, Figures 2.3-2.5 show the
boxplots of the estimates of the slope in the 500 simulations for both beta-binomial
regression approaches.
The simulation study shows that similar to the real data application, differences
in the results provided by both beta-binomial regression approaches depend on the
scenarios. Indeed, results begin to differ as the dispersion parameter φ and maximum
score number m increase. For instance, Table 2.4 and Figure 2.3 show that when
there is a low dispersion in the data (φ = 0.01) results provided by both approaches
tend to be very similar. However, if a large dispersion is considered (φ = 2) results
provided by both approaches are completely different (see Table 2.6 and Figure 2.5).
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Table 2.4: Results of the simulation study for the bell-shaped distribution (φ = 0.01)
for n = 100 individuals and R = 500 replicates.
β0 = 1 β1 = −0.3
Model Mean EMS Mean ESD ASD EMS CP PCSS
m = 4 BBhglm 1.015 0.048 -0.305 0.061 0.065 0.004 97.8 100
BBreg 1.009 0.046 -0.303 0.059 0.064 0.003 97.4 100
m = 10 BBhglm 0.997 0.019 -0.299 0.039 0.041 0.001 96.4 100
BBreg 0.995 0.019 -0.298 0.038 0.041 0.001 96.2 100
m = 20 BBhglm 1.013 0.013 -0.303 0.031 0.030 0.001 93.8 100
BBreg 1.010 0.013 -0.302 0.031 0.030 0.001 93.4 100
EMS: Expected Mean Square errors; ESD: Empirical Standard Deviation; ASD: Average
Standard Deviation; CP: Coverage Probability of 95%; PCSS: Percentage the Covariate effect is
Statistically Significant.
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Figure 2.3: Boxplots of the slope estimates in the simulation study for the bell-
shaped scenario (φ = 0.01). Simulations performed for n = 100 individuals and
R = 500 replicates.
It has been mentioned before that, due to the fact that marginal and conditional
approaches do not model the same quantity, they cannot be compared directly.
Therefore, conclusions of the simulation study will not be obtained by comparing
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Table 2.5: Results of the simulation study for the flat-shaped distribution (φ = 0.5)
for n = 100 individuals and R = 500 replicates.
β0 = 1 β1 = −0.3
Model Mean EMS Mean ESD ASD EMS CP PCSS
m = 4 BBhglm 1.286 0.346 -0.385 0.143 0.124 0.028 93.8 94.2
BBreg 0.967 0.090 -0.291 0.082 0.086 0.007 96.8 96.0
m = 10 BBhglm 1.426 0.421 -0.427 0.131 0.125 0.033 90.0 96.0
BBreg 0.957 0.072 -0.289 0.071 0.074 0.005 95.8 98.6
m = 20 BBhglm 1.589 0.649 -0.478 0.150 0.132 0.054 81.4 96.0
BBreg 0.997 0.066 -0.303 0.070 0.070 0.005 95.8 99.4
EMS: Expected Mean Square errors; ESD: Empirical Standard Deviation; ASD: Average
Standard Deviation; CP: Coverage Probability of 95%; PCSS: Percentage the Covariate effect is
Statistically Significant.
φ=0.5
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Figure 2.4: Boxplots of the slope estimates in the simulation study for the flat-
shaped scenario (φ = 0.5). Simulations performed for n = 100 individuals and
R = 500 replicates.
both approaches like with like, but instead, we will analyse results provided by each
approach on its own. Finally, some conclusion about the adequacy of the approaches
will be offered together with some recommendations.
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Table 2.6: Results of the simulation study for the U-shaped distribution (φ = 2) for
n = 100 individuals and R = 500 replicates.
β0 = 1 β1 = −0.3
Model Mean EMS Mean ESD ASD EMS CP PCSS
m = 4 BBhglm 1.990 2.433 -0.610 0.347 0.270 0.217 91.4 61.0
BBreg 0.798 0.134 -0.250 0.091 0.103 0.011 93.6 73.0
m = 10 BBhglm 2.719 6.002 -0.823 0.481 0.369 0.505 86.8 41.2
BBreg 0.791 0.130 -0.248 0.085 0.096 0.010 93.8 77.0
m = 20 BBhglm 3.027 8.050 -0.920 0.539 0.413 0.675 78.2 24.2
BBreg 0.777 0.134 -0.247 0.084 0.093 0.010 93.4 79.8
EMS: Expected Mean Square errors; ESD: Empirical Standard Deviation; ASD: Average
Standard Deviation; CP: Coverage Probability of 95%; PCSS: Percentage the Covariate effect is
Statistically Significant.
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Figure 2.5: Boxplots of the slope estimates in the simulation study for the U-shaped
scenario (φ = 2). Simulations performed for n = 100 individuals and R = 500
replicates.
On the one hand, as regards BBreg approach, several remarkable conclusions
can be appreciated. First of all, regarding the bias of the estimates, it is shown
that the EMS of the estimates remain very small in all the scenarios, especially
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in the slope parameter where the highest value is equal to 0.011 (see Table 2.6).
Therefore, we conclude that variability in the data does not affect the parameter
estimation by BBreg approach, which maintains very close to the real value. In
terms of the variance of the estimates, Tables 2.4-2.6 show that the ESD and ASD
of the estimates are almost equal in all the scenarios, concluding that the algorithm is
coherent with the estimation process. Additionally, it can be appreciated that as the
maximum score number m increases the variance of the estimates (both empirical
and average) decreases and, as the bias remains constant, the EMS is reduced.
Indeed, this is a logical result as increasing the maximum score number m we are
somehow increasing the sample size, and therefore, the estimator is more efficient.
Finally, we have to remark that the interpretation of the regression parameters in
BBreg approach is made in terms of population average, which can be very useful
for clinical applications.
On the other hand, regarding BBhglm approach, results differ for several rea-
sons. Firstly, we have to keep in mind that the interpretation of the bias does not
make any sense in this case where the value being modelled was not the marginal
expectation, but the logit of the conditional mean instead. In fact, the simulation
study was performed in a marginal context, and hence, regression parameters in a
conditional approach do not have the same meaning. Nevertheless, it can be ap-
preciated in Figures 2.3-2.5 and Tables 2.4-2.6 that the estimates begin to distance
from the marginal approach value as the dispersion parameter increases. Indeed,
as noticed by Lee and Nelder (2004), in a mixed-effects regression context, differ-
ent model approaches tend to be more similar as the heterogeneities of individuals
are small. However, not only the bias but the standard deviation of the estimates
(empirical and average) increase for larger values of the dispersion parameter φ.
Compared to BBreg approach, we realise that the BBhglm approach doubles the
variances in large variability scenarios. Consequently, significance tests of the pa-
rameter estimates based on the estimated standard deviations tend to accept the
null hypothesis, and therefore, conclude that there does not exist any relationship
between the covariate and the response variable. In this sense, we find a contradic-
tion between marginal and conditional models, because as it was stated by Senn in
the comments to the paper by Lee and Nelder (2004): “After all, if the treatment
cannot affect individuals, it has no effect on populations...”. However, Tables 2.5-2.6
show that the previous statement does not hold in the simulation study, because,
for instance, in the last scenario (m = 20 and φ = 2) the percentage the covariate
effect is statistically significant in the model is equal to 79.8% in BBreg, but only
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24.2% in BBhglm. In addition, it can be appreciated that the increment of the
maximum number of scores m does not reduce the variability of the estimates in
BBhglm approach, in fact, it increases, which in our opinion could be because the
estimator is not efficient.
To sum up, we have shown that the BBreg approach performs adequately in
terms of bias and variances of the estimations. Moreover, even in large variability
scenarios, it is able to capture the effect of the covariate on the response variable. In
contrast, BBhglm results cannot be interpreted based on the marginal mean because
conditional approaches are considered, and instead, they should be interpreted on an
individual level holding the same value of the predicted random effect. However, we
have shown that when the variability in the data is large enough (φ = 1 or φ = 2),
the BBhglm approach is not able to capture the effect of covariates that do affect
the population average.
Finally, it is worth mentioning that while the BBreg approach converged in all
the simulated scenarios, the BBhglm approach had several convergence problems,
especially in the U-shaped scenario (φ = 2) where it got a convergence rate of
45.09%, 39.18% and 37.37% when m = 4, m = 10 and m = 20 respectively.
2.5 Conclusions and discussion
It is known that differences in the behavior of regression coefficients in so-called
marginal and conditional models are based on a failure to compare them like with
like. In fact, it was shown by Lee and Nelder (2004) that these differences are
mainly caused by the choice of unidentifiable constraints on the random effects.
When we are defining a mixed-effect model, it may be reasonable to assume that an
individual’s unobserved trail (vi) follows a certain distribution. However, the center
of this distribution cannot be identified as it is confounded with the intercept term.
One solution is to fix the first moment of the random effects to some previously
defined constraint. Nevertheless, the restriction of the expectation of the random
effects affects the estimation procedure of the model (Lee and Nelder, 1996) and, in
fact, the election of the constraints is crucial if the fixed effects in different models
are going to be comparable in general (Lee and Nelder, 2004).
Some HGLMs, for instance, models based on a conditional Poisson distribution,
display an easy decomposition of the model which allows the comparison of different
random effects models, but even the marginal model. For example, assume two
random effects models based on the Poisson distribution. On the one hand, the
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normal-Poisson HGLM (Poisson GLMM), which we will denote as NP, is defined as
Yi|vi ∼ Poisson(µni ) and vi ∼ N (0, λn)
ηni = log(µ
n
i ) = x
′
iβ
n + vi.
On the other hand, the gamma-Poisson HGLM, denoted as GP, is defined as
Yi|ui ∼ Poisson(µgi ) and ui ∼ Gamma(1, λg)
ηgi = log(µ
g
i ) = x
′
iβ + log ui,
or equivalently,
µgi = exp(x
′
iβ)ui,
where Gamma(1, λg) denotes the gamma distribution with mean 1 and variance λg.
Note that the superscript n makes reference to the NP model and g to the GP.
Each conditional model leads to a specific marginal model. The GP model leads
to the marginal model
logE[Yi] = logE [E [Yi|ui]] = logE[µgi ] = x′iβg
while the NP leads to
E [log (µni )] = x′iβn.
These two models are different because the expectation does not commute with the
log function, and hence, fixed coefficients cannot be directly compared. Indeed,
the definition of the marginal mean depends on the scale on which the margins are
formed. However, even the NP model offers an easy decomposition to the marginal
mean as
E[Yi] = E
[
exp
(
x′iβ
n + vi
)]
= exp
(
x′iβ
n
)
E [v∗i ] ,
where v∗i follows the well known log-normal distribution. Indeed, the expectation of
the log-normal distribution has an analytic known expression
E [v∗i ] = exp
(
λn
2
)
.
Therefore, we have that
x′iβ
g = x′iβ
n +
λn
2
,
and hence, βg and βn are comparable.
72 Chapter 2
In the binomial-beta HGLM, however, the transformation of the linear predictor
to the marginal first order is not so direct. In fact, in BBhglm approach we have
that
ηbi = logit (E [Yi|ui]) = logit
(
pbi
)
= x′iβ
b + log
ui
1 + ui
,
where E [yi|ui] = pbi is the conditional mean and the superscript b makes reference
to the use of beta distributed random effects. If we try to calculate the marginal
expectation of the outcome variable in BBhglm approach, we have that
E[Yi] = E [E [Yi|ui]] = E
[
mpbi
]
= mE
[
pbi
]
,
where
pbi =
ui exp
(
x′iβ
b
)
1 + ui
[
exp
(
x′iβ
b
)− 1]
which does not follow any known distribution, but specially, it does not have an
analytic expectation. Therefore, we cannot compare BBreg and BBhglm regression
coefficients like to like. Nevertheless, from a practical point of view, researchers
working on PROs must be provided with a valid method of analysis for this kind of
data.
Therefore, in this chapter, we have carried out a simulation study where the ad-
equacy of BBreg and BBhglm approaches when analysing PRO data was examined.
Among different conclusions, the most relevant one was that, in some situations,
the conditional BBhglm approach is not able to identify covariates which had an
statistically significant effect on the marginal mean of the outcome. However, it
seems clear to think that if a covariate cannot affect individuals, it has no effect
on populations. In fact, the previous result does not go with marginal and condi-
tional models assumption, as if a variable has a statistically significant effect on the
marginal mean, the effect on the conditional mean must be statistically significant as
well (Lee and Nelder, 2004). Consequently, due to the fact that the main objective
of most of the PROs studies is to find out relationships that could exist between
the measured covariates and the response variables, we recommend the use of the
marginal approach as a unified technique for analysing PRO data.
In conclusion, our results showed that when the goal of the study is to detect
and interpret the effect of explanatory variables in the health-status of patients, the
method of analysis must be cautiously selected. In fact, when there is large vari-
ability in the data, we showed that the BBhglm approach does not offer appropriate
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results in terms of covariates statistical significance. Therefore, we recommend the
use of BBreg approach as a unified technique for analysing PRO data and, in order
to provide a useful tool to the researchers, it has been implemented by the authors
in the PROreg R-package available in CRAN (further discussion about the PROreg
R-package is compiled in Chapter 5).
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CHAPTER 3
LONGITUDINAL ANALYSIS: A
BETA-BINOMIAL MIXED-EFFECTS
MODEL APPROACH
“As far as the law of mathematics refer to reality, they are not
certain; and as far as they are certain they do not refer to
reality”
Albert Einstein, 1878− 1955
The work developed in this chapter is being reviewed in Biometrical Journal and it has
been partially presented in the Conference - 38th Annual Conference of the International
Society for Clinical Biostatistics.
Najera-Zuloaga, J., Lee, D.-J. and Arostegui, I. (2017). A beta-binomial mixed-effects
model approach for analysing longitudinal patient reported outcomes. Biometrical Journal (under
review)
38th Annual Conference of the International Society for Clinical Biostatistics. Beta-binomial
mixed-effects model for analyzing longitudinal binomial data with overdispersion. Najera-Zuloaga,
J., Lee, D.-J. and Arostegui, I. Proceedings. Vigo, July 10 - 13, 2017.
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3.1 Introduction
3.1.1 Introduction to longitudinal models
Longitudinal studies play a key role in many frameworks such as health, social and
behavioural sciences. They are indispensable to study the change in an outcome over
time. The measurement of study participants repeatedly through the time allows the
direct analysis of temporal changes within individuals and the factors that influence
the change. Due to the fact that the study of the temporal change is so essential to
almost every discipline, the number of longitudinal studies has increased in the past
30 to 40 years (Fitzmaurice et al., 2008).
A longitudinal study is defined as an investigation where participant outcomes
and possibly treatments or exposures are collected at multiple follow-up times. In-
deed, a longitudinal study generally contains multiple or repeated measurements
on each subject in the research. Consequently, the repeated measurements are
correlated within subjects and, thus, it requires special statistical techniques for
valid analysis and inference. There is a wide variety of statistical challenges when
analysing longitudinal data:
Heterogeneity: it is usual, specially in behavioural sciences, that there exist dif-
ferences between individuals. The overall mean response in a sample drawn
from a population does not provide any information about each individual de-
viation. Indeed, when the same subjects are repeatedly measured over time,
their responses are multivariate and have a complex random-error structure
that must be accommodated in the model. Moreover, each individual can be
expected to have each own trend line, which deviates systematically from the
overall mean trend line. Furthermore, in many studies personal features can
be unobservable, leading to unexplained heterogeneity in the population. Con-
sequently, the modelling of this unobserved heterogeneity is one of the main
challenges of longitudinal models. For example, the modelling of the unob-
served heterogeneity in terms of variance components (or random effects in
mixed-effects models) is one way to accommodate the correlation between the
repeated measurements over time and to better describe individual differences
in the statistical characterization of the observed data.
Time-dependent covariates: longitudinal studies allow repeated measurements not
only of the outcome variable, but also of the covariates. Consequently, time-
dependent covariates can be included in the model. The inclusion of covariates
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in the model that change over time can result in many complex analytic issues.
The goal is to estimate the dynamic relationship between the variables over
time, but notice that it is an individual within relationship, and may vary from
individual to individual. Consequently, while our main goal is to determine if
there exists a relationship between the variables in the whole population, one
must be able to model the dynamic relationship within individuals.
Missing data: longitudinal studies tend to present missing data, as not all the
subjects remain in the study until it finishes. Indeed, the basic problem is that
even in randomized and well-controlled clinical trials, subjects available at the
beginning of the study can be considerably different from subjects available at
the end.
Hierarchical structure: in addition to the correlation structure produced by the
repeated measurements of the same individual, the clustering of individuals
within some grouping units (schools, hospitals, clinics, etc.) produces an ad-
ditional correlation structure between the observations, that violates the inde-
pendence assumption of traditional fixed-effects models.
There are still more challenges when analysing longitudinal data, however as
it has been stated we could consider the cited as the most relevant. Moreover,
as the complexity of the model increases, challenges to deal with the correlation
structure of the defined model increase. The advantage of longitudinal models,
however, is that all the available information from each subject can be used in the
analysis, increasing both the statistical power and the ability to estimate subject-
specific effects. Furthermore, the use of the full information decreases the bias due
to arbitrary exclusion of subjects with incomplete response or the simple imputation
of values for replacing missing responses.
3.1.2 Methodologies for analysing longitudinal data
During the last years, several modelling approaches have been developed by many
authors in order to deal with the previous mentioned challenges associated with lon-
gitudinal models. In this section, we will enumerate the most widely used method-
ologies when analysing longitudinal data. We will also introduce them shortly, and
we will define the advantages and disadvantages of each one.
Reduction: the reduction approach, referred as derived variable by some authors
(Hedeker and Gibbons, 2006), is based on the reduction of the repeated mea-
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surements into a summary variable. Indeed, once reduction has been per-
formed, this approach is no longitudinal any more, since there is only one
observation per subject. The main problem of this approach is that the un-
certainty in the derived variable is proportional to the number of repeated
measurements for which it was computed. In unbalanced cases each sub-
ject has a different number of measurements and hence different uncertainties.
Consequently, the homoscedasticity assumption of the model is not ensured.
Moreover, the reduction of the repeated measures decreases the number of ob-
servations and hence, there is a considerably loss of statistical power. Finally,
the reduction of the outcome does not allow the inclusion of time-dependent
variables in the model, as the temporal aspect of the data is removed.
Analysis of variance: the analysis of variance (ANOVA) for repeated measure-
ments (Winer, 1971) is used to compare three or more group means where
the participants are the same in each group. The model assumes compound
symmetry which implies constant variances and covariances over time. This is
an assumption that hardly will be held in longitudinal data for two different
reasons. First, attrition, variances will increase over time because the number
of people that response reduces. Second, it looks reasonable to assume that co-
variances for proximal measurements will be larger than covariances for distal
measurements. The model allows a different trend line per subject, however,
the trends only differ in the intercept, which implies that all the subjects be-
have equally over time. It looks more reasonable that subjects differ not only
in the baseline, but also in the rate of change (slope) from the overall trend
line.
Multivariate analysis of variance: the multivariate analysis of variance (MANOVA)
was proposed for longitudinal data analysis by Bock (1985). The MANOVA
model is simply an ANOVA model with several dependent variables, i.e., while
the ANOVA model tests for differences in means between two or more groups,
the MANOVA model tests differences in two or more vectors of means. This
approach transforms the repeated measurements to orthogonal polynomial co-
efficients (e.g. constant, linear, quadratic growth rates), which are used as
multivariate responses in the MANOVA model. The main disadvantage of
this approach is that it does not deal with missing data, so all the subjects
must have the same number of repeated measurements, which is very unlikely
in practise.
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Mixed-effects models: mixed-effects regression models are quite widely used in dif-
ferent frameworks, specially for the analysis of longitudinal data (Laird and
Ware, 1982). For example, as it was introduced in Section 2.1.1 GLMMs are
a general methodology that include random effects in the linear predictor of a
GLM, which can easily accommodate the correlation structure of longitudinal
data. We will develop these models in more detail in Section 3.2. Mixed-
effects regression models include the term mixed-effects because they consists
of a fixed component (regression coefficients) and a random component (ran-
dom effects). Mixed-effects regression models are quite robust to missing data
and irregularly spaced measurements, furthermore, they can easily deal with
time-independent and time-dependent covariates.
Generalised estimating equations: The generalised estimating equations (GEEs)
(Zeger and Liang, 1982) are a general alternative to mixed-effects models,
which are computationally very convenient. GEE approach extends the clas-
sical GLMs (see Section 2.1.1) to the case of correlated data. They can be
used to analyse a wide variety of outcomes and do not require complex numer-
ical evaluation of the likelihood for nonlinear models. They model the overall
mean relationship of the variables and the within-subject dependency sepa-
rately. GEE models are also called marginal models, where the term marginal
makes reference to the assumption that the mean response only depends on
the covariates of interest and not on any random effects or previous responses.
Among the previously defined methodologies for analysing longitudinal data, the
most widely used and appropriate include the mixed-effects regression approaches
and GEE. The larger difference between these two approaches is that GEE models
are based on quasi-likelihood estimation, and so the full likelihood of the data is
not specified. Therefore, while GEE models are considered partial-likelihood meth-
ods, the mixed-effects models are considered full-likelihood methods as they use all
the available data from each subject. The advantage of statistical models based on
partial-likelihood is that they are computationally easier and generalise quite easily
to different distribution forms of the repeated outcome variables. However, they
are more restrictive in their assumption regarding missing data, limiting their ap-
plicability in some cases. Moreover, full-likelihood models provide subject-specific
effects which are quite useful when analysing individual-within variability and when
predicting future responses for a given subject or a group of subjects in hierarchical
structures.
80 Chapter 3
On the one hand, GEE approach calculates the marginal mean for each subject,
even if some of those means have limited information due to subject drop out. Then
standard errors are adjusted taking into account the correlation structure of the
repeated measures over time and/or subject clustering. On the other hand, mixed
effects regression approaches use all the available information to calculate subject-
specific trends that would have been observed if the subjects had stayed until the
end of the study. Hence, if future subject responses are related to previous mea-
surements, both approaches can conclude quite different estimated mean responses
at the end of the study. In fact, the main difference between both methodologies
appears when the missing data are dependent on the previous observed responses for
each subject. However, it is difficult to imagine that if the missing data for a given
subject had been observed, the response would not have been related to previous
measurements of the same subject. That is, GEE assume that the missing data are
missing at random and do not depend on the previous measurements.
Therefore, in this thesis we will consider a mixed-effects approach as the most
appropriate for the analysis of hierarchical or longitudinal PRO data. In fact, this
chapter is based on the development of a mixed-effects model based on the beta-
binomial distribution. To achieve that goal, in Section 3.2 we make a review of
the existing literature describing the most used mixed-effects regression approaches.
Then, in Section 3.3 we present the description of the model we propose, the de-
velopment of an estimation and inference methodology and the comparison of its
performance with similar approaches in the literature. In order to show the perfor-
mance of our proposal and compare it with available methodology in the literature,
a simulation study is carried out in Section 3.4. Finally, with the purpose of showing
the applicability of the developed methodology, we apply it in both COPD Study
and Paquid Research Programme described in Section 1.3.1 and Section 1.3.2 re-
spectively. We finish the chapter providing some conclusions in Section 3.6.
3.2 Mixed-effects models in the literature
During the last years, many authors have described in the literature different ap-
proaches to deal with mixed-effects regression models in a longitudinal data frame-
work: variance component models (Dempster et al., 1981), random-effects models
(Laird and Ware, 1982), empirical Bayes models (Hui and Berger, 1983), random
coefficient models (De Leeuw and Kreft, 1986), mixed models (Longford, 1987),
random regression models (Gibbons et al., 1988), two-stage models (Bock, 1989),
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multilevel models (Goldstein, 1995) and hierarchical linear models (Raubenbush
and Bryk, 2002). In fact, all the previous mentioned approaches have a common
characteristic, they accommodate the dependence of the repeated measurements
by the inclusion of random effects per subject. These random subject effects de-
scribe subject-specific trends over time and measure the correlation structure of the
data. In addition, they calculate the degree of subject variation that exists in the
population of subjects. Apart from that, as it has been mentioned in Section 3.1,
mixed-effects model are very useful for analysing longitudinal data, basically be-
cause they are very flexible with missing data, allowing the inclusion of subjects
with incomplete data in the model. Consequently, compared to procedures where
complete data is necessary, the use of all the available information increases the
statistical power of the model and decreases the bias estimation, as subjects with
complete data may not be a representative set of all the population. Additionally,
studies where the follow-up times are not uniform can be incorporated in the model,
as mixed-models assume the time as a continuous variable, and hence, subjects’
responses do not have to be measured at the same time points.
During the last years many regression models have been proposed for analysing
various types of data, where, in most cases, the underlying mean structure is still
the linear model defined as
h(µ) = Xβ,
where h(·) is defined as a monotonic link function, X is a full rank matrix composed
by the covariates and β is a fixed parameter vector of length p+ 1, being p typically
small.
We have mentioned that the use of mixed-effects models arises when the inde-
pendence assumption of the observed measurements fail. In the next section we will
describe in more detail the scenarios where the essential independence assumption
of the observations fail. For instance, assume that Yij is the random variable asso-
ciated with jth observation of the ith subject. We will consider that the number of
measurements change from subject to subject, so for each subject i, i = 1, . . . , n, we
denote the number of observations as ti. Consequently, we can determine each Yij
as
Yij = µ+ ui + eij , (3.1)
where µ is the fixed overall mean parameter, ui is the subject effect that determines
the mean for subject i, and eij is the residual effect that accounts for the error of
each j observation of the ith subject, i = 1, . . . , n, j = 1, . . . , ti.
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The random effects are usually assumed Gaussian with mean zero and known
variance structure, however, other types of distributions could be considered. For
instance, as it was deeply discussed in Section 2.2.2, Lee and Nelder (1996) developed
the HGLMs, where the random effects can follow any distribution conjugate to the
distribution of the conditioned dependent variable. Nevertheless, in this section
we will only focus on the usual mixed-effects models, where the random effects are
assumed normal with mean zero.
Hence, we assume that the subject specific random effects ui are iid ui ∼
N (0, σ2u), and that the residual effects eij are iid eij ∼ N (0, σ2), being indepen-
dent random effects. Additionally, we assume that observations from the same
subjects are correlated. Given the model in Equation (3.1), the covariance between
two different measurements of the same subject is determined by
Cov(Yij , Yik) = Cov(µ+ ui + eij , µ+ ui + eik)
= Cov(ui + eij , ui + eik)
= Cov(ui, ui) + Cov(ui, eik) + Cov(eij , ui) + Cov(eij , eik)
= Var(ui) = σ2u,
for i = 1, . . . , n and j, k = 1, . . . , ti, being k 6= j. Consequently, by the definition
in Equation (3.1), we have determined a correlation structure between different
observations for the same subject, which matches with the dependence assumption
of the data. Hence, the correlation between different observations of the same subject
is defined as,
Corr(Yij , Yik) =
Cov(Yij , Yik)√
Var(Yij)Var(Yik)
=
σ2u
σ2u + σ
2
.
In summary, we have shown that the inclusion of subject-specific random effects
not only allows subjects to differ from the overall mean, but also accommodates the
dependence structure of different observations of the same individual.
It is straightforward to define the model in Equation (3.1) as
Y i = µ1ti + vi,
where Y i = (Yi1, . . . , Yiti)
′ is the vector of the measurements of individual i, 1ti is
the vector of 1s of length ti and vi are the random effects, which follow a multivariate
3.2. Mixed-effects models in the literature 83
normal distribution with mean 0 and variance-covariance matrix
D = σ2Iti + σ
2
uJ ti ,
where Iti is a ti × ti identity matrix and J ti is a ti × ti matrix of 1s. Different
variance-covariance matrices can be chosen depending on the dependence structure
of the data, such as uncorrelated subjects, uncorrelated between and within subjects,
uncorrelated between and autocorrelated within subjects, correlated between but not
within subjects, etc (McCulloch and Searle, 2001).
In the next section, we will discuss on when a covariate effect should be considered
as fixed or as random. Then, we will describe the most commonly used mixed-effects
model approaches: the linear mixed model (LMM), where the dependent variable
follows a normal distribution, and, the already mentioned GLMM for dependent
variables following any distribution from the exponential family.
3.2.1 Fixed or random effects?
When fitting a statistical model, assumptions must be considered in order to the
model be appropriate. When we are interested in applying a regression model to a
dataset, one of the most important decisions we have to make is if a covariate that
we want to introduce in the model is going to be considered as fixed or, conversely,
it is going to be assumed as a random sample of a random distribution. We have
already mentioned that in longitudinal studies, due to heterogeneity, i.e. the lack of
independence in the repeated measurements, a random effect is usually considered
for each subject. However, apart from the correlation between repeated responses of
the same subject, there could be other reasons why an additional covariate should
be assumed as random. As it was pointed out in the previous section, subjects could
be clustered in grouping units (schools, clinics, hospitals, etc.), and consequently,
the data could present a correlation structure due to hierarchies. We present two ex-
amples in order to understand when a subject clustering factor should be considered
as fixed or random.
Example 3.1: Weight loss by pills
Suppose we have a clinical trial in which five pills are administered to indi-
viduals trying to reduce their weight. Assume that Yij is the random variable
associated with the weight reduction for jth person receiving the pill i. We
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can consider that
E[Yij ] = µi = µ+ αi, (3.2)
where µ is a general mean and αi is the effect on the weight reduction due to
pill i, i = 1 . . . , 5.
In this modelling of the expected value of Yij , the µi’s (and αi’s) are fixed
effects because the five pills used in the clinical trial are the only pills being
studied. They are the only five being used, and in using them there is no
though for any other pill. This is the concept of fixed effects. We consider the
pills being used and no others, and so the effects are called fixed effects, and
the model, fixed effects model.

Example 3.2: Nutritional centres
Assume that we choose a pill, anyone, for losing weight from Example 3.1 and
develop a clinical trial where the pill is administered to patients from 7 random
nutritional centres in the Basque Country. The model for the random variable
Yij , which represents the weight loss for patient j at the ith nutritional centre,
would be
E[Yij ] = µ+ ui (3.3)
with i = 1, . . . , 7 for the 7 nutritional centres. Notice that it is reasonable to
think of those centres as a random sample of centres from some distribution
of nutritional centres, maybe all the centres in the Basque Country.
Notice that Equation (3.3) is essentially the same algebraically as Equation
(3.2), except for having ui in place of αi. However, the underlying model
assumptions are different. On the one hand, in Equation (3.2) the effect of pill
i in the loss weight, αi, is considered a fixed effect as it was already decided that
it was a pill of interest in the study. On the other hand, in Equation (3.3) each
ui is the effect of weight loss of patients being observed in nutritional centre
i, but i centre is not a pre-selected centre, it is just one centre from among
all the nutritional centres in the Basque Country that has been numbered in
the trial as centre i. Consequently, nutritional centres in the study have been
randomly selected with the object of treating them as a representation of all
the nutritional centres in the Basque Country. Hence, inference and results
from the study can be made about all the population. In fact, the main feature
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of random effects is that they can be used as the basis for making inferences
about populations from which they were selected. Therefore, ui is called a
random effect and the model in Equation (3.3) is considered a mixed-effects
model, as it combines fixed-effects, µ, and random-effects, ui. As result, the
model in Equation (3.3) allows the inference about the variance of the random
effects, which measures the variation among nutritional centres. Furthermore,
they allow the prediction of centres that are likely to have the best weight
reduction.

We have shown two examples where the decision of whether certain effects are
fixed or random was quite obvious, but there are some cases that it is not. The
context the data was collected and the approach that is given to a covariate in the
model are determinant so as to decide if the covariate should be treated as fixed or
random. The main question when deciding the behaviour of a factor in the model
is if it is reasonable to consider the levels of the factor as a random sample from a
population which have a distribution. If the answer is yes, then the effects should
be considered as random, otherwise, if it is not, then they are fixed.
3.2.2 Linear mixed-effects model
In this subsection we will study the LMMs whose definition allows the extension
to non-Gaussian models. Moreover, theoretical results are ’clean’ in the sense that
estimation through approximated likelihood matches with the estimation through
the marginal likelihood. Basically, the LMMs are the generalization of the LMs to
the inclusion of random effects. The standard LMM specifies that
Y = Xβ +Zu+ e, (3.4)
where Y is a n × 1 vector of the random dependent variable, X and Z are n × p
and n× q known design matrices, β is a p× 1 vector of the fixed effects, u is a q× 1
vector of the random effects and e corresponds to the n × 1 vector of error terms.
The model assumes that u and e are independent and normally distributed.
Without loss of generality we can assume that the expectation of the random
effects is 0 as, if it were otherwise, E[u] = τ , we could rewrite Equation (3.4) as
Y = Xβ+Zτ +Z(u−τ ). Defining X∗ = [X Z], β∗ = (β′, τ ′)′ and u∗ = (u−τ ),
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we obtain an equivalent formulation of the model as Y = X∗β∗ + Zu∗ + e where
E[u∗] = 0.
Although the elements of u are random variables, it is useful to define the model
conditional on their unobservable but realised values. This specification of the model
allows an immediate extension to non-normal models. We assume that conditional
on the unobservable random effects u, the dependent outcome variable is normally
distributed with expectation equal to
E[Y |u] = Xβ +Zu, (3.5)
where E[Y |u] means E[Y |U = u], being U the random variable and u the realiza-
tions of the random variable.
Let’s assume that the variance-covariance matrices of the random effects D and
error term Σ are parametrized by an unknown vector of variance components θ.
Hence, the conditional variance of the measured outcome variable is defined as
Var[Y |u] = Σ. Therefore, we assume that conditional on the unobservable ran-
dom effects u, the outcome variable is drawn from the following distribution
Y |u ∼ N (Xβ +Zu,Σ), (3.6)
where u ∼ N (0,D) and Σ is a matrix parametrized by the unknown parameter
vector θ. The advantage of this new definition in Equation (3.5) is that we do
not have to specify an error term, which does not make sense in non-linear models.
Following we present the parameter estimation process for LMMs which is very
useful for future developments of more complicated models.
First, from Equation (3.6) we conclude that the marginal expectation and vari-
ance of the outcome variable are defined as
E[Y ] = E
[
E[Y |u]] = E[Xβ +Zu] = Xβ
Var[Y ] = Var
[
E[Y |u]]+ E[Var[Y |u]]
= Var[Xβ +Zu] + E[Σ]
= ZDZ ′ + Σ = V .
(3.7)
Notice, that the fixed effects enter only through the mean, while the random effects
design and variance-covariance matrices enter only through the marginal variance
of the outcome variable.
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Based on the first and second order moments defined in Equation (3.7), the
marginal log-likelihood of the model is defined as
logL(β,θ|y) = logf(y|β,θ)
= −1
2
log|V | − 1
2
(y −Xβ)′V −1(y −Xβ),
(3.8)
where θ enters in the equation through the marginal variance V and y = (y1, . . . , yn)
′
is the observed vector for the outcome variables.
For fixed θ, if we derive the marginal log-likelihood with respect to β, we obtain
the score equations for the fixed effects of the model as
S(β) =
∂
∂β
logL(β,θ|y) = (y −Xβ)′V −1X. (3.9)
Matching Equation (3.9) equal to zero, we reach the well-known generalised or
weighted least-squares formula, from which we get the maximum likelihood esti-
mation of the fixed effects in the model,
(X ′V −1X)β = XV −1y. (3.10)
We obtain the standard errors of the estimates of the fixed effects by the negative
of the inverse of the Fisher information matrix, which in LMMs is defined as
I(βˆ) = X ′V −1X.
Sometimes, specially when observations are grouped by a specific characteristic,
the interest of the analysis is not only to estimate the fixed coefficients, but also to
predict the realized values of the random effects. Note that assumptions concerning
random and fixed effects are completely different. While the fixed effects are con-
sidered constant values, the random effects are considered effects that come from a
larger population of effects. Consequently, the way of dealing with the two kind of
effects should not be the same. Hence, to emphasize this distinctions, we would say
that fixed effects are estimated, but we would use the prediction for the obtained
realized values of the random effects. The problem is that, in these situations, the
marginal log-likelihood function in Equation (3.8) does not offer any information
concerning the random effects.
The log-likelihood of all the parameters in the model is based on the joint density
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of the dependent outcome variable and random effects, i.e.
L(β,θ,u|y) = fy|u(y|u)fu(u),
where the first term is the conditional distribution of the outcome variable, which
from Equation (3.6) we know that follows a normal distribution, and the second term
corresponds to the distribution of the random effects, which by model assumption is
considered normal. Hence, we can express the joint log-likelihood of the parameters
as,
logL(β,θ,u|y) =− 1
2
log|Σ| − 1
2
(y −Xβ −Zu)′Σ−1(y −Xβ −Zu)
− 1
2
log|D| − 1
2
u′D−1u.
(3.11)
Again, for fixed θ, given the fixed effects parameters β, we take the derivative of
the log-likelihood with respect to the random effects and obtain the score equation
for u as
S(u) =
∂
∂u
logL(β,θ,u|y) = Z ′Σ−1(y −Xβ −Zu)−D−1u.
Setting it to zero, the prediction of the random effects is the solution of
(Z ′Σ−1Z +D−1)u = Z ′Σ−1(y −Xβ). (3.12)
Equation (3.12) offers the so-called best linear unbiased predictor (BLUP) of the
random effects, best in the sense of minimized mean square error of prediction
(Robinson, 1991).
Notice that the maximum likelihood estimates of the fixed effects in Equation
(3.10) and the BLUP of the random effects in Equation (3.12), are the joint max-
imiser of the joint log-likelihood in Equation (3.11) (Pawitan, 2001). This provides
a useful technique when dealing with non-normal models, where the computation of
the marginal likelihood is not so direct.
Combining both score equations for β and u from the joint log-likelihood in
Equation (3.11), we have that(
X ′Σ−1X X ′Σ−1Z
Z ′Σ−1X Z ′Σ−1Z +D−1
)(
β
u
)
=
(
X ′Σ−1y
Z ′Σ−1y
)
. (3.13)
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The advantage of this formulation is that we can estimate fixed effects and predict
random effects without having to compute the marginal variance V or its inverse.
The estimating procedure, which is called Jacobi or Gauss-Seidel method in lin-
ear algebra, also known as the iterative backfitting algorithm in statistics, is fully
explained in Breiman and Friedman (1985).
Until now, we have considered the variance parameters fixed in the estimation
of the fixed and random effects in the model. However, following, we develop the
estimation algorithm of the variance parameter θ. From the marginal log-likelihood
in Equation (3.8) we can derive the profile log-likelihood of the parameter vector θ
as
logL(θ|y,β) = −1
2
log|V | − 1
2
(y −Xβˆ)′V −1(y −Xβˆ) (3.14)
where βˆ is the maximum likelihood estimation of the fixed effects obtained from ei-
ther the marginal score equation in Equation (3.10) or the joint estimation procedure
in Equation (3.13). The disadvantage of this formulation of the profile log-likelihood
for θ is that we have to compute the marginal variance V , but specially its inverse.
However, an alternative formulation has been developed in the literature which is
based on the decomposition of all the terms involving the variance-covariance ma-
trix V . By Woodbury formula in Property D.2 and a partitioned matrix result in
Appendix D.1, the profile log-likelihood in Equation (3.14) is reduced to
logL(θ) =− 1
2
log|Σ| − 1
2
(y −Xβˆ −Zuˆ)′Σ−1(y −Xβˆ −Zuˆ)
− 1
2
log|D| − 1
2
uˆ′D−1uˆ− 1
2
log|Z ′Σ−1Z +D−1|
= logL(βˆ,θ, uˆ)− 1
2
log|Z ′Σ−1Z +D−1|,
(3.15)
where θ enters in the function through Σ,D, βˆ and uˆ (see Pawitan (2001) for more
details). Again, βˆ and uˆ are the maximum likelihood joint estimates in Equation
(3.13). It is important to note that, the profile log-likelihood of the variance param-
eters in Equation (3.15), also called modified profile log-likelihood, is equal to the
joint-likelihood function in Equation (3.11) plus the additional term
−1
2
log |Z ′Σ−1Z +D−1|,
where Z ′Σ−1Z +D−1 corresponds with the Fisher information matrix of the ran-
dom effects, i.e. the negative of the second derivative of the joint log-likelihood in
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Equation (3.11) with respect to u. A full inference procedure can be carried out for
the dispersion components θ through the modified profile log-likelihood. Further-
more, the modified profile log-likelihood is much easier to manipulate than likelihood
functions involving the term V or its inverse.
Generalisation and extension to several random effects is straightforward, as if
the model were defined as
E[Y |u1,u2] = Xβ +Z1u1 +Z2u2,
we could define the random effects as u = (u′1,u′2)′ and the random effects design
matrix as Z = [Z1 Z2]. Hence, the previous model will reduce to
E[Y |u] = Xβ +Zu
and all the previous theory would be now applicable.
3.2.3 Generalised linear mixed-effects model
The use of a random structure is not only restricted to linear models, as we have
explained in the previous section. Sometimes, it is useful to incorporate random
effects into non-linear models to accommodate correlated data, or to consider levels
of a factor as selected from a population of levels (hierarchies) in order to make
inference to that population. GLMMs extend the previously developed LMMs to
non-linear models and the classical GLMs (see Section 2.1.1) to the inclusion of
random effects (McCulloch and Searle, 2001).
The GLMM model, like the LMM model, assumes that the outcome response
vector Y consists of conditionally independent elements, i.e. given a vector of ran-
dom effects u, the dependent outcomes Y1, . . . , Yn are conditionally independent,
each with a distribution density from the exponential family,
Yi|u ∼ fyi|u, indep. i = 1, . . . , n
fyi|u = exp{[yiψi −A(ψi)]/φ− c(yi, φ)}.
(3.16)
where yi is the observation that corresponds to the random variable Yi.
From the exponential family theory we know that the conditional expectation of
the outcomes, which we denote µi, is related to ψi via the identity µi = ∂A(ψi)/∂ψi.
Indeed, it is the transformation of this mean what we want to model as a linear
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function of both fixed and random effects,
E[Yi|u] = µi,
h(µi) = x
′
iβ + z
′
iu,
where h(·) is a known link function, x′i is the ith row of the full rank model matrix
X for the fixed effects, β are coefficients of the fixed effects, z′i is the ith row
of the model matrix Z for the random effects and u are the random effects. We
complete the model specification assigning a distribution to the random effects,
which is usually assumed normal with mean 0 and variance-covariance matrix D,
i.e. u ∼ N (0,D). Finally, we assume that the variance-covariance matrix of the
random effects D is specified by a vector of parameters λ.
Let be θ defined as a unknown vector of variance components of the model which
consists of the dispersion parameter of the exponential family distribution, φ, and
the parameters needed for specifying the variance-covariance matrix of the random
effect, λ.
In LMMs, we have shown in Equation (3.7) that the marginal expectation of
the response variable is modelled in the same way as in LMs, i.e. E[Y ] = Xβ.
Consequently, as it has been mentioned, in LMMs the estimation of the fixed ef-
fects by the marginal model matches with the conditional model estimation (joint
estimation). However, due to the fact that the model specification in GLMMs is
made conditional on the value of u, and not in a marginal way, some aspects must
be taken into account. In this case, the marginal expectation of Yi is defined as
E[Yi] = E[E[Yi|u]] = E[µi] = E[h−1(x′iβ + z′iu)],
which, in general, cannot be simplified due to the non-linear function h−1(·). More-
over, the marginal variance of Yi is computed as
Var[Yi] = Var
[
E[Yi|u]
]
+ E
[
Var[Yi|u]
]
= Var[µi] + E[φv(µi)]
= Var[h−1(x′iβ + z′iu)] + E[φv(h−1(x′iβ + z′iu))],
where Var[Yi|u] = φv(µi) is the variance of an exponential family distribution (see
Section 1.4.1). Again, the marginal variance cannot be simplified due to the non-
linear function h−1(·). Similar to LMMs, the introduction of random effects in the
linear predictor of a GLMM also defines a correlation structure between observations
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which have any random effect in common. Namely, for i, j = 1, . . . , n being i 6= j,we
assume that
Cov(Yi, Yj) = Cov(E[Yi|u],E[Yj |u]) + E[Cov(Yi, Yj |u)]
= Cov(µi, µj) + E[0]
= Cov(h−1(x′iβ + z′iu), h−1(x′jβ + z′ju)),
which cannot be implicitly solved due to non-linear terms in the formula.
Based on GLMMs specification in Equation (3.16), we can derive the marginal
likelihood of the model as
L(β,θ|y) =
∫
Rq
n∏
i=1
fyi|u(yi|u,θ)fu(u|θ)du (3.17)
where fyi|u(yi|u,θ) is the exponential family distribution of the conditional out-
comes, fu(u|θ) is the normal density function and yi is the observation of the out-
come variable Yi. Notice that the integration is over the q-dimensional distribution
of u.
While in LMMs the marginal likelihood in Equation (3.8) is relatively simple,
the general case is notoriously difficult. In general, there is no closed form solution
for integrating the random effects out. Hence, numerical methods, such as Gauss-
Hermite quadrature (McCulloch and Searle, 2001), must be applied. However, al-
though the numerical approximation of the marginal likelihood works relatively well
in some cases (e.g. independent random effects), for more complicated structures
(e.g. correlated random effects) the exact approach is no longer tractable.
The basis of the likelihood approximation in GLMMs is the extended or joint
likelihood approach (Pawitan, 2001), which it is defined as
logL(β,θ,u) = logfy|u(y|u,θ) + logfu(u|θ), (3.18)
where, as before, logfy|u(y|u,θ) corresponds to the exponential family distribution
of the conditional outcome vector and logfu(u|θ) is the normal density function
of the random effects. This approximated log-likelihood is generally much easier
to evaluate and optimize than the marginal likelihood presented in Equation (3.17).
For fixed θ, unlike in LMMs, in GLMMs estimations through the extended likelihood
are not exactly equal to those through the marginal likelihood. However, Lee and
Nelder (1996) showed that under fairly general conditions the two estimates are
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asymptotically close.
For a fixed value of θ, similar to GLMs, we can use a quadratic approximation
of the conditional log-density function logfy|u(y|u) to normalize the log-likelihood
form and derive an iterative weighted least squares algorithm for performing the
estimation (see Appendix B.2). Hence, given some initial values of the fixed and
random effects, β0 and u0, the conditional log-likelihood of the outcomes in Equation
(3.18) can be approximated by
−1
2
log|Σ| − 1
2
(yw −Xβ −Zu)′Σ−1 (yw −Xβ −Zu) ,
where yw is defined as the working vector with elements
ywi = x
′
iβ
0 + z′iu
0 +
∂h
∂µi
(yi − µ0i ) where µ0i = h−1(x′iβ0 + z′iu0), (3.19)
and Σ is a diagonal matrix of the variance of the working vector defined as
Σii =
(
∂h
∂µi
)2
φvi(µ
0
i ), (3.20)
where φvi(µ
0
i ) is the conditional variance of Yi given u, i = 1, . . . , n. Notice that
the derivatives ∂h/∂µi are also evaluated at the current values of β and u.
Hence, we can derive an approximation of the extended log-likelihood of GLMMs
in Equation (3.18) as
logL(β,θ,u) ≈− 1
2
log|Σ| − 1
2
(yw −Xβ −Zu)′Σ−1 (yw −Xβ −Zu)
− 1
2
log|D| − 1
2
u′D−1u,
(3.21)
which leads to the usual log-likelihood of a LMM shown in Equation (3.11). Con-
sequently, based on LMM’s joint estimation development, we can conclude the fol-
lowing estimation equations,(
X ′Σ−1X X ′Σ−1Z
Z ′Σ−1X Z ′Σ−1Z +D−1
)(
β
u
)
=
(
X ′Σ−1yw
Z ′Σ−1yw
)
,
where, in this case, yw is the working vector defined in Equation (3.19) through
the normalization of the conditional log-likelihood of the responses and Σ is the
variance matrix of the working vector defined in Equation (3.19), which needs to be
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recomputed in each iteration of the estimation procedure. Therefore, notice that the
computation of the estimates of the fixed and random effects in GLMMs requires
repeated applications of norm-based formulas.
We have shown that even in LMMs the computation of the profile log-likelihood
of the variance components θ cannot be done directly from the joint or extended
log-likelihood owing to the bias of the estimates of fixed and random effects. It is
shown in Equation (3.15) that the profile log-likelihood of the variance components
is equivalent to a modification of the joint log-likelihood. The approximation meth-
ods of variance components estimation in GLMMs can be performed in different
ways (Pawitan, 2001), however one of the most widely used technique is to estimate
θ by maximising a modified profile log-likelihood similarly as in the normal case.
Breslow and Clayton (1993) developed a restricted likelihood approach for perform-
ing estimation of variance components in GLMMs based on a heuristic justification
in terms of Laplace’s integral approximation. The method consists of a penalisation
of the extended likelihood defined in Equation (3.21) as
logL(θ) = logL(βˆ,θ, uˆ)− 1
2
log|Z ′Σ−1Z +D−1|,
where βˆ and uˆ are the computed joint estimations for fixed θ. Notice that the
formula corresponds to the penalisation of the joint likelihood in LMMs. However
there are some differences. For instance, in the normal case, Σ is typically a simple
function of a variance component, but in GLMMs it is also a function of µ, and,
consequently, of β and u. Therefore, since µ is unknown it is convenient to compute
Σ using βˆ and uˆ. It has been shown in many examples that the estimation procedure
provides solutions that are close to the exact marginal estimates (Pawitan, 2001).
3.3 Beta-binomial mixed-effects model
The objective of this section is to extend the BBreg approach presented in Chapter
2 allowing for the inclusion of random effects in the linear predictor. As it has
been stated though the thesis, the beta-binomial distribution does not belong to
the exponential family and, consequently, GLMM (McCulloch and Searle, 2001),
or even, HGLM (Lee and Nelder, 1996), theory cannot be directly applied in this
framework.
In the next sections, we will define a mixed-effects regression model based on
the beta-binomial distribution. Additionally, we will develop an estimation and
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inference procedure for all the parameters involved in the model. However, not all
the parameters in the model share the same characteristics, and hence, care must
be taken when estimating them, considering different approaches. Moreover, we will
provide a goodness-of-fit test based on the deviance. Finally, we will present some
approaches that fit similar models in the literature and we will compare them with
our proposal.
3.3.1 Model definition
Let Y = (Y1, . . . , Yn)
′ be a set of random outcome variables of length n, which con-
ditioned on the random effects u, are assumed to be iid drawn from a beta-binomial
distribution. To complete the model specification, as in LMMs and GLMMs, we as-
sume that the random effects u follow a multivariate normal distribution with mean
0 and variance-covariance matrix D, which depends on a vector of parameters λ
and it is non-singular. Summarizing, we assume that we have
Yi|u ∼ BB(mi, pi, φ), i = 1, . . . , n, (3.22)
where u ∼ N (0,D). In the same way as in GLMMs, we define the parameter vector
θ = (φ,λ′)′ consisting of all the dispersion or variance components of the model, i.e.
the correlation or dispersion parameter of the conditional beta-binomial distribution
φ and the vector of all variance parameters of the random effects λ.
Consider that the response outcomes Y depend on a set of given covariates
X1, . . . , Xk. Hence, following BBreg approach, we connect the probability parameter
of the beta-binomial distribution with the observed covariates and random effects,
assumed fixed when conditioning, by means of a logistic link function, i.e.
ηi = logit(pi) = log
(
pi
1− pi
)
= x′iβ + z
′
iu, i = 1, . . . , n, (3.23)
where ηi is the linear predictor of the model, pi is the probability parameter of the
conditional beta-binomial distribution, β are the fixed effects, xi is the ith row of
the full rank model matrix X composed by the given covariates, u are the random
effects and zi is the ith row of the model matrix for the random effects. Notice that,
as in all mixed-effects models, the correlation structure of the observed data, such as
longitudinal repeated measures or hierarchies, is defined by the model matrix of the
random effects Z. We will denote the presented beta-binomial mixed-effects model
as BBmm.
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3.3.2 Estimation
Let assume that y = (y1, . . . , yn)
′ is the vector of the n observations of the outcome
variables. The marginal likelihood in BBmm approach is defined as
L(β,θ|y) =
∫
Rq
n∏
i=1
fy|u(yi|β, φ,u)fu(u|λ)du (3.24)
where q is the number of levels or components of the random effects, fy|u(yi|β, φ,u)
is the beta-binomial density function defined in Equation (1.20) and fu(u|λ) is the
distribution of the random effects which is assumed normal. Similar to GLMMs,
the marginal likelihood cannot be evaluated in closed form, and moreover, due to
the complexity of the beta-binomial distribution, numerical computation is almost
intractable. Therefore, approximation procedures must be developed to perform the
inference in the model.
Equivalently, we can consider the marginal likelihood of the model in Equation
(3.24) in an exponential form as
L(β,θ|y) =
∫
Rq
exp
{
n∑
i=1
logfy|u(yi|β, φ,u) + logfu(u|λ)
}
du.
Thus, considering that the summation of twice differentiable regular functions is
a twice differentiable regular function, we can apply the Laplace’s method for the
integral approximation of the marginal likelihood of the model (see Appendix C for
further details). Consequently, ignoring multiplicative constant terms, we have that
logL(β,θ|y) ≈ l(β,θ|y, u˜) = h(β,θ|y, u˜)− 1
2
log|M | (3.25)
where,
h(β,θ|y,u) =
n∑
i=1
logfy|u(yi|β, φ,u) + logfu(u|λ)
=
n∑
i=1
[
yi−1∑
k=0
log(pi + kφ) +
mi−yi−1∑
k=0
log(1− pi + kφ)−
mi−1∑
k=0
log(1 + kφ)
]
− 1
2
log|D| − 1
2
u′D−1u
(3.26)
is the joint log-likelihood of the model, u˜ is the solution of ∂h/∂u = 0 and M is
3.3. Beta-binomial mixed-effects model 97
the adjusted term defined as
M =
∂2h
∂u∂u′
∣∣∣
u=u˜
.
The resulting marginal likelihood approximation in Equation (3.25) is the first
order Laplace approximation, and it is equivalent to integrating the random effects
out (see Lee and Nelder (2001) for further details).
Joint estimation of fixed and random effect
For the estimation of the fixed effects, we assume that the dispersion parameter
vector θ is fixed and try to maximise the approximated log-likelihood of the model
defined in Equation (3.25). For fixed θ, we denote the approximated log-likelihood
as
l(β|y, u˜,θ) = A(β) + h(β|y, u˜,θ). (3.27)
Hence, the score equations of the fixed parameters of the model correspond to
S(β) =
∂
∂β
l(β|y, u˜,θ) = A(β)
∂β
+
∂h(β|y, u˜,θ)
∂β
. (3.28)
In GLMMs, Breslow and Clayton (1993) showed that A(β) depends on β through
the variance of the working vector or weight matrices defined in Equation (3.20).
Assuming that this variance or weight matrix varies slowly as a function of β, they
proposed to ignore the term ∂A(β)/∂β in obtaining the marginal MLEs.
Given that the beta-binomial distribution does not belong to the exponential
family, the normalization of the density function through the working vector theory
cannot be applied directly. Hence, the previous statement is not directly extensible
in this case. However, in BBmm approach we have that the adjustment term is
defined as
A(β) = −1
2
log|M | = −1
2
log|Z ′WSZ −D−1| (3.29)
where S = diag(pi(1− pi)), W = diag(wi), wi = −vipi(1− pi) + ξi(1− 2pi),
ξi =
∑yi−1
k=0
1
pi + kφ
−∑mi−yi−1k=0 11− pi + kφ
vi =
∑yi−1
k=0
1
(pi + kφ)2
+
∑mi−yi−1
k=0
1
(1− pi + kφ)2
(3.30)
and pi = 1/[1 + exp(−x′iβ − z′iu)] for i = 1, . . . , n, being all the previous formulas
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evaluated at u = u˜ (see Appendix D.2, Equation (D.11) for further details). There-
fore, similar to GLMMs, we have shown in Equation (3.29) that in BBmm approach
the adjustment term, A(·), only depends on β through the weight matrices W and
S.
In order to show that the weight matrices vary slowly as a function of the fixed
effects, we randomly fix some values of a covariate X, dispersion parameter vector
θ and random effects u, and compare the joint-likelihood in Equation (3.26), the
adjustment term in Equation (3.29) and the sum, or equivalently, the approximation
of the log-likelihood of the model in Equation (3.27), as functions of β. Figure 3.1
shows the distribution of each mentioned function and the value where they reach
the maximum. It can be appreciated that the low scale of the adjustment term
does not alter the summation and that we get identical distributions for the joint
likelihood and the approximated likelihood. Therefore, as it is shown in the left-hand
side figure, both functions get the maximum in the same point, meaning that the
effect of the adjustment term is redundant, and that the effects of the fixed effects
in the weight matrices is insignificant.
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Figure 3.1: Distribution of the approximated marginal likelihood, joint log-likelihood
and the penalisation term. The value where each function gets the maximum is also
displayed.
Consequently, we can assume that the adjustment term in Equation (3.29) is flat
with respect to β and, following Breslow and Clayton (1993) argument, ignore it in
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the maximisation process of the fixed effects in the model.
We have shown that the adjusted term in the approximated log-likelihood in
Equation (3.25) does not carry (almost) any information about the fixed effects,
and hence, that all the information regarding β is collected by the joint likelihood
in Equation (3.26). The adjusted term in the approximated log-likelihood does not
depend on β, and hence, the random effects are canonical for the fixed effects. Lee
et al. (2006) proved that if the random effects in the model are canonical for the fixed
effects, then the MLE of the fixed effects through the marginal likelihood coincides
with the MLE from the joint maximiser of the joint log-likelihood. Therefore, based
on the previous statement, we can derive the MLE of the fixed effects by the joint
maximisation of the log-likelihood presented in Equation (3.26).
Differentiation of the joint log-likelihood in Equation (3.26) with respect to β
and u leads to the next score equations for the mean parameters,
S(β) =
∂h1
∂p
∂p
∂β
= ξ′SX
S(u) =
∂h1
∂p
∂p
∂u
+
∂h2
∂u
= ξ′SZ − u′D−1
where ξ = (ξ1, . . . , ξn)’ and ξi and S have been defined in Equation (3.30), and
h1 and h2 correspond to the log-density function of the beta-binomial and normal
distributions respectively (see Appendix D.2 for further details).
Different numerical algorithms may be used to solve the previous equations it-
eratively, such as the Newton-Raphson procedure. However, similarly to the cross-
sectional model, we derive a estimation algorithm based on the delta method for
several reasons. As it was explained in Section 2.2.1, due to the complexity of the
beta-binomial density function and the fact that it does not belong to the exponen-
tial family, estimation process based on the Newton-Raphson algorithm could be
hard to obtain, and even sometimes inappropriate (see Section 2.2.1). For instance,
the second derivatives of the joint log-likelihood with respect to the fixed and ran-
dom effects are quite complicated and the application of the expectation operator
to conclude to the Fisher scoring algorithm intractable.
First, we assume that u is fixed and try to get the estimation of β for those
fixed realizations of the random effects. Following the delta algorithm described
in Equation (2.8), we have that the approximation of the matrix of the second
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derivatives corresponds to
∂2h
∂β∂β′
≈ ∂p
∂β
′ ∂2h
∂p∂p′
∂p
∂β
.
Consequently, we have that
∂2h
∂β∂β′
≈ −X ′SV SX,
where V = diag(v1, . . . , vn) and vi = −∂ξi/∂pi has been defined in Equation (3.30)
for i = 1, . . . , n (see Appendix D.2, Equation (D.6) and Equation (D.8) for further
details).
At this point, we can apply the Fisher scoring algorithm where the negative of the
second derivatives is replaced by its expectation in a Newton-Raphson procedure.
However, as it was explained in the cross-sectional beta-binomial regression model in
Section 2.2.1, the expectation of V is intractable, and therefore,the observed Fisher
information must be used in the algorithm instead. This adjustment will usually
increase the rate of convergence, though the algorithm may be less stable if the
starting points are far from the maximum (Jørgensen, 1984). Therefore, we have
that the estimation equations for the fixed effects are defined as
βˆ
(r+1)
= βˆ
(r) − (−X ′SV SX)−1X ′Sξ.
where S,V and ξ are evaluated at the current r value of β. Hence, after some easy
operations we have that
βˆ
(r+1)
= (X ′SV SX)−1X ′SV Sνβ, (3.31)
where νβ = Xβ
(r) + (SV )−1ξ being V and ξ evaluated at βˆ
(r)
.
Once fixed the estimated βˆ, the same procedure can be developed to get the
estimation equations for the random effects. Given that the development of the
estimation procedure for the random effects is almost equal to the one performed for
the fixed effects, we will only show the final estimating equation which corresponds
to
uˆ(r+1) = (Z ′SV SZ +D−1)−1Z ′SV Sνu, (3.32)
where νu = Zu
(r) + (ZV )−1ξ being ξ and V evaluated at uˆ(r). More details about
the derivatives of the approximated log-likelihood can be found in Appendix D.2.
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Estimation of variance components
For the estimation of the dispersion or variance component vector θ, the (marginal)
maximum log-likelihood estimator might be substantially biased due to the esti-
mates of β (Lee and Nelder, 2001). Many authors have defined different likelihood
adjustments to perform inferences in the variance components in several situations
in the literature. For instance, Patterson and Thompson (1971) developed a re-
stricted or residual maximum likelihood (REML) criteria in LMMs and Breslow
and Clayton (1993) extended the approach to GLMMs. However, Lee and Nelder
(1996) developed a more general approach based on the so called adjusted profile
h-likelihood, which they proved that it is equivalent to the previously defined like-
lihood adjustments in each situation. The adjusted profile h-likelihood is defined
as
hp = hA
∣∣∣
β=βˆ,u=uˆ
,
where hA is an adjusted h-likelihood defined as
hA = h+
1
2
log{det(2piH−1)}, (3.33)
where h is the joint log-likelihood defined in Equation (3.26) and H is the corre-
sponding Hessian matrix of the model. The performed penalisation on the joint
log-likelihood is equivalent to integrating the random effects out, as in the first or-
der Laplace approximation in Equation (3.25), and then, eliminating nuisance fixed
effects β by conditioning on the maximum likelihood estimates βˆ (Lee and Nelder,
2001). Therefore, maximum adjusted profile h-likelihood estimators can be derived
for variance parameters by solving iteratively
∂hA
∂θi
∣∣∣
β=βˆ,u=uˆ
= 0,
where βˆ and uˆ are evaluated in each iteration.
As shown in Chapter 2, the delta algorithm offers an approximation procedure
of the second derivatives of the log-likelihood, which defines the Hessian matrix of
the model as
H ≈
(
X ′SV SX X ′SV SZ
Z ′SV SX Z ′SV SZ +D−1
)
, (3.34)
where all the terms involving the formula have been previously defined (see Appendix
D.2, Equations (D.5), (D.6), (D.8) and (D.10) for further details). It is worth
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noticing that D is the only term in the Hessian matrix that depends on λ, the vector
of the variance components of the random effects. Besides, unlike the usual GLMM
or even HGLM where the dispersion parameter of the conditional distribution can be
explicitly taken out from the Hessian matrix, in the BBmm the matrix V depends
implicitly on the dispersion parameter φ. Consequently, the computation of the score
equation for the dispersion parameter of the conditional beta-binomial distribution
is computationally more expensive than in models where the conditional distribution
belongs to the exponential family.
Hence, the score equations for the variance parameters of the BBmm approach
are defined as
∂hp
∂θi
=
∂h(β,θ,u)
∂θi
∣∣∣
β=βˆ,u=uˆ
+
1
2
∂log
(
det(H−1)
)
∂θi
, (3.35)
for i = 1, . . . , k + 1, where k is the number of parameters needed for specifying D,
i.e. the length of the vector λ. Notice that θi refers to either the beta-binomial
dispersion parameter φ or a parameter of the vector of variance components λ.
Property D.4 (see Appendix D.1) offers an easy decomposition of the second
term in Equation (3.35) as,
∂log
(
det(H−1)
)
∂θi
= −∂log (det(H))
∂θi
= −trace
[
H−1
∂H
∂θi
]
,
which simplifies the score equation of the variance components. In addition the score
equations can be even more simplified depending on the variance parameter we are
trying to estimate.
On the one hand, as it has been mentioned, due to the fact that the dispersion
parameter φ cannot be taken out from the Hessian matrix, the score equation for
φ is more complicated than in usual approaches. In BBmm approach, the score
equation for the dispersion parameter φ of the conditioned beta-binomial distribution
is defined as
∂hp
∂φ
=
n∑
i=0
[
yi−1∑
k=0
k
pi + kφ
+
mi−yi−1∑
k=0
k
1− pi + kφ −
mi−1∑
k=0
k
1 + kφ
]
+ trace
[
H−1
(
X ′SJSX X ′SJSZ
Z ′SJSX Z ′SJSZ
)]
,
(3.36)
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where J = diag(ji), and
ji =
1
2
∂vi
∂φ
=
yi−1∑
k=0
k
(pi + kφ)3
+
mi−yi−1∑
k=0
k
(1− pi + kφ)3
for i = 1, . . . , n. Numerical algorithms, such as Newton-Raphson can be applied to
get the maximum adjusted profile h-likelihood of the dispersion parameter of the
conditioned beta-binomial distribution.
On the other hand, by Property D.6, the score equation for the variance param-
eters of the random effects is defined as
S(θi) =− 1
2
trace
[
D−1
∂D
∂θi
]
+
1
2
u′D−1
∂D
∂θi
D−1u
+
1
2
trace
[
PD−1
∂D
∂θi
D−1
] (3.37)
where P is the right bottom block of H−1 defined as
P =
[
Z ′SV SZ +D−1 −Z ′SV SX (X ′SV SX)−1X ′SV SZ]−1 . (3.38)
Example 3.3: One independent random component
The easiest situation is the assumption of an unique independent random com-
ponent. Suppose that the random effects u = (u1, . . . , uq)
′ are iid with a nor-
mal distribution of mean 0 and variance σ2u. Namely, the variance-covariance
matrix of the random effects is defined as
D = σ2uIq.
Thus, after some calculus, following Equation (3.37) we have that
S(σu) = −σ−1u trace [Iq] + σ−3u u′Iqu+ σ−3u trace [P ] ,
and hence, the maximum adjusted profile estimator of σu is achieved by the
iterative use of
σˆu
(r+1)2 =
1
q
uˆ′uˆ+
1
q
trace [P ] ,
where P has been defined in Equation (3.38) and the matrices involving the
formula are evaluated at σˆu
(r), the estimate of σu in the rth iteration.
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
Example 3.4: Two independent random components
Another possible scenario is the assumption of two independent random com-
ponents. Assume that we have u1 = (u11, . . . , u1q1)
′ and u2 = (u21, . . . , u2q2)′
where they are independent with variance-covariance matricesD1 = σ
2
1Iq1 and
D2 = σ
2
2Iq2 respectively. Similarly, without loss of generalisation, we could
assume that the model consists of a unique random component u = (u′1,u′2)′
where the variance-covariance matrix is defined as
D =
(
D1 0
0 D2
)
=
(
σ21Iq1 0
0 σ22Iq2
)
.
Following Equation (3.37), we have that the score equations for each dispersion
parameter σ1 and σ2 are defined as
S(σ1) = −σ−11 trace
(
Iq1 0
0 0
)
+ σ−31 u
′
(
Iq1 0
0 0
)
u+ σ−31 trace
[
P
(
Iq1 0
0 0
)]
= − q1
σ1
+
1
σ31
u′1u1 +
1
σ31
trace(1:q1) [P ]
and
S(σ2) = −σ−12 trace
(
0 0
0 Iq2
)
+ σ−32 u
′
(
0 0
0 Iq2
)
u+ σ−32 trace
[
P
(
0 0
0 Iq2
)]
= − q2
σ2
+
1
σ32
u′2u2 +
1
σ32
trace(q1+1:q2) [P ] ,
where trace(a:b) corresponds to the trace of the matrix only considering the
diagonal elements that are between the ath and bth position, i.e.
trace(a:b)[P ] =
b∑
i=a
P ii.
Notice that as the variance parameters are independent the score equations
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correspond to the first example where only a random component was assumed.
Estimation of σ1 and σ2 is performed by the iterative use of
σˆ1
(r+1)2 =
1
q1
uˆ1
′uˆ1 +
1
q1
trace(1:q1) [P ] ,
σˆ2
(r+1)2 =
1
q2
uˆ2
′uˆ2 +
1
q2
trace((q1+1):(q1+q2)) [P ] ,
where matrices involving the formulae are evaluated at σˆi
(r), the estimate of
σi in the rth iteration, i = 1, 2.
Following Example 3.4, it is straightforward to generalise the estimating equa-
tions for any number of independent random components in the model.

Example 3.5: Two correlated random components
It is common in some studies the assumption that two random effects are
correlated with each other (Hedeker and Gibbons, 2006). For instance, assume
that we have a study where n individuals are measured at ti scenarios, i =
1, . . . , n, and that we construct the following linear predictor of the model,
ηij = x
′
ijβ + z
′
1iju1i + z
′
2iju2i,
for i = 1, . . . , n and j = 1, . . . , ti or in matrix notation,
η = Xβ +Z1u1 +Z2u2,
where u1 = (u11, . . . , u1n)
′ and u2 = (u21, . . . , u2n)′ are two individual level
random effects. Equivalently, we can rewrite the model for a unique random
component as,
η = Xβ +Zu
where Z = [Z1 Z2] and u = (u
′
1,u
′
2)
′.
As well as in the previous examples, we assume that u1 and u2 are normally
distributed random effects with mean 0 and variance-covariance matrix D1 =
σ21In and D2 = σ
2
2In respectively. However, in this example we assume that
the first random component is correlated with the second random component
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for each individual. Namely, we assume that the variance-covariance matrix
of the unique random component u is defined as
D =
(
σ21In ρIn
ρIn σ
2
2In
)
,
where ρ is the covariance term between the two random effects for the same
individual.
We know by Property D.6 in Appendix D.1 that the inverse of D is defined as
D−1 =
( (
σ21 − ρ2σ−22
)−1
In −
(
σ21 − ρ2σ−22
)−1
ρσ−22 In
− (σ22 − ρ2σ−21 )−1 ρσ−21 In (σ22 − ρ2σ−21 )−1 In
)
,
which is much more complicated than in the previous examples.
For instance, in order to evidence the complexity of the estimation of the
dispersion parameters when correlation is included, we are going to show the
score equation for σ1. Before applying Equation (3.37) some calculus must be
done, such as
D−1
∂D
∂σ1
= D−1
(
2σ1In 0
0 0
)
= 2σ1
(
(σ21 − ρ2σ−22 )−1In 0
(σ22 − ρ2σ−21 )−1ρσ−21 In 0
)
,
and,
D−1
∂D
∂σ1
D−1 = 2σ1
(
(σ21 − ρ2σ−22 )−1In 0
(σ−22 − ρ2σ−21 )−1ρσ−21 In 0
)
D−1
=
2σ1
σ21 − ρ2σ−22
×
(
(σ1 − ρ2σ−22 )−1In −(σ21 − ρ2σ−22 )−1ρσ−22 In
−(σ−22 − ρ2σ−21 )−1ρσ−21 In (σ−22 − ρ2σ−21 )−1ρ2σ−21 σ−22 In
)
.
Therefore, we obtain that the score equation for the variance parameter of the
first random component u1 is defined as
S(σ1) = − nσ1
σ21 − ρ2σ−22
+
σ1
σ21 − ρ2σ−22
u′D˘1u+
σ1
σ21 − ρ2σ−22
trace
[
PD˘1
]
,
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where
D˘1 =
(
(σ1 − ρ2σ−22 )−1In −(σ21 − ρ2σ−22 )−1ρσ−22 In
−(σ−22 − ρ2σ−21 )−1ρσ−21 In (σ−22 − ρ2σ−21 )−1ρ2σ−21 σ−22 In
)
.
It can be appreciated the complexity of the solution of the equation due to
all terms involving σ1. The score equations for the rest of the variance pa-
rameters σ2 and ρ are quite similar to the presented equation. Therefore,
numerical algorithms, such as Newton-Raphson, should be used to solve the
score equations of the variance parameters of the random effects.

Estimation algorithm
The estimation algorithm of the BBmm approach can be formulated in the following
way:
Step 1. Give initial values for βˆ
(0)
, uˆ(0) and θˆ
(0)
= (φ(0),λ(0)).
Step 2. Set r1, r2 ←− 0.
Step 3. Fix θˆ
(r2)
:
Step 3.1. fix uˆ(r1) and iterate Equation (3.31) until convergence of
βˆ
(r1+1)
,
Step 3.2. fix βˆ
(r1+1)
and iterate Equation (3.32) until convergence of
uˆ(r1+1),
Step 3.3. set r1 ←− r1 + 1,
Step 3.4. iterate between Step (3.1.), Step (3.2.) and Step (3.3.)
until convergence.
Step 4. Fix βˆ
(r1)
and uˆ(r1):
Step 4.1. fix λ(r2) and estimate φ(r2+1) iterating Equation (3.36),
Step 4.2. fix φ(r2+1) and estimate λ(r2+1) iterating Equation (3.37),
Step 5. r2 ←− r2 + 1.
Step 6. Iterate between Step 3., Step 4. and Step 5. until convergence.
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3.3.3 Inference
In order to perform inference of the fixed effects, we must provide a procedure to
estimate the variance of the estimation of β. The following property proved by Lee
and Nelder (1996) will allow us to estimate Var[βˆ] in a simple and closed form.
Property 3.1. Let
V =
(
V 11 V 12
V 21 V 22
)
= n
(
Var[βˆ] Cov[βˆ, uˆ− u]
Cov[uˆ− u, βˆ] Var[uˆ− u]
)
and M =
1
n
(
B C
C ′ D
)
,
where B,C and D are matrices such that
Bij = − ∂
2h
∂βi∂βj
∣∣∣
β=βˆ,u=uˆ
, Cij = − ∂
2h
∂βi∂uj
∣∣∣
β=βˆ,u=uˆ
and Dij = − ∂
2h
∂ui∂uj
∣∣∣
β=βˆ,u=uˆ
.
Then, if E[M ] is non-singular, under appropriate regularly conditions, M−1 con-
verges to V as n→∞.
In addition, this holds when entries of M are replaced by corresponding expec-
tations since B, C and D are sums of matrices. Therefore, the variance-covariance
matrix of the estimates in BBmm approach is given by the inverse of the Hessian
matrix H defined in Equation (3.34). Nevertheless, Lee and Nelder (1996) proved
that when the realized values of the random effects are known (estimated) the esti-
mation of Var[βˆ] corresponds to the inverse of the first block of H. Therefore, in
BBmm approach we have that
Var[βˆ] = (X ′SV SX)−1. (3.39)
Hence, the estimation of the variance of the MLE of the fixed effects takes into
account the information loss caused by estimating the random effects.
Danaher (1987) showed that the beta-binomial distribution satisfies the regular-
ity conditions in Definition 1.1 in Chapter 1. Hence, we have that the MLE of the
regression parameters in BBmm approach follows a normal distribution. Therefore,
the relationship in Equation (3.39) allows us performing statistical test on the esti-
mates of β = (β1, . . . , βp+1), such as the Wald’s test (Pawitan, 2001). The Wald’s
test is used to test H0 : βi = β0,H1 : βi 6= β0 , i = 1, . . . , p+ 1
3.3. Beta-binomial mixed-effects model 109
assuming that under H0 the Wald statistic
z =
βˆi − β0√
Var[βˆi]
follows a normal distribution with mean 0 and variance 1.
Deviance
When dealing with random effects regression models, Lee and Nelder (1996) pro-
posed the use of three different deviance functions depending on the model compo-
nent we want to test. First, they proposed the deviance based on the joint likeli-
hood in Equation (3.26), i.e. −2h, for testing random effects. Second, the deviance
consisting of the marginal likelihood, −2 logL, for testing the fixed effects, and, fi-
nally, the deviance based on the marginal likelihood conditional on the fixed effects,
−2logfθ(y|βˆ) for testing the variance components where fθ(y|βˆ) is the marginal
density function of the model. However, in models where the marginal likelihood
is hard to obtain, for instance the BBmm, they proposed the use of approximation
likelihoods instead. Consequently, for testing fixed effects Laplace approximation
of the marginal likelihood defined Equation (3.25) can be used, whereas for testing
the variance components the adjusted profile likelihood defined in Equation (3.33)
should be used instead.
Nevertheless, the main utility of the deviance function lies in the goodness-of-fit
criterion. The same authors defined a scaled deviance as
D(y, µˆ) = −2 [l(µˆ, φ|y,u)− l(y, φ|y,u)] (3.40)
where l(µˆ, φ|y,u) = logf(y|u, βˆ) and µ = E[y|u], for testing the goodness-of-fit of
the model. In addition, they proposed the following formula to estimate the degrees
of freedom of the model
d.f. = n− trace (H−1H∗) ,
where in BBmm approach H∗ is defined as
H∗ =
(
X ′SV SX X ′SV SZ
Z ′SV SX Z ′SV SZ
)
.
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They conclude that if the computed scaled deviance is much larger than the
estimated degrees of freedom, we may suspect the absence of some necessary fixed
or random effects in the linear predictor of the model. Notice that the scaled deviance
is based on the conditioned density function of the model, so it cannot be used for
testing dispersion parameters (Lee and Nelder, 1996).
3.3.4 Latent variable interpretation
In linear regression models, either fixed or mixed effects models, it is straightforward
to determine with the variance-covariance structure of the residuals. However, notice
that in non-linear regression models, the specification of the linear predictor does
not allow the inclusion of any error term. In this context, the latent variable theory
results of main interest as it allows estimating the variability that exits between the
errors of underlying latent variables associated with each observation.
For instance, assume that there is an unobservable continuous random variable
Y ∗i defined in the real line R, such that the binary variable Yi takes the value 1 if and
only if Y ∗i exceeds a certain threshold γ. We will denote Y
∗
i as the latent variable.
Therefore, we have the following relationship,
pii = Pr(Yi = 1) = Pr(Y
∗
i > γ).
Without loss of generality, as the location and scale of Y ∗i are arbitrary, we take
the threshold to be zero and standardize the latent variable Y ∗i to have standard
deviation equal to one.
Suppose now that the outcome depends on some given covariates X1, . . . , Xp. In
order to model the dependence of the correlated data, we define the following linear
model for the latent variable,
Y ∗i = x
′
iβ + i,
where i is the error term, which it is assumed to have a distribution with cumulative
density function F (i).
Under this model, the probability of observing a positive outcome is given by
pii = Pr(Y
∗
i > 0) = Pr(i > −ηi) = 1− F (−ηi),
where ηi = x
′
iβ is the linear predictor. If the distribution of the error term i is
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symmetric about zero, we have that F (x) = 1− F (−x), and consequently
pii = F (ηi),
which defines a GLM for binary responses with a link function equal to F−1(·).
Depending on the features of the data to be analyzed there is a wide variety of
link functions available in the literature. In particular, when dealing with binary or
binomial data it is common to link the expectation of the dependent variable with
the given covariates by means of a logit function as it corresponds to the canonical
link function (see Section 2.1.1 for more details). The logit link function is defined
as
ηi = log
pii
1− pii ,
where the cumulative density function of the logistic distribution is defined as
pii = F (ηi) =
eηi
1 + eηi
,
being −∞ < ηi <∞. Therefore, we can derive the standard density function as,
f(x) =
∂F (x)
∂x
=
ex
(1 + ex)2
,
which maintains the following symmetric property
f(−x) = e
−x
(1 + e−x)2
=
1
ex(1 + e−x)2
=
1
(1 + ex)(1 + e−x)
=
1
e−x(1 + ex)2
=
ex
(1 + ex)2
= f(x).
Moreover, the first and second order moment of the distributions are defined as
E[x] =
∫ ∞
−∞
xf(x)dx =
∫ ∞
−∞
xex
(1 + ex)2
=
xex
1 + ex
− log(1 + ex)
]∞
−∞
= 0,
Var[x] =
∫ ∞
−∞
x2f(x)dx =
∫ ∞
−∞
x2ex
(1 + ex)2
=
pi2
3
.
Consequently, the standard logistic distribution is symmetric, has mean zero and
variance pi2/3. The shape is very close to the normal distribution but it has heavier
tails as it can be appreciated in Figure 3.2 where both distributions shapes are
displayed.
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Figure 3.2: Distribution of the standard logistic distribution together with the nor-
mal distribution of mean 0 and variance pi2/3.
Therefore, the coefficients in a regression model where the logit link function has
been applied can be interpreted not only in terms of log-odds, but also as effects of
the covariates on a latent variable that follows a LM with logistic residuals. One of
the main contributions of this new specification of a regression model based on the
logit link function is that we can conclude with correlations between latent variables
associated with observations.
For instance, assume that we have a longitudinal study where n individuals
are measured in ti time points, i = 1, . . . , n. Moreover, assume that the BBmm
approach, which is based on a logit link function as shown in Equation (3.23), is
used for the modelling the data. Assume that Y ∗ij is the latent variable associated
with the observation of the ith individual on the jth observations, i = 1, . . . , n and
j = 1, . . . , ti. As explained before we can link the latent variable with the linear
predictor concluding that
Y ∗ij = x
′
ijβ + ui + ij ,
where ui ∼ N (0, σ2u) are independent random effects and ij are independent error
terms that follow a logistic distribution, being ui and ij independent i = 1, . . . , n and
j = 1, . . . , ti. Therefore, the expectation, the variance and the covariance between
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two latent variables of the same individual in BBmm approach are defined as,
E[Y ∗ij ] = E[x′ijβ + ui + ij ] = x′ijβ
Var[Y ∗ij ] = Var[x′ijβ + ui + ij ] = Var[ui] + Var[ij ] = σ2u +
pi2
3
Cov[Y ∗ij , Y ∗ik] = Cov[x′ijβ + ui + ij ,x′ikβ + ui + ik] = Cov[ui + ij , ui + ik]
= Var[ui] + Cov[ij , ik] =
σ2u if j 6= kσ2u + pi2/3 if j = k
where in a matrix notation corresponds to
E[Y ∗i ] = E[x′iβ + 1tiui + i] = x
′
iβ
Var[Y ∗i ] = Var[x′iβ + 1tiui + i] = σ
2
uJ ti +
pi2
3
Iti
where Y ∗i = (Y ∗i1, . . . , Y
∗
iti
)′, 1ti is a ti length vector of 1s, i = (i1, . . . , iti)′, Iti is the
ti×ti identity matrix and J ti is a ti×ti matrix of 1s. Consequently, the inclusion of a
random intercept per individual defines a specific correlation structure between the
latent variables associated with the observations of the same individual. Different
linear predictors, i.e. different random effect structures, lead to different correlation
structures. Specially, it is worth noticing that in longitudinal models where random
slopes are included, correlation between different latent variables is not fixed, but
instead depends on the slope variable, which it is usually defined as the time variable.
Therefore, the introduction of random effects that interact with the time variable
defines a correlation structure that changes over time, which measures the dynamic
relationship between the covariates and the outcome variables.
3.3.5 Similar approaches in the literature
It has been mentioned before that PROs have some special features, such as cor-
relation within patient responses and overdispersion, which make the fit through
exponential family distributions inappropriate (Arostegui et al., 2007). We have
defined in Section 3.2 the most widely used mixed-effects models when dealing with
longitudinal data, however, these regression approaches strict the model assumption
to exponential family distributions and Gaussian random effects. Due to the fact
that in cross-sectional data the analysis of PROs through regression models based
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on exponential family distributions is not appropriate enough, the extension to the
inclusion of Gaussian random effects for longitudinal studies will fail in the same
assumption, as Gaussian random effects are only included to model the hierarchical
structure of the correlated data.
In the literature, although few, there exist some flexible models which allow the
correct analysis of PROs in a longitudinal framework, at least in the model assump-
tion. The are two different ways of solving the fitting problem caused by the features
of PROs in mixed-effects framework: (i) include non-Gaussian random effects in a
GLMM approach or, (ii) assume conditional distributions that do not belong to the
exponential family. Following, we define the most widely used regression models
based on the cited two approaches.
We have defined in Section 2.2.2 the so-called HGLMs, where additional non-
Gaussian random effects can be included in the linear predictor of a classical GLM
(Lee and Nelder, 1996). Therefore, in PROs longitudinal framework, these models
assume that conditional on some beta and Gaussian random effects, the outcomes
follow a binomial distribution, defining the so-called binomial-beta-normal regression
model. That way, the beta random effects account for the PROs characteristics,
while the Gaussian random effects accommodate the hierarchical structure of the
longitudinal data. However, in Section 2 we have shown that in independent data
framework the performance of the marginal approach is more appropriate than the
conditional beta-binomial regression approach in terms of parameter estimation and
statistical significance. Therefore, in a longitudinal framework, even if Gaussian
random effects are introduced in the linear predictor of the BBhglm to accommodate
the correlation given by the repeated measurements, the incapacity of the conditional
model approach to assess the effect of some covariates may have on the PROs, will
lead again to the same estimation problems (see Chapter 2, Section 2.4 for more
details).
Based on a similar approach, Molenberghs et al. (2010) developed a general
methodology which combines both mixed-effects models (GLMMs) and non-Gaussian
effects to accommodate overdispersion. Similar to the HGLMs the election of the
distribution of the non-normal random effects is based on the conjugacy assumption.
Nevertheless, in contrast to HGLM where the conjugate random effects are included
as additive terms in the linear predictor of a GLMM, in the combined model the
effects multiply the parameter being modelled.
For instance, Molenberghs et al. (2012) defined the beta-binomial model with
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logit link as
yi ∼Bin(mi, pi = θiκi),
κi =
exp(x′iβ)
1 + exp(x′iβ)
(3.41)
where θi ∼ Beta(1/α, 1/α). When normal random effects are included in Equation
(3.41), closed forms cannot be reached for the mean or the variance of the model.
In addition, only when beta dispersion random effects are assumed in the model
conjugacy applies. Therefore, the authors defined the concept of strong conjugacy
as a way of expressing in which cases conjugacy remains when normal random effects
are included in the linear predictor. The strong conjugacy allows the construction
of combined models, i.e. the inclusion of Gaussian random effects and conjugate
multiplicative effects in the linear predictor of a GLM. This approach leads to the
following definition of the combined beta-binomial model,
κi =
exp(x′iβ + z
′
iu)
1 + exp(x′iβ + z
′
iu)
, (3.42)
where u ∼ N (0,D) are the usual Gaussian random effects. However, it ends up
that the combined beta-binomial regression does not satisfy the strong conjugacy
criteria if the logistic function is used. The authors avoided the strong conjugacy
problem by defining the logit model from the probit link function which does satisfy
the strong conjugacy. The authors used that
exp(y)
1 + exp(y)
≈ Φ(cy) (3.43)
where Φ(·) is the normal cumulative density function and c = (16√3)/(15pi).
Summarizing, the definition in Equation (3.42) performs the model assuming
a binomial distribution of the outcome and including two different random effects,
different in the distribution and in the form they are included in the linear predictor.
Therefore, it is straightforward to assess the differences that exists between the model
in Equation (3.42) and our proposed BBmm approach. From our point of view it
seems more reasonable to assume the marginal beta-binomial distribution as given
rather than assuming a conditional binomial distribution. In Chapter 2, we showed
that in independent data the marginal beta-binomial regression approach turned to
be more appropriate than the conditional approach in terms of the estimation and
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interpretation of the effects of the covariates. Therefore, although we do not directly
compare our proposal with the model in Equation (3.41), similar results may be
obtained due to the conditional feature of the approach. In addition, the extension
to the combined models in Equation (3.42) include two random effects that interact
in the linear predictor, which may mask the interpretation of the subject-specific
realizations and the variance of each random component.
Until now, we have defined mixed-effects model approaches based on the first
criteria, i.e. the addition of non-Gaussian random effects in the linear predictor of a
GLMM to account for the PROs characteristics. However, there exists in the liter-
ature a widely used methodology based on the second criteria, i.e. the assumption
of non-exponential family distributions. The so-called generalised additive model
for location, scale and shape (GAMLSS) was developed by Rigby and Stasinopoulos
(2005) and it is a very flexible methodology which not only deals with a very wide
range of distributions, but also allows the inclusion of random effects to accommo-
date correlation of longitudinal data in all the parameters of the given distribution.
The beta-binomial GAMLSS specification corresponds to the proposed BBmm ap-
proach, however differences in the estimation procedure lead to different parameter
estimates as it will be shown.
Due to the similarity that exists in the beta-binomial mixed-effects model def-
inition between the proposed BBmm and GAMLSS approaches, we will define
GAMLSS in more detail in the following lines. The GAMLSS approach models
the vector of parameters ζ = (ζ1, . . . , ζs)
′ of a general population probability den-
sity function f(y|ζ). It assumes that, for j = 1, . . . , s, each distribution parameter
ζj is connected to some given covariates and random effects, and hence, that, for
i = 1, . . . , n, the observations yi are independent given those random effects.
Let y = (y1, . . . , yn)
′ be the observations of the response variables and, for
j = 1, . . . , s, gj(·) be a known monotonic link function connecting ζj to the given
covariates and random effects through
gj(ζj) = ηj = Xjβj +
Kj∑
k=1
Zkjukj , (3.44)
where ζj and ηj are vectors of length n, βj = (β1j , . . . , βpjj)
′ is the fixed effects
parameter vector of length pj , Xj is a known design matrix of order n×pj composed
by the given covariates, Zkj is a fixed known n× qkj design matrix composed by the
random structure of the model and ukj is a random vector of length qkj . The model
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assumes that, for each j = 1, . . . , s and k = 1, . . . ,Kj , the random effects vector ukj
has a normal distribution with mean 0 and variance-covariance matrix Dkj , where
Dkj depends on a vector of hyperparameters λkj . Notice that for each distribution
parameter ζj , j = 1, . . . , s, the random effects vectors ukj , k = 1, . . . ,Kj , can be
combined into a single vector uj = (u
′
1j , . . . ,u
′
Kjj
)′ with a single design matrix
Zj = [Z1 · · ·ZKj ]. Therefore, the formulation of the GAMLSS approach is now
defined as
gj(ζj) = ηj = Xjβj +Zjuj ,
where gj(·), ηj , βj and Xj have been previously defined in Equation (3.44), but
now uj is a random effects vector of length qj =
Kj∑
k=1
qkj and Zj is a known n × qj
design matrix of the random effects.
In BBmm approach we have considered that the only parameter that depends
on the given covariates is the mean or probability parameter and hence, we have
assumed that the dispersion parameter φ is equal for all the individuals. Therefore,
in terms of the BBmm approach specification, GAMLSS beta-binomial regression
model is defined as g1(ζ1) = η1 = Xβ1 +Zug2(ζ2) = η2 = β2 (3.45)
where, on the one hand, ζ1 = (ζ1i, . . . , ζ1n)
′ is the location parameter assumed dif-
ferent for each individual, which corresponds to the probability parameter of the
conditional beta-binomial distribution p and g1(·) is the logistic link function. On
the other hand, ζ2 is the scale parameter assumed equal for all the individuals, which
corresponds to the dispersion parameter of the conditional beta-binomial distribu-
tion φ and g2(·) is the logarithm link function. As it can be appreciated the model
assumptions match with the BBmm approach, however, we will show that there
exist remarkable differences in the estimation procedure that lead to misleading
conclusions.
Finally, it is worth noticing that Wu et al. (2017) proposed a longitudinal beta-
binomial model for overdispersed binomial data where they estimated regression
parameters under a probit model using the GEE approach (Zeger and Liang, 1986).
It has been stated in Section 3.1.2 that mixed-effects model approaches are more
appropriate for analyzing longitudinal data as they are more flexible regarding drop
out (missing data), but specially, because they do allow for subject-specific effects
which could be quite useful to understand individual variability in the longitudinal
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response process and predicting responses for a given subject or a set of individuals
from a particular grouping hierarchy. Therefore, as we have mentioned before, we
will only focus on mixed-effects regression models for the analysis of longitudinal
PROs.
3.3.6 Comparison to other approaches
It is straightforward to find out differences between BBmm and previously cited
regression approaches where the conditional distribution belongs to the exponen-
tial family and non-Gaussian random effects are included in the linear predictor.
However, it is not straightforward to appreciate the differences among BBmm and
approaches considering non-exponential family distributions, such as GAMLSS. In-
deed, as we have mentioned before, the main difference between BBmm and GAMLSS
methodologies remains in the estimation process. In fact, while the estimation proce-
dure of BBmm approach is based on a classical full likelihood framework, GAMLSS
is based on an empirical Bayesian argument to make the inference.
As it was shown in Section 3.3.5, the GAMLSS approach is able to model all
the parameters of the conditional distribution by the inclusion of fixed and random
effects in the linear predictors. In particular, the beta-binomial distribution consists
of two parameters, the probability parameter p and the dispersion parameter φ.
Therefore, GAMLSS approach allows for the modelling of both parameters through
fixed and random effects. However, in order to compare like with like the GAMLSS
and the BBmm approaches, the linear predictor corresponding to the dispersion
parameter is restricted to the inclusion of a unique fixed effect. Let us denote β∗ the
vector that contains the fixed effects β1, for modelling the probability parameter,
and β2, for the dispersion parameter (see Equation (3.45) for more details).
The estimation procedure of the fixed and random effects (in all the linear pre-
dictors) in GAMLSS methodology is done by means of a posterior mode estimation
(Berger, 1985). Indeed, the model assumes that the joint distribution of all the
parameters involving the model is given by
f(y,β∗,u,λ) = f(y|β∗,u)f(u|λ)f(λ)f(β∗),
where f(y|β∗,u) corresponds to the beta-binomial distribution and f(u|λ) is the
normal distribution of the random effects, and f(λ) and f(β∗) are appropriate prior
distributions of λ and β∗ parameters respectively. Assuming that the hyperparam-
eters λ, i.e. the variance components of the random effects, are fixed and, assuming
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a constant improper prior for β∗, then the posterior distribution for the fixed and
random effects is given by
f(β∗,u|y,λ) ∝ f(y|β∗,u)f(u|λ). (3.46)
Therefore, the estimation of β∗ and u in GAMLSS approach is done by the joint
maximisation of the posterior distribution in Equation (3.46). Notice that the log-
arithm of the defined posterior distribution for β∗ and u coincides with the joint
log-likelihood in BBmm presented in Equation (3.26), i.e.
log f(β∗,u|y,λ) ∝ log f(y|β∗,u) + log f(u|λ) = h(β,θ|y,u),
where β is the fixed effect in BBmm approach which corresponds to β1 in GAMLSS
approach and φ (or β2 in GAMLSS) is included in the variance components vector θ.
Consequently, the estimation of the fixed and random effects in GAMLSS is done by
maximising the joint likelihood exactly as in BBmm approach. However, notice that
there is a crucial difference. In GAMLSS approach the dispersion parameter φ is
modelled by a unique fixed effect (exp(β2)), and hence, as the rest of the fixed effects,
it is estimated by maximising the joint log-likelihood (posterior likelihood). On the
contrary, in BBmm approach the dispersion parameter φ is considered as a variance
parameter and included in the variance parameter vector θ. Lee and Nelder (1996)
showed that the estimates of dispersion parameters must be done by a penalisation
of the joint likelihood in order to avoid the bias owing to the estimates of the fixed
and random effects. The idea is based on the assumption that only parameters
that are canonical can be estimated jointly. Therefore, in contrast to GAMLSS,
in BBmm approach the joint log-likelihood is penalised before maximisation with
respect to θ, and hence to φ, is performed. Indeed, based on the idea of avoiding
the bias of previous estimations of fixed and random effects, even in GAMLSS,
the joint log-likelihood (posterior likelihood) is penalised for the estimation of the
hyperparameters λ.
3.4 Simulation study
In this section, we carry out a simulation study in order to evaluate the performance
of BBmm and GAMLSS approaches when analyzing beta-binomial mixed-effects
models. In order to perform the simulation study, we use our R-package PROreg
presented more in detail in Chapter 5, while the GAMLSS approach is implemented
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with the gamlss R-package version 5.0-2 (Stasinopoulos and Rigby, 2007).
We have generated 100 random realizations of 200 observations of a dependent
variable Y , which conditional on some simulated random effects follows a beta-
binomial distribution with fixed maximum number of scores m, probability param-
eter p and dispersion parameter φ. For the sake of clarity, we only consider a single
covariate in the linear predictor, which follows a normal distribution of mean 1 and
standard deviation 2. Consequently, only two fixed effects (in BBmm terminology)
have been considered, β0 = 1 and β1 = −1.5. Furthermore, we have considered
50 realizations of the random effects assuming a normal distribution of mean 0 and
standard deviation σ, where each component is randomly connected from 1 to 9
observations. Note that, according to the general notation in Equation (3.22), in
this case we consider the vector of the variance components of the random effects λ
equal to σ and D = σ2I50. Therefore, the model is defined as
logit(p) = Xβ +Zu
where β = (β0, β1), u is the random effects vector of length 50,
X =

X1
...
X50

200×2
where Xi =

1 xi,1
...
...
1 xi,ni

ni×2
and Z =

1n1 0 · · · 0
0 1n2 · · · 0
...
...
. . .
...
0 0 · · · 1n50

200×50
where 1ni is a column vector of 1s of length ni, being ni ∈ {1, . . . , 9} and
50∑
i=1
ni = 200.
Indeed, this case study can be considered as a longitudinal study where each of the
50 individuals has from 1 to 9 repeated realizations of an event.
The simulation study has been divided in several scenarios depending on the
variability of both the random effects and the conditional beta-binomial distribution.
We consider three possible values, {0.5, 1, 1.5}, for the dispersion parameters φ and
σ, and hence, a total of 9 scenarios with all the possible combinations are defined.
Estimates of all the parameters have been obtained with both methodologies.
However, only results for the slope, β1, and the beta-binomial dispersion parame-
ter φ will be shown due to the following reasons. First, for simplicity, clarity and
brevity, given that including the same analysis for all the parameters can make the
reading quite dense and mask relevant conclusions. Second, to study the relation-
ship between the outcome variable with individual or patient characteristics has
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become one of the primary aims of many longitudinal studies in medical or biolog-
ical framework. Consequently, we consider that the slope, β1, is the focus of many
studies, and hence, it needs an in-depth analysis in order to check the efficiency
of the algorithms. Finally, as we have mentioned in Section 3.3.6, the main dif-
ference between the estimation approaches lies in the estimation of the dispersion
parameter of the conditional beta-binomial distribution. Hence, in order to look for
differences between the algorithms, we also show a detailed analysis of the estima-
tion of log(φ). Nevertheless, adequacy of the estimates for the other parameters has
been also checked.
Table 3.1 shows the results of the simulations for the mentioned parameters. On
the one hand, the mean, ASD, ESD, EMS and coverage probability of the 95% Wald
confidence intervals for the estimates of the slope β1 are shown. On the other hand,
the mean, ASD, ESD and EMS of the estimates of the logarithm of the conditional
beta-binomial dispersion parameter φ are also shown for the defined scenarios.
Results show that the ASD and ESD in BBmm approach remain quite similar in
all the scenarios. However, as regards to the GAMLSS approach, results are more
contradictory. Even in the lowest dispersion case, i.e. σ = 0.5, φ = 0.5, the ASD
doubles the value of the ESD. Hence, GAMLSS approach inflates the standard devi-
ation of the estimates and consequently, confidence intervals for the slope parameter
are larger than they should, which makes the coverage probability pointless. Fur-
thermore, although in GAMLSS confidence intervals are over-estimated, it can be
appreciated in Table 3.1 that as variance parameter σ increases BBmm approach
gets much better results in terms of coverage percentage of the slope. For instance,
in the largest variability scenario (φ = 1.5 and σ = 1.5) the coverage probabil-
ity of the GAMLSS approach is equal to 33%, while in the BBmm approach it is
83%. Therefore, we can conclude that as the dispersion parameter of the random
effects increases, results provided by the GAMLSS approach worsen in terms of the
significance of the parameters.
Regarding the EMS of the parameters, Table 3.1 shows than when the dispersion
of the random effects is low (σ = 0.5) both methodologies perform similarly. How-
ever, when the variance parameter σ increases there exist differences between the
approaches. EMS in the BBmm approach remains quite constant in all the scenarios,
nevertheless in the GAMLSS approach they increase as the dispersion parameter of
the random effects increases.
Figure 3.3 shows the estimates of parameters β1 and log(φ) for the different
scenarios. In the right panel, we can observe the resulting estimations for the slope
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Figure 3.3: Boxplots of the estimates of the parameters β1 and log(φ). In the right
panel the plots show the estimates for β1, while in the left panel estimates for log(φ)
appear. Each group of boxplots describes three scenarios corresponding to the all 9
scenarios.
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Table 3.1: Results for 100 converged simulations with 200 number of observations.
Scenarios β1 log(φ)
σ φ Method Mean ESD ASD EMS CP Mean ESD ASD EMS
0.5 0.5 BBmm -1.500 0.127 0.110 0.016 92 -0.727 0.232 0.162 0.055
GAMLSS -1.449 0.120 0.244 0.017 99 -0.549 0.195 0.395 0.059
1 BBmm -1.520 0.151 0.131 0.023 91 -0.051 0.182 0.163 0.036
GAMLSS -1.456 0.128 0.256 0.019 100 0.106 0.143 0.400 0.032
1.5 BBmm -1.530 0.166 0.143 0.028 88 0.323 0.208 0.171 0.050
GAMLSS -1.469 0.147 0.255 0.023 100 0.466 0.186 0.410 0.038
1 0.5 BBmm -1.472 0.113 0.105 0.014 91 -0.774 0.193 0.165 0.044
GAMLSS -1.280 0.096 0.215 0.058 95 -0.254 0.151 0.387 0.215
1 BBmm -1.441 0.145 0.121 0.025 85 -0.091 0.227 0.164 0.060
GAMLSS -1.255 0.112 0.214 0.073 90 0.311 0.171 0.394 0.126
1.5 BBmm -1.494 0.180 0.137 0.032 88 0.296 0.180 0.174 0.044
GAMLSS -1.279 0.126 0.217 0.065 89 0.686 0.169 0.408 0.107
1.5 0.5 BBmm -1.462 0.117 0.100 0.015 90 -0.752 0.217 0.171 0.051
GAMLSS -1.092 0.074 0.182 0.172 30 0.121 0.137 0.382 0.681
1 BBmm -1.483 0.142 0.119 0.021 93 -0.314 0.198 0.171 0.057
GAMLSS -1.097 0.093 0.186 0.171 35 0.585 0.134 0.394 0.361
1.5 BBmm -1.469 0.180 0.132 0.033 83 0.309 0.208 0.178 0.052
GAMLSS -1.098 0.114 0.187 0.174 33 0.904 0.165 0.407 0.275
ESD: Empirical Standard Deviation; ASD: Average Standard Deviation; EMS: Expected Mean
Square errors; CP: Coverage Probability of 95%.
β1, while in the left panel estimates for the logarithm of the beta-binomial dispersion
parameter φ are shown. It is worth mentioning that BBmm approach gives similar
bias of the slope parameter in all the scenarios, and hence, we can conclude that
it is a stable methodology as the variance of the data do not alter its performance.
However, it can be noticed that as the variance parameter σ increases, the bias of
the estimate of the slope parameter in GAMLSS increases as well. Besides, similar
results can be obtained from the estimation of the dispersion parameter of the beta-
binomial distribution φ. Apparently, the increase of σ do not affect the estimations
of φ through BBmm approach, but, on the contrary, it worsens the performance of
GAMLSS approach considerably.
In summary, we have shown that, not only estimates of the slope, but also
estimates of the dispersion parameter φ are more accurate in terms of bias and
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expected mean square error in BBmm approach than in GAMLSS. In addition,
we also have evidenced the over-estimation of the standard deviation of the es-
timates in GAMLSS approach, which could conclude on inappropriate statistical
inference. Consequently, based on the results of the simulation study we can state
that, although both methodologies perform similarly with low variance parameter
σ, estimates with BBmm approach are better in general as σ increases. Hence, we
propose the use of BBmm methodology as an unified way to analyse real data by a
beta-binomial mixed-effect model.
3.5 Application to real data
In this section, we apply the developed beta-binomial mixed-effects model approach
to the data introduced in Chapter 1.
First of all, as an illustration of the applicability of the proposed regression
approach, we analyse the Paquid research programme data (see Section 1.3.2). As
it was mentioned, the Paquid research programme was developed to measure the
cognitive status and incidence of dementia and Alzheimer’s disease in elderly people
in South-Western France. It contains MMSE measurements which have already
been fully described in Section 1.2.3. For the real application, we use a subsample of
the Paquid dataset which is freely available at lcmm R-package (Proust-Lima et al.,
2017). In order to show the adequacy of the proposed methodology, we validate
the obtained results in terms of the effects of the covariates in the cognitive status
comparing them with the results in the literature when analysing the incidence of
dementia and Alzheimer.
Finally, once the applicability of the proposed methodology has been illustrated
by the analysis of the Paquid data, we focus our attention on the COPD Study
introduced in Section 1.3.1. However, compared with the cross-sectional analysis of
the COPD Study in Chapter 2, in this case, we will analyse longitudinal measure-
ments provided by the SGRQ which was introduced in Section 1.2.2. Therefore, we
will not only restrict the analysis to the first measurement of each individual and
instead, all the longitudinal features of the study will be considered.
3.5.1 Mini Mental Score Examination: Paquid Research Programme
It is well known that MMSE scores have a skewed distribution, accumulating values
at one or both edges (0 and 30) of the scale (Folstein et al., 1988). In fact, we
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have shown in Figure 1.7 in Section 1.4.3, that the distribution of the MMSE scores
of the Paquid program subsample tend to accumulate in the right side of the scale,
displaying a J-shaped curve, which exponential family distributions are not able to fit
appropriately. Instead, the beta-binomial distribution has been shown to be a good
candidate due to its distributional flexibility allowing for a reasonable fit compared
to the exponential family distributions. Therefore, we consider the analysis of the
Paquid research programme using a mixed-effects regression model based on the
beta-binomial distribution. The data were collected in a longitudinal context where
the measurements of each patient were observed along time. This process led to the
so-called repeated measurements and consequently, to non-independent structures
in the data. Hence, in order to accommodate the correlation that may exit among
longitudinal measurements provided by each patient, we include individual level
random effects in the linear predictor of the model. That way, we assume that the
ni observations of the ith patient are iid drawn from a beta-binomial distribution.
Following BBmm approach, we link the probability parameter of the beta-binomial
distribution with the given covariates and random effects by means of a logit link
function. In other words, we assume that,
yij |ui ∼ BB(mi, pij , φ) indep. j = 1, . . . , ni
ηij = logit(pit) = x
′
ijβ + ui,
(3.47)
where β are the fixed effects, xij is a row of the full rank design matrix composed by
the covariates and ui is the random component attributed to the ni observations of
the ith individual, i = 1, . . . , n, n = 498 and j = 1, . . . , ni. Hence, we assume that
observations from different individuals are independent, while the observations from
the same individual are connected through a random component. Therefore, we pro-
pose a random intercept model where the random effects vector u = (u1, . . . , un)
′ is
drawn from a multivariate normal distribution with mean 0 and variance-covariance
matrix D = σ2uIn.
If we consider the latent variable interpretation described in Section 3.3.4, we
can assume that a continuous latent variable Y ∗ij underlines the observed yij for the
ith individual in time j, i = 1, . . . , n and j = 1, . . . , ni. That way, the variance of
the random effects u, σ2u, represents the between-subject variation of the model, and
the variance of the logistic distribution of the errors in the model for y∗ij , pi
2/3, rep-
resents the variation within subjects (McCullagh and Nelder, 1989). Consequently,
correlation between two latent observations of the same individual, y∗ik and y
∗
ij , is
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defined as ρ = σ2u/(σ
2
u + pi
2/3).
Table 3.2: Results for the application of the random intercepts beta-binomial mixed-
effects model in the Paquid research programme subsample.
Covariates Levels Estimate SD p-value
(Intercept) - 3.580 0.216 <0.001
Dependency level no - - -
mild -0.094 0.043 0.027
moderate -0.358 0.046 <0.001
severe -1.145 0.061 <0.001
Age - -0.050 0.003 <0.001
Age at dementia diagnosis - 0.043 0.003 <0.001
Dementia diagnosis no - - -
yes -0.570 0.028 <0.001
Age at the entry of the cohort - -0.015 0.003 <0.001
Educational level no - - -
yes 0.604 0.028 <0.001
log(φ) - -6.567 0.806 -
σ - 0.615 0.043 -
SD: Standard deviation.
Table 3.2 illustrates the results after the application of the BBmm approach in
the Paquid data subsample. It can be appreciated that all the covariates in the
model are statistically significant, concluding that they alter the cognitive status of
patients. The standard deviation of the heterogeneity between the individuals at
baseline is 0.615. The total deviance of the model is 1898.1, and the null deviance or
deviance of the null model is equal to 6791.1, where the p-value associated with the
goodness-of-fit deviance test is lower than 0.001. Several conclusions can be obtained
from the clinical interpretation of data in Table 3.2. First, as it was expected, a more
severe dependency status worsens the cognitive status of the subject. Second, the
increase of the age also worsens the cognitive mental status of the patients. Indeed,
an increase of 5-year increases by 1/exp(−5 × 0.050) = 1.284 the odds of having
a smaller MMSE score or worse cognitive status. Moreover, both the diagnosis of
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dementia (βdem = −0.570) and a later entry in the study (βage init = −0.015) also
increase the risk of having worse cognitive status (lower MMSE score). However,
a later dementia diagnosis (βage dem = 0.043) and having at least primary school
educational level (βCEP = 0.604) increases the odds of having a larger MMSE score,
i.e. a better cognitive status. The estimated standard deviation of the random effects
is 0.615, which means that the correlation between latent observations of the same
individual is 0.6152/(0.6152 + pi2/3) = 0.103. Additionally, Table 3.2 shows that
the estimation of the dispersion parameter of the beta-binomial distribution is φ =
0.001 (log(φ) = −6.567), indicating that dispersion of the outcome data decreases
when the covariates are included in the model (the beta-binomial distributional fit
performed in Chapter 1 led to φ = 0.113).
The obtained results are similar to the results available in the literature regard-
ing the effect of the analysed covariates in the MMSE scores. For instance, in other
study, Matallana et al. (2011) stated that there exists a correlation between the edu-
cational level and the cognitive status of the patients and, in fact, they showed that
a higher educational level is related with a higher score in the MMSE questionnaire.
On the whole, we have applied the proposed methodology to the Paquid research
programme and we have reached clinically valid results which are in line with the
available literature for the analysis of the MMSE questionnaire. In addition, re-
garding the interpretation of the covariate effect, we have shown that the BBmm
approach offers an easy quantification of the effects in terms of odds-ratio which is
very familiar to clinical researchers.
3.5.2 St. George’s Respiratory Questionnaire: COPD Study
One of the main objectives of the COPD Study was to assess the evolution of the
health-status of the patients during the cohort. Although in the COPD Study
longitudinal data was picked up by means of two different PRO questionnaires,
we will only show the analysis of the lung disease specific, the SGRQ (see Section
(1.2.2)). We believe that results for one instrument are enough to illustrate practical
validity of the proposed methodology. Moreover, pneumologists were interested in
measurements provided by the SGRQ due to the fact that it is an specific respiratory
questionnaire, and therefore, it could show the clinical evolution of patients more
precisely than the SF-36. They were interested to know if there is a substantial
(statistically and clinically significant) worsening, or at least a change, in the health-
status of COPD patients as time goes by, and in that case, quantify the evolution
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and detect variables related to it. More detailed results over time will be discussed
jointly with clinical researchers in a future work.
In Section 1.2.2, we have described the SGRQ, which decomposes the health-
status of the patients in three dimensions: activity, symptoms and impacts. We have
mentioned that originally, each dimension is bounded in a 0−100 scale. However, as
it was displayed in Figure 1.6 the normal distribution does not offer an appropriate
fit of the scores, and additionally, it does not match with the boundary condition,
leaving tails out of the 0 − 100 scale. Therefore, we have proposed a recoding
procedure of the scores in order to apply the beta-binomial distribution. Based on
the result provided by Jones (2005), there exits a clinically significant change in the
score only if a four points threshold is exceeded. Consequently, we have divided the
SGRQ scores in four length subintervals and then recode them as it was shown in
Table 1.5 in Chapter 1.
As regards to the statistical methodology, we will use the BBmm approach to
assess the health evolution of the COPD patients. For that purpose, for each di-
mension a longitudinal study is carried out where subject-specific random intercepts
and slopes are included in the model. In fact, the model is defined as follows: as-
sume that we have n individuals where each individual provides ki measurements
over time, i = 1, . . . , n. We denote as yij the observation of the ith individual in
the jth time point which, conditioned by the random effects u and v, is iid drawn
from a beta-binomial distribution with parameters mi, pij and φ, i = 1, . . . , n and
j = 1, . . . , ki. In addition, we assume that we measure the day each response was
provided and include them in a year-scale in the time covariate t. Finally, we apply
the following model to the data
ηij = log
(
pij
1− pij
)
= (β0 + ui) + (β1 + vi)tij , (3.48)
where ηij is the linear predictor of the model, β0 and β1 are the regression pa-
rameters, ui ∼ N (0, σu) and vi ∼ N (0, σv) are the random effects of the model
and pij is the probability parameter of the beta-binomial distribution i = 1, . . . , n,
j = 1, . . . , ki. For the sake of clarity, we are going to describe the meaning of each
parameter in Equation (3.48):
• holding the contribution of each individual ui and vi, β0 stands for the intercept
of the regression, i.e. the expected health-status of the population at baseline.
• holding the contribution of each individual ui and vi, β1 stands for the slope
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of the regression, i.e. the expected evolution of the health-status of the popu-
lation.
• ui represents the difference of the population’s and ith individual’s health-
status at baseline.
• vi represents the difference of the health-status evolution between the ith in-
dividual and the population.
• σu determines the standard deviation of the health-status of the individuals
at baseline.
• σv determines the standard deviation that exists in the health-status evolution
between the patients.
Table 3.3 shows the results of the model in Equation (3.48) applied to the three
SRGQ dimensions of the COPD Study. It displays the estimation, standard de-
viation and p-values associated with the estimation of each regression parameter.
Additionally, it shows the odds-ratio for the estimation of the slope. Table 3.3 also
displays the estimation and standard deviation of the dispersion parameters of the
model σu, σv and log(φ).
It must be mentioned that the algorithm failed to converge showing that the
estimation of σv tended to zero for the impacts dimension. Therefore, we adjusted
the model in Equation (3.48) removing the random slopes effects from the linear
predictor and evaluated it again in the mentioned dimension. Consequently, the
estimation of σv is not displayed in Table 3.3 for impacts.
Regarding the interpretation of the results, Table 3.3 shows that the evolution of
the patients differs from one dimension to the others. For the activity component of
the SGRQ, the estimated coefficient of time in years is 0.027. Therefore, the odds-
ratio of having a worsening in activity dimension is 1.027 (exp(0.0270) = 1.027)
for each year of evolution. In terms of the interpretation, each year of evolution is
associated with an odds-ratio of 1.028 for a worse activity, in other words, each year
of evolution is associated with a 2.8% worsening in activity, which is statistically
significant (p= 0.001). Moreover, the standard deviation of the random effects are
σu = 1.180 and σv = 0.123 for the random intercepts and slopes respectively. On the
one hand, it means that centred in −0.186 the standard deviation of the scores of the
individuals in activity is 1.180 at baseline. On the other hand, as time goes by, and
centred in 0.027, the slopes of the regression (evolutions) for different individuals
have a standard deviation equal to 0.123.
130 Chapter 3
Table 3.3: Results for the beta-binomial longitudinal model applied to the three
SGRQ dimensions provided in the COPD Study.
Dimension Covariate Estimate SD OR p-value
Activity
(Intercept) -0.186 0.026 − <0.001
Year 0.027 0.008 1.027 0.001
σu 1.180 0.037 − −
σv 0.123 0.006 − −
log(φ) -3.295 0.086 − −
Symptoms
(Intercept) -0.306 0.029 − <0.001
Year 0.007 0.009 1.007 0.493
σu 0.760 0.025 − −
σv 0.093 0.006 − −
log(φ) -2.610 0.057 − −
Impacts
(Intercept) -1.320 0.023 − <0.001
Year 0.003 0.007 1.003 0.673
σu 0.972 0.030 − −
log(φ) -4.050 0.115 − −
SD: Standard deviation; OR: Odds-ratio.
For the symptoms component of the SGRQ, the estimated coefficient of time
in years is 0.007. Therefore, the odds-ratio of having a worsening in the symptoms
dimension is 1.007 (exp(0.007) = 1.007) for each year of evolution. In terms of the
interpretation, each year of evolution is associated with an odds-ratio of 1.007 for
worse symptoms, in other words, each year of evolution is associated with a 0.7%
worsening in symptoms, which is not statistically significant (p= 0.493). Regarding
the variability of the random effects, on the one hand, the standard deviation of the
random intercepts or status at baseline is 0.760, which shows less variability than
activity. On the other hand, centred in 0.007, the standard deviation of the random
slopes (evolutions) is 0.093.
Finally, for the impacts component, the estimated coefficient of time in years is
0.003. Therefore, the odds-ratio of having a worsening in the impacts dimension is
1.003 (exp(0.003) = 1.003) for each year of evolution. In terms of the interpretation,
each year of evolution is associated with an odds-ratio of 1.003 for worse impacts, in
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other words, each year of evolution is associated with a 0.3% worsening in impacts,
which is not statistically significant (p= 0.673). As it has been mentioned, the stan-
dard deviation of the random slopes was equal to zero, meaning that there is no
variability in the evolution among patients. Therefore, the model is implemented
with a single random component (random intercepts) whose standard deviation is
equal to 0.972. In conclusion, in the impacts dimension the expected population evo-
lution is not statistically significant and, moreover, there are no differences between
the evolution trend of different patients.
It must be mentioned that the standard deviations of the random slopes in both
activity (σv = 0.123) and symptoms (σv = 0.093) dimensions are much larger than
the expected population evolution (βˆ1 = 0.027 and βˆ1 = 0.007 respectively). Conse-
quently, although in activity the population evolution is expected to worsen, there
are even patients that improve their health-status. In symptoms we may not expect
any change in the status of patients however, due to the previous argument, there
are patients that improve their quality of life while others deteriorate. In fact, this
shows the variability that exists in the PRO analysis due to the implicit subjective
nature of the outcomes. Figure 3.4 displays the expected population evolution and
the evolution of each patient in activity dimension. It is straightforward to notice in
the figure the variability that exists between the baseline health-status and evolution
in the data.
Once the unadjusted evolution of the patients has been assessed, we will fit the
same longitudinal model described in Equation (3.48), but adjusted by covariates.
In Chapter 1, we have mentioned that Esteban et al. (2016) divided the patients
participating in the COPD Study in four subtypes, were each subtype was associated
with different health-status and characteristics. Therefore, in order to measure the
evolution over time of the patients taking into account the special characteristics
they may have, we are going to fit the following model,
ηij = log
(
pij
1− pij
)
= (β0 + ui + β1Si) + (β2 + vi + β3Si)tij , (3.49)
where Si is a vector consisting of three binary variables which indicate the subtype
the ith patient belongs and β1 and β3 consist of 3 components for the B, C and D
subtypes (the A subtype has been taken as reference). As it can be appreciated in
Equation (3.49), we do not consider the option that individuals transit over subtypes
as the objective is to asses the evolution of patients that belonged to a specific
subtype at baseline.
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Figure 3.4: Estimated evolution trends in activity dimension for the individuals in
the cohort. The red line stands for the expected evolution, whereas the grey lines
refer to each individual.
Table 3.4 displays the estimation, standard deviation and p-values associated
with the estimation of each regression parameter. Additionally, it also shows the
exponential of the fixed effects coefficients that could be directly interpreted as
odds-ratios. Table 3.4 also displays the estimation and standard deviation of the
dispersion parameters of the model σu, σv and log(φ). Regarding the interpretation
of the results, Table 3.4 shows that the evolution of the patients differs from one
dimension to the others.
Several conclusions can be obtained from Table 3.4. For instance, it is worth
mentioning that the only dimension where there were differences between the evo-
lution of patients within subtypes was symptoms. In the other two, patients in
each subtype evolved equally over time hence, we did not include random slopes
as σv tended to zero in the BBmm algorithm. Table 3.4 shows that although there
are statistically significant differences between the subtypes at baseline in all the
dimensions, all of them evolve equally. Moreover, the only dimension where the evo-
lution of patients is statistically significant is activity (p-value= 0.038 for subtype
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Table 3.4: Results for the longitudinal beta-binomial model including cluster classi-
fication applied to the three SGRQ dimensions provided in the COPD Study.
Dimension Covariate Estimate SD OR p-value
Activity
(Intercept) -0.900 0.050 − < 0.001
Year 0.031 0.015 1.031 0.038
Subtype B 0.787 0.066 2.197 < 0.001
Subtype C 1.801 0.089 6.056 < 0.001
Subtype D 0.780 0.085 2.18 < 0.001
Year × Subtype B 0.013 0.021 − 0.530
Year × Subtype C -0.023 0.029 − 0.422
Year × Subtype D -0.012 0.029 − 0.691
σu 1.032 0.032 − −
log(φ) -3.013 0.073 − −
Symptoms
(Intercept) -0.561 0.053 − < 0.001
Year 0.004 0.016 1.004 0.825
Subtype B 0.282 0.071 1.326 < 0.001
Subtype C 0.740 0.090 2.096 < 0.001
Subtype D 0.189 0.091 1.208 0.037
Year × Subtype B 0.026 0.022 − 0.239
Year × Subtype C -0.033 0.030 − 0.263
Year × Subtype D -0.001 0.031 − 0.985
σu 0.726 0.024 − −
σv 0.096 0.005 − −
log(φ) -2.619 0.058 − −
Impacts
(Intercept) -1.485 0.050 − < 0.001
Year 0.010 0.015 1.010 0.503
Subtype B 0.497 0.065 1.644 < 0.001
Subtype C 1.304 0.078 3.684 < 0.001
Subtype D 0.563 0.082 1.756 < 0.001
Year × Subtype B 0.013 0.020 − 0.510
Year × Subtype C -0.047 0.025 − 0.063
Year × Subtype D -0.013 0.028 − 0.643
σu 0.983 0.031 − −
log(φ) -3.547 0.095 − −
SD: Standard deviation; OR: Odds-ratio. Subtype A was stated as reference.
A and differences between subtypes were not statistically significant). For instance,
considering the activity dimension the odds-ratios for worse initial activity were 2.2,
6.2 and 2.2 for subtypes B, C and D versus subtype A being all of them statistically
significant. As regards to evolution, the exponential of the fixed effects coefficients
cannot be interpreted directly as odds-ratios, due to the presence of interaction
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terms in the model. As an example, each year of evolution is associated with a
3.1% of worsening activity for subjects on subtype A (OR= exp(0.031) = 1.031),
whereas it is associated with a 4.5% of worsening activity for subjects on subtype
B (OR= exp(0.031 + 0.013) = 1.045), although this difference was not statistically
significant (p-value=0.530). The rest of the effects would be interpreted in a similar
way.
Therefore, in general terms, we can state that the evolution of COPD patients
does not depend on the initial health-status defined by the cluster classification, as
all of them evolve similarly over time.
3.6 Conclusions and discussion
Mixed-effects regression models are a useful technique to deal with many types of
data with hierarchical or non-independent structures. LMMs (see Section 3.2.2),
but specially GLMMs (see Section 3.2.3) are in practice the most used methodolo-
gies for analysing longitudinal or correlated data. GLMMs restrict their conditional
assumptions to exponential family distributions, which cover most of the real scenar-
ios, and include Gaussian random effects to accommodate the hierarchical structure
of the data. In Chapter 1, we have shown that PROs consist of some specific
characteristics which make the fit by exponential family distributions inadequate.
In addition, regression based on a mixture between two exponential family distri-
butions, the beta-binomial distribution, has been proposed as a good alternative
to analyse PROs in an independent data framework. However, the beta-binomial
distribution does not belong to the exponential family and, consequently, GLMM
estimation and inference theory cannot be directly applied.
In Chapter 2, we have proposed the use of BBreg approach for the analysis
of independent PROs in a regression context. In fact, we have shown through
a simulation study that BBreg obtains appropriate results in terms of parameter
estimation and variance when applied to highly dispersed binomial data. However,
the model does not allow the analysis of dependent outcomes and hence, it cannot
be applied in correlated data, longitudinal studies for instance. Therefore, in order
to provide a solution to non-independence, in this chapter we have developed the
BBmm approach. Basically, the BBmm is the extension of the BBreg to the inclusion
of Gaussian random effects in the linear predictor of the model. The random effects
accommodate the correlation that could exist between different outcomes which
allows BBmm approach to provide a new insight to perform hierarchical regression
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analysis based on the beta-binomial distribution. We have developed an estimation
algorithm based on the first order Laplace approximation for the random and fixed
effects and a penalised profile likelihood for the dispersion parameters of the model.
Based on a similar approach, the assumption of a conditional beta-binomial dis-
tribution, GAMLSS performs the model defined in Equation (3.23). GAMLSS is
a general methodology that does not restrict the distributional assumption to the
exponential family and instead, any type of density function can be analysed in a
mixed-effects approach. GAMLSS can model all the parameters involving a given
distribution and, as it was explained in Section 3.3.6, it is based on a empirical
Bayesian argument to make the inference. For instance, GAMLSS links the proba-
bility parameter p and the dispersion parameter φ of the beta-binomial distribution
with some given covariates and random effects by means of logit and log link func-
tions, respectively. For the estimation of the fixed and random effects in the model,
the joint distribution of all the parameters in the model is maximised. However, the
estimation procedure does not make any difference between fixed effects belonging
to the probability parameter or the dispersion parameter. Consequently, compared
to BBmm approach, GAMLSS does not penalise the likelihood function when esti-
mating φ, avoiding the property that only canonical parameters should be estimated
jointly. In order to compare the performance of both regression approaches, a sim-
ulation study has been carried out in some controlled scenarios. Results showed
that the penalisation of the likelihood when estimating the dispersion parameter
φ improves the results in terms of bias and coverage percentage. In this chapter,
we have focused on the development of a new estimating procedure for a mixed-
effects regression model based on the beta-binomial distribution. However, as it
was mentioned, GAMLSS does not restrict the conditional assumption to a unique
distribution or family of distributions. Therefore, although simulation only for the
beta-binomial distribution have been performed, the penalisation of the likelihood
to estimate non-canonical parameters can be useful in other situations.
On the contrary, based on a conditional approach, there exist in the literature two
methodologies that can deal with highly dispersed hierarchical binomial data. On
the one hand, in Chapter 2 we have introduced the HGLM, which can be extended
from a cross-sectional to a hierarchical framework. Avoiding the comparison between
the BBreg and HGLM approaches carried out in Chapter 2, we are now going to
focus our discussion on the interpretation of the random effects when the binomial-
beta HGLM is extended to the inclusion of Gaussian random effects. For instance,
assume that we perform a random intercepts model such as in the Paquid application
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in Section 3.5.1. The beta-binomial-normal model with random intercepts for the
jth observation of the ith individual will be defined as
Yij |ui, ωi ∼ BB(mi, pij , φ)
ηij = logit(pij) = x
′
ijβ + vi + ωi,
(3.50)
where vi = logit(ui/(1− ui)) and ui ∼ Beta(1/α, 1/α) are the same as in the cross-
sectional model, but we include ωi ∼ N (0, σω) random effects. Under this model,
vi is the random effect that accounts for the overdispersion in the binomial data,
whereas ωi accommodates the hierarchical structure. However, it seems that the
model could have identifiability problems as both random effects affect the linear
predictor in the same way. Additionally, the interpretation of the standard deviation
of the intercept random effect, as the heterogeneity at baseline, can be masked due
to the fact that results are obtained conditioned on the transformation of the beta
random effects.
On the other hand, Molenberghs et al. (2010) defined the so-called combined
models which include conjugate and normal random effects. However, unlike the
HGLM approach, the conjugate random effects do not enter additively in the linear
predictor and instead, they multiply its transformation through the antilogit func-
tion (see Section 3.3.5). Compared to BBmm model definition in Equation (3.23),
Molenberghs et al. (2012) stated that the parameters in the combined model have
a different meaning, as they are interpreted conditional on the assumed random-
effects structure. In addition, differences may be very noticeable when binomial
measurements are collected repeatedly over time or in any other hierarchical fash-
ion. Indeed, from our point of view, not only the interpretation of the fixed effects,
but specially the interpretation of the random effects is much more intuitive in the
BBmm approach as it follows classical GLMM perspective. If we fit a random inter-
cept combined beta-binomial-normal model based on Equation (3.41) and Equation
(3.42), similar to the HGLM approach, we would not be able to interpret the normal
random realizations as individual baseline differences because another beta random
realization multiplies the transformation of the linear predictor. Moreover, the stan-
dard deviation of the random intercepts would not represent the heterogeneity of
the individuals at baseline any more.
Finally, we have applied the BBmm approach in two different real datasets. The
analysis of the Paquid data has been performed as an illustration of the applicability
of our proposal. However, much more effort has been dedicated in the longitudinal
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analysis of the COPD Study. In fact, this was the motivation of this thesis as
there was no available methodology which could analyse the evolution of patients
with COPD in an appropriate way. Section 3.5.2 shows that the BBmm approach
offers clinically valid and relevant results in terms of the evolution of patients with
COPD. Moreover, all the results obtained from the longitudinal analysis of both
questionnaires included in the COPD Study, the SF-36 and the SGRQ, are being
discussed with clinical researchers and they will be included in a clinical publication
that is in preparation.
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CHAPTER 4
MULTIVARIATE ANALYSIS
“Evolution has ensured that our brains just aren’t equipped to
visualise 11 dimensions directly. However, from a purely
mathematical point of view it’s just as easy to think in 11
dimensions, as it is to think in three or four.”
Stephen Hawking , 1942-
The article based on the work developed in this chapter is under preparation for submit-
ting it to a journal.
Najera-Zuloaga, J., Lee, D.-J. and Arostegui, I. (2017). Multivariate analysis of patient
reported-outcomes based on beta-binomial mixed-effects model approach. (under preparation)
4.1 Introduction
In the previous chapters we have developed regression models based on the beta-
binomial distribution for dealing with different statistical challenges that usually
occur in PRO analysis. In Chapter 2, we have proposed a marginal beta-binomial
regression model (denoted as BBreg) for analysing overdispersed binomial data in
an independent data framework. However, in many scientific applications, we often
need to analyse data resulting from experiments in which outcomes have been mea-
sured repeatedly on a set of units, leading to the so-called repeated measurements.
A correct statistical analysis of such data should account for the hierarchical nature
of the data, allowing those measurements within subjects to be correlated, while
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observations from different individuals are independent. Marginal beta-binomial re-
gression approach is not applicable in this case, as it assumes the independence of
the outcomes being modelled. Therefore, in Chapter 3 we have developed a beta-
binomial mixed-effect model (denoted as BBmm) for the correct analysis of overdis-
persed hierarchical binomial data, hierarchical meaning that there exists a correla-
tion structure. Application of both presented methodologies has been addressed to
the analysis of PROs, which usually show an integer and bounded dispersed feature.
In Chapter 1 we have introduced different questionnaires for assessing different
types of PROs, such as cognitive status, HRQoL and so on. We have explained
that there are generic or disease-specific questionnaires and consequently, that each
questionnaire is commonly applied in different populations. We have also detailed
that questionnaires usually decompose the health aspect they are assessing in dif-
ferent dimensions, providing a multi-dimensional insight of the health-status of the
patients. Until now, either by a cross-sectional (Chapter 2) or longitudinal (Chapter
3) approach, we have analysed each of the dimensions separately, and results have
been obtained dimension by dimension.
In some cases, independent analysis of each outcome separately is enough to re-
spond all research questions, subject-matter questions for example. However, when
the interest lies in assessing the relation between some covariates and all the dimen-
sions simultaneously, in comparing longitudinal trends between dimensions, or in
the association between the dimensions and how that association evolves over time,
joint analysis of all the outcomes is preferable. In fact, dimensions are constructed
by responses from the same individuals, then, it is reasonable to think that there
may exist some correlation among different dimension scores for the same patient.
Consequently, the joint analysis of all the dimensions could accommodate some ex-
tra variability that the independent model cannot account, and therefore, improve
the modelling technique. Several regression approaches have been proposed in the
literature for the joint analysis of different responses, some of them focusing on
longitudinal data framework (Verbeke et al., 2014). In this chapter we propose a
regression approach based on the beta-binomial distribution for the joint analysis of
more than one dimension, both in cross-sectional and longitudinal framework.
In terms of notation, from now on and the rest of the chapter, we will refer to the
joint analysis of more than one response variable as multivariate analysis, whereas
the separately analysis of each outcome variable will be considered as univariate
analysis.
This chapter is organised as follows. In Section 4.2, we present a short review
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of some multivariate analysis approaches proposed in the literature, especially for
the joint analysis of different dimensions containing repeated measurements over
time. In Section 4.3, we introduce a model proposal for the joint analysis of all the
PRO dimensions provided by a questionnaire. Following, considering the proposed
model approach we carry out a multivariate analysis of the questionnaires applied
in the COPD data which have been analysed in Chapter 2 and Chapter 3 in a
univariate approach. Finally, in Section 4.5, we present a discussion about the
proposed methodology and introduce some limitations that allow us to think about
some future work.
4.2 Background
A number of approaches have been proposed in the literature for the joint mod-
elling of multivariate longitudinal outcomes (Verbeke et al., 2014). These model
approaches belong to different modelling traditions and their construction is based
on different arguments. In fact, they differ in a number of formal characteristics,
such as the structure (balanced or unbalanced), the scale of the observed outcomes
(continuous, ordinal or binary), or the way the association between and across out-
comes is modelled (with or without latent variables). In fact, the latter aspect is
important given that the use of latent variables allows for more flexible data struc-
tures but usually also has some limitations with respect to the interpretation of the
parameters.
For the remainder of the chapter, assume that Y 1, . . . ,Y k are the vectors of ran-
dom variables associated with the longitudinal measurements for the k dimensions
and let Y be the vector of all random variables.
The first modelling approach attempts to specify directly the joint density f(y)
of Y . Specification of a marginal model for Y requires assumptions about the
marginal association among the repeated measurements within each of the dimen-
sions, but also must include assumptions on the association between elements of
any two dimensions Y l and Y s, where l 6= s. However, when the dimensions Y l,
l = 1, . . . , k, are of different types (e.g. continuous or discrete) and/or in the case
of unbalanced data this approach becomes hard to deal with. When the data are
discrete, likelihood-based marginal models can be formulated (Molenberghs and Ver-
beke, 2005), but unlike the Gaussian case, they are difficult to implement unless tk
is sufficiently small (Verbeke et al., 2014), where t is the number of time points at
which measurements have been taken. In COPD Study (see Chapter 1) for exam-
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ple, measurements of different individuals are provided in different time points. In
fact, the number of different days where an outcome was measured, is equal to 656
and taking into account that a maximum of 4 measurements is provided by each
patient, the data can be considered highly unbalanced. Therefore, due to continuity
assumption of the time variable, the number of instances where observations were
measured is very high, making the specification of the joint density extremely hard.
One way to avoid the direct specification of a joint distribution for Y is to model
a subject’s measurement on a given outcome at a particular time point, conditioned
on all other tk − 1 observations. In a longitudinal context, it is often considered
natural only to condition on the past, which can be done through the so-called tran-
sition models. Transition models for discrete longitudinal data (Diggle et al., 2002)
consider the time course as a sequence of states and that transition probabilities
to be in a specific state at a particular time point depends on the previous time
point(s), but extensions to multivariate longitudinal data are possible (Zeng and
Cook, 2007). However, these extensions differ in the way the associations among
observations are modelled for the different outcomes. In fact, with more than two
outcomes, many possible factorizations are possible, all potentially leading to differ-
ent results (Diggle et al., 2002). Hence, transition models are often not considered
as the preferred choice to analyse high-dimensional multivariate longitudinal data.
In addition, similar to the specification of the marginal density function approach,
the assumption that the time, measured as continuous, is divided in instances leads
to highly unbalanced data which complicates the model development.
It is known that when either the number of dimensions or the number of instances
is high, the models defined above lead to several estimation problems (Verbeke et al.,
2014). When modelling high-dimensional longitudinal data, one option is to use one
or more latent variables for the outcome dimension, reducing the dimensionality of
the multivariate vector of outcomes. For example in PRO context, the model as-
sumes that the observed dimensions are measuring one or more underlying concepts
characterising the health-status the questionnaire is trying to assess. The general
idea is to use a factor-analytic, or principal-component type, analysis to first reduce
the dimensionality of the response vector and to use standard longitudinal models
for the analysis of the principal factors (Oort, 2001). Although dimensionality prob-
lems are solved by applying the reduction, the disadvantage is that we cannot always
interpret the resulting outcome and therefore, the model cannot be properly inter-
preted. In addition, this methodology does not correct the unbalancedness problem
of the presented multivariate analysis approaches.
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However, there exists a very flexible class of models often used for the analysis of
multivariate longitudinal data, the family of mixed-effects models. In fact, we have
made use of this approach when analysing, in a univariate approach, longitudinal
data in Chapter 3. This approach assumes that the observations represent realiza-
tions of a latent subject-specific trajectory which can be modelled parsimoniously
using relatively a small number of subject-specific parameters. Such models have
the main advantage that they do not assume balancedness, allowing for different
number of observations per individual and/or measurements of different individuals
taken at different time points.
In the next section we present two different mixed-effects models for analysing
longitudinal data in a multivariate approach. We detail the models proposal, ad-
vantages and disadvantages of each approach and offer an ‘easy’ way to compare
univariate and multivariate regression parameters in some circumstances.
4.3 Beta-binomial mixed-effects model approach
In this section we present a multivariate regression approach based on mixed-effects
models for the joint analysis of correlated dimensions drawn from a beta-binomial
distribution. Therefore, based on the mixed-effects theory, we consider the BBmm
general approach developed in Chapter 3 for performing the estimation and infer-
ence of the multivariate model proposal. The idea consist of using random effects
to accommodate not only the correlation of the repeated measurements within the
dimensions, but also the correlation that could exist among the different dimensions.
Although many authors have proposed the use of random-effects models for multi-
variate repeated measurements (Reinsel, 1984; MacCallum et al., 1997), it must be
pointed out that examples in the context of multivariate nonlinear or GLMM are
less common (Verbeke et al., 2014).
It is worth noticing that the estimation and inference theory for BBmm approach
has already been developed in Chapter 3. Hence, the objective of this section will
be the proposal of a model definition adapted to the characteristics of multivariate
longitudinal beta-binomial data.
4.3.1 Shared random effects approach
McCulloch (2008) proposed the shared random effects approach for jointly mod-
elling multiple outcomes of mixed types. He defined the model in a cross-sectional
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context however, its extension to longitudinal data is straightforward. The basic
idea is to use a random effect to build in the correlation between the dimensions,
assuming that conditional on the random effect u the dimensions are independent.
The conditionally independent assumption reflects the belief that a common set u
of underlying characteristics of the individual governs the outcomes process.
For instance, consider that we have two vectors of beta-binomial random vari-
ables Y 1 and Y 2 associated with the measurements of the same n patients for
different dimensions, and assume that we are interested in modelling them as a
function of a covariate X. For the sake of clarity, we only consider two dimensions
although extension to more dimensions is immediate. If we analyse the outcomes
separately, as done in Chapter 2, we get that
Y 1i ∼ BB(m1i , p1i , φ1) indep. i = 1, . . . , n
logit(p1i ) = β
1
0 + β
1
1xi,
Y 2i ∼ BB(m2i , p2i , φ2) indep. i = 1, . . . , n
logit(p2i ) = β
2
0 + β
2
1xi.
(4.1)
However, while Equation (4.1) would be sufficient for separate analysis, it does not
accommodate the correlation between Y 1i and Y
2
i , i = 1, . . . , n. An option to skip the
problem is to introduce a random effect per individual that will be shared by both
dimensions. Equation (4.1) is modified accordingly by modelling the distributions
conditional on the random effect u = (u1, . . . , un)
′,
Y 1i |ui ∼ BB(m1i , p1i , φ1) indep. i = 1, . . . , n
logit(p1i ) = γ
1
0 + γ
1
1xi + ui,
Y 2i |ui ∼ BB(m2i , p2i , φ2) indep. i = 1, . . . , n
logit(p2i ) = γ
2
0 + γ
2
1xi + λui, ,
ui ∼ N (0, σ2u).
(4.2)
In general model formulation, the λ multiplying ui in the equation for Y
2
i is included
to account for the fact that the linear predictors for Y 1 and Y 2 may be measured
on different scales. This formulation is useful when, for instance, we are modelling
outcomes following different distributions and hence, the random effects are included
in different transformations of the linear predictor (e.g. logit, probit, logarithm,
exponential). However, in this case, we are modelling outcomes drawn by the same
distribution using the same transformation of the conditioned expectation for the
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linear predictor construction. Therefore, as both linear predictor are defined in the
same scale, we can assume that λ = 1.
Although we have defined the model assuming that all the dimensions follow
a beta-binomial distribution, one of the main characteristics of the shared random
effects approach is that dimensions can be drawn from different distributions and
hence, different discrete and continuous variables can be analysed jointly. In ad-
dition, the number of dimensions involving the analysis does not alter the dimen-
sionality of the joint density or likelihood integration as increasing the number of
dimensions does not alter the number of random effects in the model,
f(y) =
∫
f(y1, . . . , yk|u)f(u)du =
∫ k∏
l=1
f(yl|u)f(u)du,
where k is the number of dimensions. In fact, this is the main advantage of the
shared random effects models compared to other commonly used approaches.
In order to compare fixed effects in the separate or joint model, care must be
taken. As it was discussed in Chapter 2, we cannot compare like with like fixed effects
of marginal and conditional models. In fact, if we try to calculate the marginal
mean of each dimensions for the BBmm approach we end up that there is not a
closed form. However, we could apply the approximated relationship between the
logit and the probit link functions defined in Equation (3.43) to conclude with an
approximated comparison of the fixed effects in both approaches. Let us assume
that Φ(X) = Pr{Z < X|X}, where Z ∼ N (0, 1) and Φ() is the standard normal
cumulative density function. On the one hand, we have that
E[Y li ] = E
[
exp(γl0 + γ
l
1xi + ui)
1 + exp(γl0 + γ
l
1xi + ui)
]
≈ E
[
Φ(c(γl0 + γ
l
1xi + ui))
]
= E
[
Pr
(
Z < c(γl0 + γ
l
1xi + ui)|ui
)]
= Pr
[
Z < c(γl0 + γ
l
1xi + ui)
]
= Pr
[
Z − cui√
1 + cσu
<
c√
1 + cσu
(γl0 + γ
l
1xi)
]
= Φ
(
c√
1 + cσi
(γl0 + γ
l
1xi)
)
,
(4.3)
where the fourth identity holds because the expected value of the conditional prob-
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ability is the unconditional probability (McCulloch, 2008) and c = (16
√
3)/(15pi),
l = 1, 2. On the other hand, based on the marginal model, it is straightforward to
conclude that
E[Y li ] = E
[
exp(βl0 + β
l
1xi)
1 + exp(βl0 + β
l
1xi)
]
≈ Φ
(
c(βl0 + β
l
1xi)
)
. (4.4)
Therefore, based on Equation (4.3) and Equation (4.4), we can compare the fixed
effects in the univariate and multivariate approaches by
βlr =
γlr√
1 + cσu
, r = 0, 1. (4.5)
In terms of the BBmm approach definition in Equation (3.23), we can rewrite the
multivariate longitudinal (or hierarchical) model in the following way. Assume that
we have n different individuals which report ti outcomes repeatedly in k dimensions,
so
Y lij |ui ∼ BB(mli, plij , φl) indep.
ηlij = logit(p
l
ij) = β
l
0 + β
l
1xij + zijui
u = (u1, . . . , un)
′ ∼ N (0,D)
i = 1, . . . , n, j = 1, . . . , ti, l = 1, . . . , k. Or equivalently, in a matrix way
η = Xβ +Zu
where,
X = Ik ⊗X∗, X∗i =

1 xij1 · · · xijp
...
...
. . .
...
1 xiti1 · · · xitip
 ,
Z = 1k ⊗Z∗,Z∗ =

1t1 0 · · · 0
0 1t2 · · · 0
...
...
. . .
...
0 0 · · · 1tn
 ,
β = (β1, . . . ,βk)′, βl = (βl0, . . . , β
l
p)
′,
u = (u1, . . . , un)
′,
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being p the number of covariates in the model and 1s a 1s vector of length s,
i = 1, . . . , n, j = 1, . . . , ti and l = 1, . . . , k. Notice that compared to the BBmm
approach defined in Chapter 3, in the multivariate model we allow φl the dispersion
parameter of the beta-binomial distribution vary from one dimension to the other.
One of the disadvantages of the shared random effects approach when analysing
repeated measurements jointly, is that the correlation between different dimensions
is determined by the dimension’s intrinsic correlation given by the repeated mea-
surements. For example, assume that Y 1 and Y 2 are vectors of random variables
representing different dimensions which contain repeated measurements for a set of
n individuals and that we apply a longitudinal model with shared random intercepts,
η1 = logit(p1) = β01n + u+ β1t,
η2 = logit(p2) = β21n + u+ β3t,
where u ∼ N (0, σuIn) and p1 and p2 are the probability parameters of the con-
ditional Y 1 and Y 2 beta-binomial vectors of variables respectively. Based on the
latent approach developed in Chapter 3 Section 3.3.4, we can define the latent vari-
ables associated with each dimension as
y1∗ = β01n + u+ β1t+ 1
y2∗ = β21n + u+ β3t+ 2
where l are independent error terms that follow a logistic distribution, l = 1, 2.
We can calculate the correlation between the latent variables associated with each
dimension for the ith individual as
Corr[Y 1∗ij , Y 2∗is ] =
Cov
[
Y 1∗ij , Y
2∗
is
]
√
Var
[
Y 1∗ij
]√
Var
[
Y 2∗is
]
=
Cov
[
β0 + ui + β1tij + 
1
ij , β2 + ui + β3tis + 
2
is
]
√
Var
[
β0 + ui + β1tij + 1i j
]√
Var
[
β2 + ui + β3tis + 2is
]
=
Var [ui]√
σ2u + pi
2/3
√
σ2u + pi
2/3
=
σ2u
σ2u + pi
2/3
,
(4.6)
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where 1 ≤ j ≤ s ≤ ti and j 6= s.
Additionally, we have that the correlation between observations of the same
individual in each dimension is defined as
Corr
[
Y 1∗ij , Y
1∗
is
]
=
σ2u
σ2u + pi
2/3
, (4.7)
where 1 ≤ j 6= s ≤ ti, l = 1, 2.
Therefore, the correlation structure within each dimension dictates the associ-
ation between the different dimensions. For example, the model would not allow
that Y 1 and Y 2 to be independent if repeated measurements of Y 1 are strongly
correlated. In fact, the assumption that the error components follow a logistic dis-
tribution does not impose any restriction and, if any distribution has been chosen,
we would have reached the same conclusion (Verbeke et al., 2014). The restriction
of the correlation can be relaxed by allowing different but correlated random effects
for the various dimensions.
4.3.2 Correlated random effects approach
In the previous section we have described that the shared random effects approach
contains many desirable properties such as (i) allowing for different types of out-
comes; (ii) allowing for (highly) unbalanced data; and (iii) ‘easy’ transition of the
comparison of the fixed effects form the multivariate to the univariate model. How-
ever, we have mentioned that in some occasions the rigidity of the imposed corre-
lation structures makes them unrealistic to be useful in real practise. This can be
solved by allowing for different random effects for each dimension as,
Y lij |uli ∼ BB(mli, plij , φl) indep.
ηlij = logit(p
l
ij) = β
l
0 + β
l
1xij + ziju
l
i
u = (u1
′
, . . . ,uk
′
)′ ∼ N (0,D)
(4.8)
where ul = (ul1, . . . , u
l
n)
′, i = 1, . . . , n, j = 1, . . . , ti, l = 1, . . . , k.
This new model relaxes the shared random effects assumption in the sense that
the correlation structure of the individual outcomes no longer dictates the association
between pairs of measurements from different dimensions. Under the conditional
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independence the joint marginal density is given by
f(y) =
∫
f(y1, . . . ,yk|u)f(u)du
=
∫
· · ·
∫ k∏
l=1
f(yl|ul)f(u1, . . . ,uk)du1 · · · duk,
(4.9)
which increases the dimensionality as more dimensions and, hence, more random
effects, are included in the model. In fact, the Laplace approximation developed in
Chapter 3, Section 3.3.2, for the calculation of the marginal likelihood may involve
in inappropriate approximations if the dimensionality of the integral is high (Shun
and McCullagh, 1995). Moreover, due to the complexity of the beta-binomial dis-
tribution, when more than two dimensions are analysed the estimation procedure
developed in Chapter 3 is not tractable any more. In fact, many PRO questionnaires
decompose the health-status that are assessing in more than two dimensions. Con-
sequently, in thesis, the real data will be analysed by the proposed shared random
effects approach.
4.4 Application to COPD Study
In this section, we perform the COPD Study analysis carried out in Chapter 2 and
Chapter 3 in a multivariate approach. On the one hand, we are going to adjust a
model for the joint analysis of the eight dimensions provided by SF-36 in a cross-
sectional fashion and compare the results with the univariate analysis provided in
Chapter 2. On the other hand, we carry out a longitudinal joint analysis of the three
dimensions provided by the SGRQ. We will compare the obtained results with the
results provided in Chapter 3, where each of the dimension was analysed separately
in a univariate approach.
4.4.1 Cross-sectional analysis
In this section, we analyse the eight dimensions provided by the SF-36 Health Survey
in the COPD Study simultaneously, using a multidimensional approach based on
the shared random effects model. In fact, the shared random effects approach is
applied for accommodating the correlation that may exist between measurements
of the same patients in different dimensions. In Chapter 2 we have analysed each
of the dimension separately in an univariate approach. Consequently, in order to
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maintain the model assumption for assessing the differences that may exist between
the univariate and multivariate models, following Chapter 2, exclusively data from
the first visit to the outpatient clinic is going to be considered. Consequently, the
joint analysis of the SF-36 dimensions is going to be performed in a cross-sectional
framework.
In Section 4.3.1 we have shown that the shared random effects approach is based
on a general mixed-effects model where the model is specified in a particular way.
Therefore, estimation and inference of the parameters involving the model do not
require any extension of the BBmm approach developed in Chapter 3, with the
exception of the dispersion parameter of the beta-binomial distribution, which can
vary for different dimensions. In fact, the model we are going to apply for the joint
analysis of the eight dimensions of the SF-36 in COPD Study is defined as
Y li |ui ∼ BB(mli, pli, φl) indep.
ηli = log
pli
1− pli
= x′iβ
l + ui
(4.10)
where xi is the ith row of a full rank matrix composed by the given covariates, β
l
are the regression parameters for each dimension and ui are independent random
effects being ui ∼ N (0, σ2u), i = 1, . . . , 543, l = 1, . . . , 8. Notice that in the COPD
Study the number of individuals is equal to 543. The model defined in Equation
(4.10) can be redefined following the generic notation of BBmm approach as
Y |u ∼ BB(m,p,φ) indep.
η = log
p
1− p = X
∗β + u
where X = I8 ⊗ X being X the model matrix composed by the given covari-
ates defined in Equation (4.10), Y = (Y 1
′
, . . . ,Y 8
′
)′ being Y l = (Y l1 , . . . , Y l543) the
outcomes variable vector of the lth dimension, β = (β1
′
, . . . ,β8
′
)′ a vector con-
taining the regression coefficients involving the linear predictor of each dimension,
φ = (φ1, . . . , φ8)′ the vector of the dispersion parameters of the beta-binomial distri-
bution and u = (u1, . . . , u543)
′ independent normally distributed random effects with
variance-covariance matrix equal to σ2uI543. Hence, the BBmm approach developed
in Chapter 3 has been used to fit the model.
Table 4.1 and Table 4.2 show the results for the univariate and multivariate
analysis of the SF-36 dimensions in COPD data. Although in the multivariate
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approach all the dimensions have been analysed jointly, due to the lack of space,
results are displayed dividing physical dimensions (Table 4.1) and mental dimensions
(Table 4.2). For the variable selection, we retain in the model those covariates whose
influence in the outcome variable was statistically significant (p-value< 0.05) in at
least one of the approaches. The tables show the estimated value of the regression
parameters β together with the standard deviation and the p-value associated with
the significance of the estimation in both approaches. Additionally, they display
the estimation and standard deviation of the vector of dispersion parameters of the
beta-binomial distributions, φ.
The first conclusion we address from Table 4.1 and Table 4.2 is that the estimated
values of the regression parameters are quite similar in the two approaches, both in
magnitude and sign. Therefore, they lead to similar interpretations regarding the
effect of the covariates in the analysed dimensions. However, there are some differ-
ences that could lead to contradictory results in terms of the significance of the effect
of the covariates. As it can be appreciated, the inclusion of a shared random effect
that accounts for the correlation between different dimensions reduces the dispersion
parameter of the beta-binomial distribution, as the variance structure is split in two
components. Consequently, the standard deviations associated with the estimates of
the regression parameters differ, being lower for the multivariate approach in most
of the dimensions (6 out of 8). Therefore, different conclusions will be obtained
for instance in mental health dimension if a univariate or a multivariate approach
would have been implemented. In fact, age and FEV1% covariates do not have a
statistically significant effect (p-values equal to 0.051 and 0.069 respectively) in the
univariate approach, while in the joint analysis of the dimensions both covariates
offer statistically significant effects (p-values equal to 0.045 and 0.023 respectively).
Summarizing, we can state that, although the joint analysis of cross-sectional
dimensions do not alter the estimates of the regression parameters in the model, there
could be differences in the variance of the estimates leading to contradictory results
in terms of the significance of the effect. Therefore, in cases where it is possible, we
recommend the use of the multivariate approach as it offers a better measurement
of the variability of the data splitting it in two components, the correlation and the
overdispersion.
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Table 4.1: Multivariate and univariate analysis of the eight dimensions provided by
the SF-36 in COPD patients. Results for the physical dimensions are displayed.
Multivariate (σ = 0.535) Univariate (Chapter 2)
Estimate SD p-value Estimate SD p-value
Physical functioning
Intercept -0.478 0.386 0.215 -1.091 0.455 0.017
Dyspnea2 -0.652 0.096 < 0.001 -0.580 0.112 < 0.001
Dyspnea3 -1.417 0.102 < 0.001 -1.281 0.120 < 0.001
Dyspnea4 -2.432 0.151 < 0.001 -2.207 0.176 < 0.001
Depression -0.521 0.109 < 0.001 -0.544 0.130 < 0.001
Anxiety -0.415 0.076 < 0.001 -0.404 0.090 < 0.001
Age 0.009 0.003 0.005 0.012 0.004 0.002
BMI -0.021 0.006 < 0.001 -0.018 0.007 0.009
FEV 0.007 0.002 0.001 0.006 0.003 0.012
Sex 0.467 0.130 < 0.001 0.461 0.155 0.003
WalkingTest 0.003 < 0.001 < 0.001 0.004 < 0.001 < 0.001
log(φ) -3.845 0.214 − -2.826 0.116 −
Role physical
Intercept 1.310 0.707 < 0.001 1.100 0.690 0.111
Dyspnea2 -1.366 0.354 < 0.001 -1.296 0.340 < 0.001
Dyspnea3 -2.478 0.356 < 0.001 -2.349 0.341 < 0.001
Dyspnea4 -3.429 0.417 < 0.001 -3.291 0.405 < 0.001
Anxiety -0.812 0.204 < 0.001 -0.732 0.199 < 0.001
Age 0.020 0.009 0.030 0.021 0.009 0.020
log(φ) -0.306 0.117 − -0.103 0.109 −
Bodily pain
Intercept 2.575 0.393 < 0.001 2.454 0.396 < 0.001
Dyspnea2 -0.495 0.227 0.030 -0.504 0.227 0.027
Dyspnea3 -0.837 0.239 < 0.001 -0.811 0.239 0.001
Dyspnea4 -1.160 0.312 < 0.001 -1.091 0.316 0.001
Anxiety -0.652 0.162 < 0.001 -0.612 0.163 < 0.001
FEV -0.013 0.005 0.010 -0.012 0.005 0.020
log(φ) -0.742 0.089 − -0.559 0.085 −
General health
Intercept -0.950 0.307 0.002 -1.005 0.343 0.004
Dyspnea2 -0.412 0.099 < 0.001 -0.391 0.110 < 0.001
Dyspnea3 -1.012 0.108 < 0.001 -0.969 0.120 < 0.001
Dyspnea4 -1.235 0.155 < 0.001 -1.175 0.173 < 0.001
Depression -0.539 0.139 < 0.001 -0.560 0.156 < 0.001
Anxiety -0.390 0.094 < 0.001 -0.362 0.105 0.001
Age 0.018 0.004 < 0.001 0.018 0.004 < 0.001
FEV 0.006 0.003 0.041 0.005 0.003 0.056
log(φ) -2.636 0.108 − -2.297 0.117 −
SD: Standard Deviation; BMI: Body Mass Index; FEV1%: Forced Expiratory Volume in one
second in percentile.
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Table 4.2: Multivariate and univariate analysis of the eight dimensions provided by
the SF-36 in COPD patients. Results for the mental dimensions are displayed.
Multivariate (σ = 0.535) Univariate (Chapter 2)
Estimate SD p-value Estimate SD p-value
Vitality
Intercept 0.417 0.286 0.145 0.342 0.335 0.308
Dyspnea2 -0.792 0.119 < 0.001 -0.765 0.137 < 0.001
Dyspnea3 -1.592 0.123 < 0.001 -1.544 0.142 < 0.001
Dyspnea4 -1.947 0.157 < 0.001 -1.893 0.183 < 0.001
Depression -0.928 0.142 < 0.001 -0.927 0.166 < 0.001
Anxiety -0.644 0.094 < 0.001 -0.598 0.112 < 0.001
Age 0.018 0.004 < 0.001 0.018 0.005 < 0.001
log(φ) -2.557 0.107 − -1.891 0.084 −
Social functioning
Intercept 2.859 0.249 < 0.001 2.674 0.250 < 0.001
Dyspnea2 -0.657 0.266 0.014 -0.565 0.268 0.035
Dyspnea3 -1.402 0.265 < 0.001 -1.254 0.267 < 0.001
Dyspnea4 -1.780 0.310 < 0.001 -1.598 0.314 < 0.001
Depression -0.459 0.225 0.041 -0.471 0.232 0.043
Anxiety -1.232 0.158 < 0.001 -1.179 0.163 < 0.001
log(φ) -1.278 0.120 − -1.036 0.109 −
Role emotional
Intercept 2.924 0.404 < 0.001 2.769 0.390 < 0.001
Dyspnea2 -0.664 0.434 0.126 -0.612 0.418 0.143
Dyspnea3 -1.495 0.429 < 0.001 -1.376 0.414 0.001
Dyspnea4 -2.164 0.485 < 0.001 -2.042 0.467 < 0.001
Anxiety -1.705 0.233 < 0.001 -1.642 0.227 < 0.001
log(φ) 0.579 0.154 − 0.669 0.150 −
Mental health
Intercept 1.229 0.409 0.003 0.994 0.460 0.031
Dyspnea2 -0.380 0.128 0.003 -0.333 0.142 0.019
Dyspnea3 -0.872 0.134 < 0.001 -0.793 0.149 < 0.001
Dyspnea4 -1.225 0.174 < 0.001 -1.135 0.196 < 0.001
Depression -0.852 0.137 < 0.001 -0.866 0.157 < 0.001
Anxiety -1.302 0.095 < 0.001 -1.244 0.108 < 0.001
Age 0.011 0.004 0.045 0.010 0.005 0.051
BMI 0.018 0.008 0.024 0.018 0.009 0.044
FEV -0.007 0.003 0.023 -0.006 0.003 0.069
log(φ) -3.046 0.177 − -2.297 0.117 −
SD: Standard Deviation; FEV1%: Forced Expiratory Volume in one second in percentile; BMI:
Body Mass Index.
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4.4.2 Longitudinal analysis
The second real data application of the beta-binomial shared random effects ap-
proach is performed in a longitudinal or repeated measurements context. Similar to
the joint analysis of the SF-36 Health Survey, one of the objectives of this section
is the comparison of the longitudinal analysis of some dimensions in univariate and
multivariate approaches. For this aim, have considered the analysis of the SGRQ in
COPD Study which was carried out in Chapter 3, where each of the three dimensions
was analysed separately. As a result of the univariate analysis, several conclusions
were addressed in terms of the evolution of the patients with COPD. Therefore, in
this section we will perform the same analysis of the dimensions but analysing them
all together in a multivariate approach. Therefore, differences in the results in terms
of the evolution of the patients provided by both approaches will be compared.
In Chapter 3, we have analysed each dimension separately with a random inter-
cept and slope model. In order to maintain the model assumption, we propose a
shared random intercept and slope effects model for the joint analysis of the dimen-
sions provided by the SGRQ. In fact, the model could be defined for any longitudinal
multivariate analysis where random intercepts and slopes would be shared. For in-
stance, assume that we have n individuals measured in k dimensions where the lth
dimension contains tli repeated measurements of the ith individual, i = 1, . . . , n,
l = 1, . . . , k. Then, we can propose the following multivariate random intercept and
slope model based on BBmm approach,
Y lij |ui, vi ∼BB(mli, plij , φl) indep.
ηlij = log
plij
1− plij
= (βl0 + ui) + (β
l
1 + vi)Tij
(4.11)
where Y lij is the random variable associated with the jth repeated measurement of
the ith individual in the lth dimension, Tij is the time in years from the beginning
of the study where the jth observation of the ith individual was performed, βl0 is
the overall intercept, βl1 is the overall slope and ui and vi are the random intercept
and slope of the ith individual respectively assuming that ωi = (ui, vi) ∼ N (0,D),
where
D =
(
σ2u 0
0 σ2v
)
,
l = 1, . . . , k, i = 1, . . . , n, j = 1, . . . , tlij .
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Table 4.3 shows the results of the multivariate longitudinal model proposed in
Equation (4.11) applied to activity, impacts and symptoms dimensions of the SGRQ
in the COPD Study. It also displays the longitudinal univariate results of each
dimension. The main aim of this analysis is to measure the evolution of the patients
with COPD and hence, contrary to the previous COPD multivariate analysis in
Section 4.4.1, all the repeated measurements of each individual have been introduced
in the model. In addition, in order to assess the evolution of the patients, such as
performed in Chapter 3 Section 3.5.2 and as it was showed in Equation (4.11), only
time has been introduced as a covariate in the model.
Table 4.3 displays the estimates and standard deviations of all the parameters
in the model together with the p-values associated with the effect of the covariates.
It must be noticed that in the impacts dimension there is no estimation of the
random slope in the univariate model because, as it was pointed out in Chapter 3,
the estimation of σv tended to zero.
Table 4.3: Multivariate and univariate longitudinal analysis of the SGRQ in COPD
Study.
Multivariate Univariate (Chapter 3)
Estimate SD p-value Estimate SD p-value
Activity
Intercept -0.151 0.030 < 0.001 -0.185 0.026 < 0.001
Time 0.012 0.010 0.212 0.027 0.008 0.001
log(φ) -2.627 0.058 − -3.305 0.087 −
σu 0.941 0.029 − 1.180 0.037 −
σv 0.130 0.005 − 0.126 0.006 −
Impacts
Intercept -0.962 0.025 < 0.001 -0.993 0.026 < 0.001
Time -0.003 0.008 0.715 0.004 0.008 0.670
log(φ) -3.627 0.095 − -3.541 0.095 −
σu 0.941 0.029 − 1.060 0.033 −
σv 0.130 0.005 − − − −
Symptoms
Intercept -0.356 0.033 0.000 -0.305 0.029 0.000
Time 0.025 0.011 0.019 0.006 0.009 0.499
log(φ) -2.228 0.045 − -2.617 0.058 −
σu 0.941 0.029 − 0.759 0.025 −
σv 0.130 0.005 − 0.097 0.006 −
SD: Standard Deviation; σu: standard deviation of the random intercepts; σv: standard deviation
of the random slopes.
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The first conclusion we address from Table 4.3 is that, although estimates re-
garding the intercept are quite similar in both approaches, there are considerably
differences in both the estimation and significance of the time covariate. In fact, it
can be appreciated in Table 4.3 that in the univariate analysis the unique dimen-
sion where the evolution of the patients is statistically significant is the activity,
whereas in the multidimensional approach it is the symptoms. Therefore, it seems
that both regression approaches lead to different conclusions about the evolution of
the patients with COPD. However, in our opinion, some details must be taken into
account before performing that comparison, and we will discuss them in the next
section.
4.5 Discussion and future work
In this chapter we have proposed a model based on a beta-binomial mixed-effect
model approach for the joint analysis of different but correlated dimensions provided
by different PRO questionnaires. The model is based on the shared random effects
approach proposed by McCulloch (2008) and as the name indicates, several random
effects are shared by different dimensions in order to accommodate the correlation.
The model can be applied to cross-sectional as well as longitudinal (hierarchical)
multivariate data. The advantage of the model is that, compared to other commonly
used multivariate analysis techniques, such as transition or reduction approaches,
dimensions drawn from different distributions can be jointly analysed and especially,
that the unbalanceness of the data, or continuity of the time variable, is not a
problem. In addition, compared to the correlated random effects model introduced
in Section 4.3.2, we do not have to concern about the dimensionality of the model
when a large amount of correlated dimensions are analysed, because the random
effects in the model are the same regardless of the number of dimensions.
In Section 4.4.1, we have shown in Table 4.1 and Table 4.2 that in cross-sectional
application the shared random effects approach lead to similar estimates compared
to the univariate approach, however the measurement of the correlation between
dimensions accommodates an extra variability. In fact, the estimates of the disper-
sion parameter of the beta-binomial distribution reduces in most of the times and
consequently, standard deviations of the estimates became smaller. Hence, variables
that in the univariate analysis were treated as non-informative, turned out to have
a statistically significant effect in the multivariate approach.
On the contrary, in Section 4.4.2, Table 4.3 displays a completely different situa-
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tion for the longitudinal application where variables that were statistically significant
in the univariate analysis are not significant in the multivariate analysis and vice
versa. These results lead to completely misleading conclusions about the evolution
of patients with COPD. In Section 4.3.1, we have developed a procedure to compare
regression coefficients in univariate and multivariate approaches in cross-sectional
framework. Equation (4.5) shows that the relationship between regression parame-
ters lies in a multiplicative term that depends on the variance of the random effects.
However, as we will show in the longitudinal context the relationship is not so direct.
In shared random effects context, if we try to compare the fixed effects between
both univariate and multivariate longitudinal approaches, the marginal expectation
of an outcome in the multivariate approach is obtained by
E[Y lij ] = E
[
exp
(
(γl0 + ui) + (γ
l
1 + vi)Tij
)
1 + exp
(
(γl0 + ui) + (γ
l
1 + vi)Tij
)]
≈ E
[
Φ
(
c((γl0 + ui) + (γ
l
1 + vi)Tij)
)]
= E
[
Pr
(
Z < c
(
(γl0 + ui) + (γ
l
1 + vi)Tij
)
|ui, vi
)]
= Pr
[
Z < c
(
(γl0 + ui) + (γ
l
1 + vi)Tij
)]
= Pr
[
Z − c(ui + viTij)√
1 + c(σu + σvTij)
<
c√
1 + c(σu + σvTij)
(γl0 + γ
l
1Tij)
]
= Φ
(
c√
1 + c(σu + σvTij)
(γl0 + γ
l
1Tij)
)
,
and in the univariate approach is given by
E[Y lij ] = E
[
exp
(
(βl0 + u
l
i) + (β
l
1 + v
l
i)Tij
)
1 + exp
(
(βl0 + u
l
i) + (β
l
1 + v
l
i)Tij
)]
≈ Φ
(
c√
1 + c(σlu + σ
l
vTij)
(βl0 + β
l
1Tij)
)
,
where c = 16
√
3/(15pi), l = 1, . . . , k, i = 1, . . . , n, j = 1, . . . , tlij . Notice that,
while in the first marginal expectation the random effects ui and vi correspond to
the shared random effect model, in the second equation they correspond to the
univariate analysis.
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Therefore, we have the following relationship
1√
1 + c(σu + σvTij)
(γl0 + γ
l
1Tij) =
1√
1 + c(σlu + σ
l
vTij)
(βl0 + β
l
1Tij), (4.12)
which as it can be appreciated, does not allow a straightforward comparison of the
parameters β. Consequently, unlike in the cross-sectional comparison in Equation
(4.5), the estimates of the fixed effects can differ considerably in univariate and
multivariate approaches. In fact, the shared random effects approach considers that
the subject-specific intercept and slope is equal in all the dimensions, i.e. that
the initial status and evolution of each patient differs in the same magnitude from
the population’s overall initial status and evolution in all the dimensions. Therefore,
based on this assumptions, compared to the univariate approach, modifications must
be done in the estimation of the fixed effects in order to the model be correct. In
addition, due to the shared random effects assumption, each of the approach leads to
different estimations of the dispersion parameters φ, σu and σv. Indeed, compared to
the cross-sectional framework, as it has been shown in Equation (4.6) and Equation
(4.7), each random effect must account for two correlations, the within dimension
and between dimensions. Consequently, as it can be appreciated in Table 4.3, the
longitudinal multivariate approach enlarges the estimated value of φ in most of the
dimensions, increasing the standard deviation of the estimation of the fixed effects.
Hence, different estimations and standard deviations can lead to different significance
test, leading to different interpretation of the effects of the covariates.
In fact, we have mentioned that the shared random effects modelling approach
could have some inconveniences when dealing with longitudinal data as the same
random effects must accommodate the correlation between dimensions and within
dimensions and in some cases, the considered assumption could be too rigid. In Sec-
tion 4.3 we have detailed that the correlation between two latent variables associated
with two different dimensions is determined by the correlation within dimensions,
which may be inappropriate in cases where there is a high correlation between the re-
peated measurements, but dimensions are slightly correlated. The assumption that
the initial value and the evolution of each individual behaves equally with respect to
the population overall trend in all the dimensions may be quite unrealistic indeed.
CHAPTER 5
SOFTWARE DEVELOPMENT
“We have the duty of formulating, of summarizing, and of
communicating our conclusions, in intelligible form, in
recognition of the right of other free minds to utilize them in
making their own decisions.”
Ronald Fisher, 1890-1962
The article based on the work developed in this chapter is under preparation for submit-
ting it to a journal.
Najera-Zuloaga, J., Lee, D.-J. and Arostegui, I. (2017) PROreg: An R Package for Analysis
of Patient Reported Outcomes. (under preparation)
This chapter is focused on the implementation of the different analysis models
we have described and developed throughout the thesis in R language. We have
repeatedly mentioned that the beta-binomial distribution does not belong to the
exponential family and consequently, classical estimation procedures cannot be ap-
plied. That is why there is not much literature regarding modelling approaches
dealing with the beta-binomial distribution. Hence, due to the fact that few meth-
ods have been developed, implementation of algorithms based on the beta-binomial
distribution are not common.
The objective of this chapter is divided in two parts. In the first part, we intro-
duce and describe the R-packages available in the literature for the beta-binomial
distribution. As far as we know, it does not exist an R-package containing all the
methodology developed in this thesis. In fact, most of the packages we will mention
159
160 Chapter 5
restrict their performance to distributional fit and consequently, they do not offer
any regression approach based on the beta-binomial distribution. Therefore, the
second objective is to implement, among others, the statistical models developed
in this thesis in a R-package called PROreg, as there is no software implementation
for some of regression approaches. Additionally, the package contains many other
functions focus in the analysis of PROs, such as binomial with dispersion parameter
distribution based regression approaches or questionnaire specific functions. Indeed,
the objective of PROreg is to unify in a single R-package all the required statistical
methodology to analyse PROs, or any overdispersed binomial form, discrete and
bounded data.
5.1 R-packages for the beta-binomial distribution
There do not exist many functions that offer statistical analysis based on the beta-
binomial distribution in public domain software, especially in R language. In fact,
most of the packages containing functions to deal with the beta-binomial distribution
restrict their applicability to distributional fits. Therefore, we think that the exist-
ing R implementation has limitations when trying to analyse in both, independent
or hierarchical data framework, beta-binomial data through a regression approach,
favouring the use of GLMMs or GLMs, or even LMMs.
Table 5.1 shows the different R-packages which contain functions for dealing with
the beta-binomial distribution in a variety of analysis approaches. In the table, it
can be appreciated that although all the packages contain functions to calculate the
density and generate random realizations from a beta-binomial distribution for a
given set of parameters, most of them do not extend the analysis to an estimation
framework. Indeed, the VGAM and gamlss are the only packages which can perform
regression models based on the beta-binomial distribution, and furthermore, the
VGAM limits its applicability to independent data. Therefore, we conclude that the
gamlss is the most complete package regarding the beta-binomial distribution as
it contains functions that cover all the analysis situations displayed in Table 5.1.
However, it has been mentioned and discussed in Chapter 2 and Chapter 3 that
although the gamlss() cross-sectional regression analysis is based on the marginal
beta-binomial regression approach, there are substantial differences between the
estimation procedure of the proposed BBmm and gamlss() implementations. In
fact, in Chapter 3 it was shown that the penalisation of the profile likelihood of the
dispersion parameter of the beta-binomial in BBmm approach, improves the results
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of the parameter estimation in terms of reducing the bias. However, there is no
R-package that performs the BBmm approach developed in Chapter 3.
Table 5.1: R-packages for beta-binomial analysis.
Distribution Regression
R-package Version Dens. Rand. Est. Indep. Corr.
rmutil 1.1.0 dbetabinom() rbetabinom() − − −
TailRank 3.1.3 dbb() rbb() − − −
emdbook 1.3.9 dbetabinom() rbetabinom() − − −
VGAM 1.0-4 dbetabinom() rbetabinom() vglm() vglm() −
gamlss 5.0-2 dBB rBB gamlss() gamlss() gamlss()
Dens.: Density function; Rand: Random realizations; Est.: Estimation of the distribution; Inped.:
Independent (cross-sectional) framework; Corr.: Correlated (hierarchical) framework; Mult.:
Multivariate (shared random effects approach).
5.2 PROreg R-package
PROreg R-package is available at https://cran.r-project.org/web/packages/PROreg/.
The name of the package stands for ‘Patient Reported Outcomes Regression’ and it
offers a variety of tools, such as specific plots and regression model approaches, for
analysing different patient reported questionnaires. However, although it is focused
on the analysis of PROs, any binomial form outcome can be analysed using PROreg.
In fact, it contains regression models based on the binomial, binomial with dispersion
parameter and beta-binomial distribution for the correct analysis of any discrete
and bounded data. In addition, regression models have been developed in either
cross-sectional or hierarchical data, which increases its applicability in many real
situations.
There are many packages such as stats, that offer the analysis of regression
models in cross-sectional or hierarchical data based on the binomial or binomial with
dispersion parameter distributions (family=quasibinomial). In fact, the novelty
of the package lies in the variety of regression models based on the beta-binomial
distribution which are not so typical, especially in hierarchical framework. Apart
from the mentioned regression models, PROreg package contains additional plotting
or questionnaire-specific recoding algorithms. Indeed, the objective of the package is
to unify all the requires techniques when dealing with PROs in a regression context
in an R-package. Therefore, the PROreg R-apackage consists of the following main
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functions:
Table 5.2: Different functions available in PROreg R-package
Beta-binomial Binomial Additional functions
BB() BI() SF36rec()
·dBB() ·dBI() HRQoLplot
·rBB() ·rBI()
BBest()† BIest()†
BBreg()†‡ BIreg()†‡
BBmm()†‡ · BIiwls
· EffectsEst BBDelta() BImm()†‡
· EffectsEst NR()
· BBmm VarEst()
† stands for functions that contain print(); ‡ stands for functions that contain summary() and
print.summary().
PROreg package contains dependencies from other packages: fmsb, RColorBrewer,
car, matrixcalc, rootSolve, numDeriv, Matrix.
As mentioned before, the novelty of the package lies in the different regression
approaches that can be performed based on the beta-binomial distribution. There-
fore, following we are going to fully describe, both theoretically and practically, the
functions for analysing beta-binomial distributed data.
5.2.1 BB: The beta-binomial distribution
Description
Density and random generation for the beta-binomial distribution.
Usage
dBB(m,p,phi)
rBB(k,m,p,phi)
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Arguments
k number of simulations.
m maximum score number in each beta-binomial observation.
p probability parameter of the beta-binomial distribution.
phi dispersion parameter of the beta-binomial distribution.
Details
The beta-binomial distribution consists of a finite sum of Bernoulli dependent
variables whose probability parameter is random and follows a beta distri-
bution. Assume that we have Yj a set of variables, j = 1, ...,m, with m
integer, that conditioned on a random variable u, are independent and follow
a Bernoulli distribution with probability parameter u. On the other hand,
the random variable u follows a beta distribution with parameter p/φ and
(1− p)/φ. Namely,
Yj ∼ Ber(u), u ∼ Beta(p/φ, (1− p)/φ),
where 0 < p < 1 and φ > 0. The first and second order marginal moments of
this distribution are defined as
E[Yj ] = p, Var[Yj ] = p(1− p),
and correlation between observations is defined as
Corr[Yj , Yk] = φ/(1 + φ),
where j, k = 1, ...,m are different. Consequently, φ can be considered as a
dispersion parameter.
If we sum up all the variables we will define a new variable which follows a
new distribution that is called beta-binomial, and it is defined as follows. The
variable Y follows a beta-binomial distribution with parameters m, p and φ if
Y |u ∼ Bin(m,u), u ∼ Beta(p/φ, (1− p)/φ).
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Value
dBB gives the density of a beta-binomial distribution with the defined m, p and
phi parameters.
rBB generates k random observations based on a beta-binomial distribution
with the defined m, p and phi parameters.
Examples
> set.seed(12)
> # We define the parameters for the simulation.
> m <- 10
> p <- 0.4
> phi <- 1.8
>
> # We perform k beta-binomial simulations for those parameters.
> k <- 100
> bb <- rBB(k,m,p,phi)
> bb
[1] 0 10 10 9 10 10 8 0 10 4 7 10 1 0 0 10 8 5 3 0 9 2 4
[24] 0 7 0 1 0 8 6 5 0 0 0 8 0 0 0 1 10 9 7 10 1 10 3
[47] 8 4 0 8 0 10 0 2 0 1 10 10 0 4 9 2 0 8 0 0 3 9 7
[70] 4 0 5 0 0 6 7 0 1 10 0 0 0 0 0 0 3 0 0 2 0 0 3
[93] 10 0 10 10 10 0 10 1
>
> # We estimate the probability of each point for the fixed parameters.
> dd <- dBB(m,p,phi)
> # We are going to plot the histogram of the created variable,
> # and using dBB() function we are going to fit the distribution:
> hist(bb,col="grey",breaks=seq(-0.5,m+0.5,1),probability=TRUE,
main="Histogram",xlab="Beta-binomial random variable")
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5.2.2 BBest: Estimation of the parameters of a beta-binomial dis-
tribution
Description
This function performs the estimation of the parameters of a beta-binomial
distribution for the given data and maximum score number in each observation.
There are two different approaches available for performing the estimation of
the parameters: (i) method of moments, and, (ii) maximum likelihood ap-
proach.
Usage
BBest(y,m,method="MM")
Arguments
y response variable which follows a beta-binomial distribution.
m maximum score number in each beta-binomial observation.
method the method used for performing the estimation of the probability and
dispersion parameters of a beta-binomial distribution, ”MM” for the
method of moments and ”MLE” for maximum likelihood estimation.
Default ”MM”.
Details
BBest function performs the estimation and inference of the parameters of a
beta-binomial distribution for the given data. The estimations can be per-
formed using two different approaches, the method of moments (MM) and the
maximum likelihood estimation (MLE) approach.
The density function of a given observation y that follows a beta-binomial
distribution with parameters m, p and φ is defined as
f(y|p, φ) =
(
m
y
)
Γ(p/φ+ y)
Γ(p/φ)
Γ((1− p)/φ+m− y)
Γ((1− p)/φ)
Γ(1/φ)
Γ(1/φ+m)
.
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The first and second order moments are defined as
E[Y ] = mp,
Var[Y ] = mp(1− p)
[
1 + (m− 1) φ
1 + φ
]
.
Hence, if y = (y1, ..., yn)
′ is the given data, we can conclude with the MM from
the previous as
pˆMM = E[y]/m,
φˆMM =
Var[y]−mpˆMM (1− pˆMM )
m2pˆMM (1− pˆMM )− Var[y]
where E[y] is the sample mean and Var[y] is the sample variance.
On the other hand, the MLE of both parameters is obtained from the max-
imisation of the log-likelihood of the model defined as
logL(p, φ|y) =
n∑
i=1
[
log
(
m
yi
)
+
yi−1∑
k=0
log(p+ kφ) +
m−yi−1∑
k=0
log(1− p+ kφ)
−
mi∑
k=0
log(1 + kφ)
]
,
where if yi = 0 then
yi−1∑
k=0
log(p + kφ) = 0 and if yi = mi then
m−yi−1∑
k=0
log(1 −
p+kφ) = 0. Therefore, the MLE of p and φ are obtained solving the following
score equations,
S(p) =
∂
∂p
logL(p, φ|y) =
n∑
i=1
[ yi−1∑
k=0
1
p+ kφ
+
m−yi−1∑
k=0
1
1− p+ kφ
]
= 0
S(φ) =
∂
∂φ
logL(p, φ|y) =
n∑
i=1
[ yi−1∑
k=0
k
p+ kφ
+
m−yi−1∑
k=0
k
1− p+ kφ
−
m∑
k=0
k
1 + kφ
]
= 0
Numerical algorithms are required to solve both equations. In the PROreg
package we have implemented a numerical approximation algorithm based on
the Newton-Raphson procedure.
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Value
BBest returns an object of class ‘BBest’.
The function summary (i.e., summary.BBest) can be used to obtain or print a
summary of the results.
p estimated probability parameter of the beta-binomial distribution.
phi estimated dispersion parameter of the beta-binomial distribution.
pVar variance of the estimation of the probability parameter p.
psi estimation of the logarithm of the dispersion parameter phi.
psiVar variance of the estimation of the logarithm of the dispersion
parameter psi.
m maximum score number in each beta-binomial observation.
balanced if the response variable is balanced it returns ‘yes’, otherwise ‘no’.
method the used approach for performing the estimations.
Examples
> y <- rBB(k,m,p,phi)
>
> # Performing the estimation of the parameters
>
> # Method of moments:
> MM <- BBest(y,m)
>
> MM
The probability parameter of the beta-binomial distribution: 0.7124
The dispersion parameter of the beta-binomial distribution: 1.629548
Balanced data, maximum score number: 10
>
> # Maximum likelihood approach
> MLE <- BBest(y,m,method="MLE")
>
> MLE
The probability parameter of the beta-binomial distribution: 0.7066453
The dispersion parameter of the beta-binomial distribution: 1.621879
Balanced data, maximum score number: 10
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5.2.3 BBreg: Fit a marginal beta-binomial regression model
Description
BBreg function fits a marginal beta-binomial regression model, i.e., it links the
probability parameter of a beta-binomial distribution with the given covariates
by means of a logistic link function. The estimation of the parameters in the
model is done via maximum likelihood estimation.
Usage
BBreg(formula,m,data,maxiter=100)
Arguments
formula an object of class ‘formula’ (or one that can be coerced to that class):
a symbolic description of the model to be fitted.
m maximum score number in each beta-binomial observation.
data an optional data frame, list or environment (or object coercible by
as.data.frame to a data frame) containing the variables in the model.
If not found in data, the variables are taken from environment
(formula).
maxiter the maximum number of iterations in the estimation process. Default
100.
Details
The BBreg function performs a marginal beta-binomial regression model for a
given outcome and covariates. Assume that we have a set of variables Y =
(Y1, . . . , Yn)
′ which follow a beta-binomial distribution which we want to model
as a function of some covariates X1, . . . , Xk. Hence, similar to the logistic
regression, we can connect the probability parameter of the beta-binomial
distribution with the given covariates by means of a logistic link function as
ηi = logit(pi) = log
pi
1− pi = x
′
iβ,
where xi is the ith row of a full rank matrix X composed by the given covari-
ates and β are the regression coefficients.
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The estimation of the parameters in the model is done via maximum likelihood
estimation. The log-likelihood of the model for a set of observations y =
(y1, . . . , yn)
′ is defined as
logL(β, φ|y) =
n∑
i=1
[
log
(
mi
yi
)
+
yi−1∑
k=0
log(pi + kφ) +
mi−yi−1∑
k=0
log(1− pi + kφ)
−
mi∑
k=0
log(1 + kφ)
]
,
where β enters in the equation through pi.
Regarding the estimation procedures, the the regression coefficients β are cal-
culated solving the following score function,
S(β) =
∂
∂β
logL(β, φ|y) = ξ′SX
where S = diag (p1(1− p1), . . . , pn(1− pn)) and ξ = (ξ1, . . . , ξn)′ being
ξi =
yi−1∑
k=0
1
pi + kφ
−
mi−yi−1∑
k=0
1
1− pi + kφ.
In this package we have developed an estimation procedure based on the delta
algorithm which leads to the following iterative estimation equation,
βˆ
(r+1)
= (X ′SV SX)−1X ′SV Sν,
where ν = Xβ(r)+(SV )−1ξ, and the previous matrices are evaluated at βˆ
(r)
.
The estimates of β are functions of φ. Hence, if we replace β with βˆ or,
equivalently, p with pˆ, in the log-likelihood function, we obtain the profile log-
likelihood with respect to φ. In BBreg function we have developed a Newton-
Raphson based algorithm for the estimation of φ.
Value
BBreg returns an object of class ‘BBreg’.
The function summary (i.e., summary.BBreg) can be used to obtain or print a
summary of the results.
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coefficients the estimated value of the regression coefficients.
vcov the variance-covariance matrix of the estimated coefficients of the
regression.
phi the estimation of the dispersion parameter of the beta-binomial
distribution.
psi the estimation of the logarithm of the dispersion parameter of the
beta-binomial distribution.
psi.var the variance of the estimated logarithm of the dispersion parameter of
the beta-binomial distribution.
conv convergence of the methodology. If the method has converged it
returns ‘yes’, otherwise ‘no’.
fitted.values the fitted mean values of the model.
deviance the deviance of the model.
df degrees of freedom of the model.
null.deviance null-deviance, the deviance for the null model. The null model will
only include an intercept as the estimation of the probability
parameter.
null.df the degrees of freedom for the null model.
iter number of iterations in the estimation process.
X the model matrix.
y the dependent response variable in the model.
m maximum score number in each beta-binomial observation.
balanced if the response beta-binomial variable is balanced it returns ‘yes’,
otherwise ‘no’.
nObs number of observations.
call the matched call.
formula the formula supplied.
Examples:
> # We simulate a covariate, fix the parameters of the beta-binomial
> # distribution and simulate a response variable. Then we apply the
> # model, and try to get the same values.
>
> set.seed(18)
> k <- 1000
> m <- 10
> x <- rnorm(k,5,3)
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> beta <- c(-10,2)
> p <- 1/(1+exp(-(beta[1]+beta[2]*x)))
> phi <- 1.2
> y <- rBB(k,m,p,phi)
>
> model <- BBreg(y~x,m)
> model
Call: BBreg(formula = y ~ x, m = m)
Beta coefficients:
Intercept x
[1,] -10.13476 2.032702
Dispersion parameter: 1.264069
Deviance: 1236.094 on 997 degrees of freedom
Null deviance: 3437.819 on 999 degrees of freedom
Balanced data, maximum score in the trials: 10
5.2.4 BBmm: Fit a beta-binomial mixed-effects regression model
Description
BBmm function performs beta-binomial mixed-effects models, i.e., it allows the
inclusion of Gaussian random effects in the linear predictor of a marginal beta-
binomial logistic regression model in order to accommodate the correlation
among the outcomes. It allows the joint estimation of more than one outcome
vector in a multivariate framework.
Each component of the model can be specified by means of two different ways:
Outcomes: (i) determining the fixed.formula argument, or (ii) including
the vector of the outcomes y.
Fixed part: (i) determining the fixed.formula argument, or (ii) specifying
the model matrix of the covariates X.
Random part: (i) determining the random.formula argument, or (ii) spec-
ifying the model matrix of the random effects, Z, and determining the
number of random effects in each random component, nRandComp.
The estimation of the fixed and random effects in the model can be done by
means of two approaches: (i) BB-Delta, the delta algorithm developed for
the beta-binomial mixed-effects model, and (ii) using the NR R-package. The
selected method must be specified in the arguments of the function.
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Usage
BBmm(fixed.formula=NULL,X=NULL,y=NULL,random.formula=NULL,Z=NULL,
nRandComp=NULL,m,data=list(),method="BBNR",maxiter=50,show=FALSE,
nDim=1)
Arguments
fixed.formula an object of class ‘formula’ (or one that can be coerced to that class):
a symbolic description of the fixed part of the model to be fitted.
X design matrix composed by the given covariates in the model. It must
be only specified in cases where the fixed.formula argument is not
determined.
y the vector of the outcomes that are going to be modelled as a function
of the covariates. It must be only specified in cases where the
fixed.formula argument is not determined.
random.formula an object of class ”formula” (or one that can be coerced to that class):
a symbolic description of the random part of the model to be fitted.
Z design matrix composed by the correlation, or random effects
structure, of the model. It must be only specified in cases where the
random.formula argument is not determined.
nRandComp the number of random effects in each random component of the
model. It must be specified as a vector where the ith value
corresponds with the number of random effects of the ith random
component. It must be only included when the random structure of
the model is described through the matrix of the random effects Z.
m maximum score number in each beta-binomial observation.
data an optional data frame, list or environment (or object coercible by
as.data.frame to a data frame) containing the variables in the model.
If not found in data, the variables are taken from environment
(formula).
method the method for the estimation of the fixed and random effects in the
model. Two options are available: (i) ‘BB-Delta’, the delta algorithm
developed for the estimation procedure of the beta-binomial
mixed-effects regression approach; (ii) ‘NR’, general Newton-Raphson
algorithm for estimating the root of a set of n (nonlinear) equations.
maxiter the maximum number of iterations in the estimation process. Default
50.
show logical, if TRUE, then the tolerance of the stop criterion together
with the maximum difference of the fixed effects, beta-binomial
log-dispersion parameter and random effects standard deviation with
respect to the previous estimation is shown in each iteration.
nDim number of dimensions that are going to be jointly analysed. Default 1.
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Details
BBmm function performs a beta-binomial mixed effects models. It extends the
marginal beta-binomial logistic regression to the inclusion of random effects
in the linear predictor of the model. It is assumed that, conditional on some
Gaussian random effects u, each variable of the the response variable vector
Y follows a beta-binomial distribution of parameters mi, pi and φi,
Yi|u ∼ BB(mi, pi, φi), u ∼ N (0,D)
where
η = log
(
p
1− p
)
= Xβ +Zu
being X and Z model matrices composed by the given covariates and random
structure respectively and D(λ) is determined by some dispersion parameters
λ, which are included in the parameter vector θ = (φ,λ′)′.
The estimation of the fixed regression parameters β and the prediction of the
random effects u is done via the maximum likelihood, where the marginal
likelihood of the model is approximated though the joint-likelihood by a first
order Laplace approximation,
l(β,u,θ|y) ≈ log f(y|β,u,θ) + log f(u|θ). (5.1)
The previous formula does not have a closed form and numerical methods are
needed for developing a estimation procedure. Two approaches are available in
the BBmm function in order to perform the fixed and random effects estimation:
(i) A special case of the delta algorithm developed for the beta-binomial mixed-
effects model estimation, and (ii) a general Newton-Raphson algorithm.
The estimation of the dispersion parameters θ by the joint-likelihood may be
substantially biased due to the previous estimation of the fixed and random
effects. Consequently, a penalisation of the joint-likelihood must be performed
in order to get an unbiased estimation of the dispersion parameters. Lee
and Nelder (1996) proposed the adjusted profile h-likelihood for the correct
estimation of the dispersion parameters in mixed-effects model framework,
h(θ|βˆ, uˆ,y) = log f(y|β,u,θ) + log f(u|θ) + 1
2
log
[
det
(
2piH−1
)]
,
where H is the Hessian matrix of the model, i.e. the second derivatives of the
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log-likelihood with respect to β and u.
The BBmm methodology iterates between the estimations of the regression and
dispersion parameters until convergence is reached. The convergence is reached
when the tolerance of the model is lower than 10−6, where the tolerance for
the (r + 1)th iteration is defined as
tolerance(r+1) =
n∑
i=1
[
η
(r)
i − η(r+1)i
]2
∑n
i=1
[
η
(r+1)
i
]2 .
Value
BBmm returns an object of class ‘BBmm’.
The function summary (i.e., summary.BBmm) can be used to obtain or print a
summary of the results.
fixed.coef estimated value of the fixed effects of the regression.
fixed.vcov the variance-covariance matrix of the estimated fixed effects of the
regression.
random.coef predicted random effects of the regression.
sigma.coef estimated value of the standard deviations of the random effects.
sigma.var variance of the estimation of the standard deviation of the random
effects.
phi.coef estimated value of the dispersion parameter of the beta-binomial
distribution.
psi.coef estimated value of the logarithm of the dispersion parameter of the
beta-binomial distribution.
psi.var variance of the estimation of the logarithm of the dispersion
parameter of the beta-binomial distribution.
fitted.values the fitted mean values of the probability parameter of the
beta-binomial distribution.
conv convergence of the methodology. If the method has converged it
returns ‘yes’, otherwise ‘no’.
deviance deviance of the model.
df degrees of freedom of the model.
null.deviance null-deviance, deviance of the null model. The null model will only
include an intercept as the estimation of the probability parameter.
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null.df degrees of freedom of the null model.
nRand number of random effects.
nComp number of random components.
nRandComp number of random effects in each random component of the model.
namesRand names of the random components.
iter number of iterations in the estimation method.
nObs number of observations in the data.
y the vector of the outcomes that are going to be modelled as a function
of the covariates.
X design matrix composed by the given covariates in the model.
Z design matrix composed by the correlation, or random effects
structure, of the model.
D variance-covariance matrix of the random effects.
balanced if the response beta-binomial variable is balanced it returns ‘yes’,
otherwise ‘no’.
m maximum score number in each beta-binomial observation.
nDim number of dimensions that are going to be jointly analysed.
call the matched call.
formula the fixed and random supplied formulas. It only provides the formula
if it has been previously specified in the arguments of the function.
The first formula corresponds to the fixed part of the model, while the
second formula corresponds to the random structure.
Examples
> set.seed(15)
> # Defining the parameters
> nObs <- 500 # 500 observations
> m <- 10# balanced data, maximum score number equal to 10.
> nRandComp <- c(70,50) # number of random effects in each random component
> phi <- 1.1 # dispersion parameter of the beta-binomial distribution
> sigma1 <- 1.2 # standard deviation of the first random effect
> sigma2 <- 0.5 # standard deviation of the second random effect
> beta <- c(-1,3.25) # the fixed effects
>
> # Simulate
> x <- rnorm(nObs,0.5,1.5) # the covariate
> u1 <- rnorm(nRandComp[1],0,sigma1) # first random effects
> u2 <- rnorm(nRandComp[2],0,sigma2) # second random effects
> u <- as.vector(c(u1,u2))
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> # Desing matrices
> X <- model.matrix(~x)
> z1 <- as.factor(rBB(nObs,nRandComp[1]-1,0.5,2)) # correlation structure for
the first random effect
> z2 <- as.factor(rBB(nObs,nRandComp[2]-1,0.5,2)) # correlation structure for
the second random effect
> Z1 <- model.matrix(~z1-1) # model matrix of the correlation structure for
the first random effect
> Z2 <- model.matrix(~z2-1) # model matrix of the correlation structure for
the second random effect
> Z <- cbind(Z1,Z2) # correlation structure of both random effects
>
> # Calculate the linear predictor and simulate the outcome variable
> eta <- X%*%beta+Z%*%u # the linear predictor
> p <- exp(eta)/(1+exp(eta)) # apply the antilogit to the linear predictor
> y <- rBB(nObs,m,p,phi) # simulate the outcome variable
>
> # Apply the model
> model <- BBmm1(fixed.formula=y~x,random.formula=~z1+z2,m=m)
Iteration number: 1
Iteration number: 2
Iteration number: 3
Iteration number: 4
Iteration number: 5
Iteration number: 6
Iteration number: 7
Iteration number: 8
Iteration number: 9
Iteration number: 10
Iteration number: 11
Iteration number: 12
Iteration number: 13
Iteration number: 14
Iteration number: 15
> summary(model)
Call: BBmm1(fixed.formula = y ~ x, random.formula = ~z1 + z2, m = m)
Fixed effects coefficients:
Estimate StdErr t.value p.value
(Intercept) -1.02274 0.13551 -7.5474 4.44e-14 ***
x 3.26362 0.20147 16.1990 < 2.2e-16 ***
---
Signif. codes: 0 *** 0.001 ** 0.01 * 0.05 . 0.1 1
---------------------------------------------------------------
Random effects dispersion parameter(s):
Estimate StdErr
z1 1.2337309 0.1435245
z2 0.5323015 0.1105570
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---------------------------------------------------------------
Logarithm of beta-binomial dispersion parameter log(phi):
Estimate StdErr
1 0.08360297 0.1357834
---------------------------------------------------------------
Deviance of the model: 215.3224 ; with 495 degrees of freedom.
Deviance of the null model 1334.249 ; with 496 degrees of freedom.
Deviance goodness-of-fit test p-value: 0
Number of observations: 500
Number of iterations: 15
Balanced data, maximum score number: 10
Number of random effects in each random component: 70 50
Number of analysed dimensions: 1
5.2.5 Additional functions
Apart from the described functions for dealing with beta-binomial data in different
scenarios, the PROreg package also contains some other functions. As it was shown
in Table 5.2, functions based on the binomial distribution can also be performed,
whose implementation is very similar to the presented functions. For instance we
can make use of:
BI: The binomial distribution
Similar to dBB() and rBB() in Section 5.2.1 we can use dBI() and rBI()
to compute the density and random generation of the binomial with optional
dispersion parameter distribution respectively.
BIest: Estimation of the parameters of a binomial distribution with
optional dispersion parameter
BIest() estimates the parameters of a binomial distribution for a given out-
come. The estimation of a dispersion parameter, which accommodates overdis-
persion, can be selected. Implementation is similar to BBest() in Section 5.2.2.
BIreg: Fit a logistic regression model with optional dispersion parameter
BIreg() fits a logistic regression with optional dispersion parameter which in
case, it is calculated through quasi-likelihood theory introduced in Chapter 1.
The implementation is quite similar to BBreg() function in Section 5.2.3.
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BImm: Fit a logistic mixed-effects regression model
BImm() fits a logistic mixed-effects regression model where random effects are
included in the linear predictor of a logistic regression. Implementation of the
algorithm is quite similar to BBmm() introduced in Section 5.2.1.
Additionally, PROreg R-package includes some questionnaire-specific functions.
For instance, two functions are available for the SF-36 Health Survey. First, the
SF36rec() function performs the recoding of the SF-36 Health Survey based on
Arostegui et al. (2013) (see Appendix A). The inputs of the function are (i) the
dimension to be recoded and (ii) a scalar number from 1 to 8 which identifies the
input vector with a SF-36 dimension. Second, the HRQoLplot() offers a nice visual
descriptive analysis of all the dimensions provided by the SF-36. The HRQoL status
of the individuals can be drawn by groups, clusters or covariates. Following we are
going to display some code in order to show the easy application of the function and
the nice output it provides.
> set.seed(9)
> # We insert the columns in the order that has been determined:
> m <- c(20,4,9,20,20,8,3,13)
> k <- 3
> p <- runif(3,0.2,0.8)
> phi <- runif(3,0.5,1)
> dat <- data.frame(rbind(ID1=rBB(8,m,p[1],phi[1]),
ID2=rBB(8,m,p[2],phi[2]),
ID3=rBB(8,m,p[3],phi[3])))
> colnames(dat) <- c("RF", "RP", "BP","GH","VT","SF","RE","MH")
> HRQoLplot(dat,TRUE)
Short Form−36 Health Survey
PF (20)
RP (4)
BP (9)
GH (20)
VT (20)
SF (8)
RE (3)
MH (13)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ID1
ID2
ID3
CHAPTER 6
CONCLUSIONS AND FURTHER WORK
“There is nothing permanent except change”
Heraclitus of Ephesus, c. 535− c. 475
PROs are important supplements to traditional medical outcomes which play
an important role in health care and understanding health outcomes as they offer a
new insight of the health-status of patients. PROs are increasingly used as primary
outcomes and have gradually become an important element and a crucial source for
monitoring disease condition or assessing the effectiveness of treatment, especially
in chronic diseases or some health problems such as subjective discomfort and psy-
chological distress (Chang, 2007). In fact, the U.S. Food and Drug Administration
(FDA) has recommended that objective indicators combined with PROs are con-
sidered a more comprehensive form of outcome evaluation since 2006 (Speight and
Barendse, 2010). Measuring PROs can help determine the burden of preventable
diseases, injuries, and disabilities, and it can provide valuable new insights into the
relationships between PROs and risk factors.
The measurement of the effect that some risk factors may have on the health-
status of patients provided by PROs, requires the development of regression models.
Most of the regression techniques developed in the literature, such as GLMs (Mc-
Cullagh and Nelder, 1989) or GLMMs (McCulloch and Searle, 2001), are based on
the assumption that the outcome variable follows a distribution from the exponen-
tial family. In fact, exponential family distributions offer good properties which
simplify the estimation and inference procedure of regression models in many situa-
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tions. However, it has been shown in the literature that PROs are usually displayed
following a discrete and bounded U, J or inverse J-shaped distribution, accumulat-
ing values in one or both edges of the scale (Arostegui et al., 2007; Najera-Zuloaga
et al., 2017). Hence, exponential family distributions, and especially, due to the
nature of PROs, the binomial distribution, offers an inappropriate distributional
fit to PROs. In order to overcome the inappropriate distributional fit provided by
exponential family distributions, the beta-binomial distribution has been proposed
in the literature as a good candidate for modelling the shape of PROs (Arostegui
et al., 2007). The beta-binomial distribution is defined as a binomial distribution
whose probability parameter is random and drawn from a beta distribution. Hence,
it does not belong to the exponential family. Therefore, regression models based on
the beta-binomial distribution are not so common in the literature.
The first objective of the thesis was to stablish methods to provide inference in a
cross-sectional beta-binomial regression model for the analysis of PROs. In Chapter
2, we have shown that the beta-binomial distribution can be defined by means of
two different approaches, marginally or conditionally, where each approach leads to
a different regression model, BBreg and BBhglm. In that chapter, we have com-
pared the performance of both approaches when analysing PROs. It is well-known
that marginal and the conditional approaches provide different regression results
as they are modelling different expectations (Lee and Nelder, 2004). The marginal
approach refers to the whole population and it models the marginal expectation.
On the contrary, conditional approach refers to individuals and it models the condi-
tional expectation. However, we have shown through a real data application and a
simulation study that covariates that have a marginally statistical significant effect
in PROs turn out not to be statistically significant in the conditional approach. The
objective of PRO studies is usually the measurement of the effect of risk factors on
the health-status of some patients, and therefore, conclusions are drawn from the
whole population suffering from the disease. Therefore, the use of the conditional
approach can sometimes mask the effect of some covariates, making them not rele-
vant when they are statistically significant. Moreover, the assumption of a covariate
that does not affect the individuals, but affects the population can be misleading.
Following the argument by Senn in the comments to the paper by Lee and Nelder
(2004), “After all, if the treatment cannot affect individuals, it has no effect on
populations...”. Therefore, we suggest the use of the marginal BBreg approach for
the analysis of PROs when there is not correlation in the data.
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The second objective of the thesis was the extension to the of the cross-sectional
beta-binomial model to a hierarchical regression framework. In Chapter 3, we have
developed the BBmm approach which consists of the inclusion of Gaussian random
effects in the linear predictor of BBreg. That way, the Gaussian random effects
account for the hierarchical, or correlation, structure of the data while the beta-
binomial distribution accommodates the properties of PROs. We propose a proce-
dure based on the Laplace approximation and the Delta method for the estimation
of all the parameters involving the model. The proposal consists of the estimation
of fixed and random effects in the model through the maximisation of the joint like-
lihood, while the dispersion parameters are estimated by maximising a penalised
profile likelihood proposed by Lee and Nelder (2001). We compare the performance
of BBmm with other similar approaches in the literature. For instance, BBmm has
been compared to hierarchical generalised linear models (HGLMs)(Lee and Nelder,
1996) and combined models (Molenberghs et al., 2010). However, special attention
has been focused on the comparison of the BBmm with the generalised additive mod-
els for location, scale and shape (GAMLSS) by Rigby and Stasinopoulos (2005), due
to the similarities between both modelling approaches. The main difference between
GAMLSS and BBmm approaches is the penalisation of the profile likelihood in or-
der to estimate the dispersion parameter of the beta-binomial distribution. We have
shown through a simulation study that the proposed penalisation not only improves
the estimation of the dispersion parameter of the beta binomial distribution in terms
of bias, but also the estimation of the rest of parameters in the model. Therefore, we
conclude that BBmm approach is more convenient than GAMLSS to make inference
based on the beta-binomial mixed-effects model. Although, BBmm estimation pro-
cedure has been restricted to the beta-binomial distribution case, the penalisation of
the profile likelihood in order to estimate dispersion (or non-canonical) parameters
of the model, it can be useful in any other situation. However, the previous hypoth-
esis goes beyond the objectives of this thesis and therefore, it will be considered as
future work.
PROs are usually measured using questionnaires that decompose the health as-
pect they are assessing in different dimensions. Until now, either in a cross-sectional
or hierarchical scenario, the models we have proposed analysed each health dimen-
sion separately. However, it seems logical to think that dimensions that contain
measurements provided by the same individuals may have a correlation. Therefore,
the third objective was the proposal of a multivariate regression model based on
the beta-binomial distribution, which has been carried out in Chapter 4. Due to
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the advantages that mixed-effects model framework provide, we have considered the
shared random effects approach (McCulloch, 2008) and we have applied it to the
beta-binomial mixed-effects models developed in Chapter 3. Therefore, the shared
random effects model consist of including the same random effects in the linear
predictor of each dimension and, in such a way that they allow for a correlation
structure among them. We have obtained quite consistent results for cross-sectional
studies and some preliminary results when analysing longitudinal data.
The development of statistical models may be pointless unless a tool would be
provided for researchers. Therefore, the fourth objective of the thesis consisted of
the development of an R-package which compiles, among others, all the method-
ologies proposed in this thesis. The name of the implemented R-package is PROreg
(Patient-Reported Outcomes regression analysis) and it is already available at CRAN
https://cran.r-project.org/web/packages/PROreg/. The description of the main
functions as well as any other information has been provided in Chapter 5. Fig-
ure 6.1 shows the number of downloads of the R-package since it was uploaded to
CRAN untill october 2017.
Figure 6.1: Number of weekly downloads of PROreg and HRQoL R-
packages. Originally in Najera-Zuloaga et al. (2017) the package was
called HRQoL. This plot was obtained from the shiny application available at
https://dgrtwo.shinyapps.io/cranview/
Finally, researchers at the Respiratory Service at Galdakao Hospital in Spain
designed a longitudinal study where the health-status of patients with COPD was
repeatedly measured. The objective was to measure the health-status and evolu-
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tion of COPD patients who were followed for up to five years. Therefore, the last
objective of the thesis was to achieve clinically relevant and useful results regarding
the evolution and COPD patients, and to detect significant relationships between
their health-status and risk factors. This last objective was developed in Chapter 2
and Chapter 4, where relationship between the health-status of COPD patients and
covariates is assessed in a univariate and a multivariate framework. On the contrary,
the evolution of the patients was developed in Chapter 3 and Chapter 4 analysing
the dimensions separately and jointly. For instance, we conclude that patients with
COPD does not evolve in their symptomatology and disease impact as time goes by
and moreover, that the initial status at baseline does not influence that evolution.
On the contrary, the activity of COPD patients is expected to worsen over time, al-
though the initial severity of the disease does not determine the evolution, meaning
that all the patients evolve similarly.
As some final remarks, we would like to mention that part of the modelling
approaches presented in this thesis have some limitations that we will explore in
further research. On the one hand, we shown in Chapter 4 that although the mul-
tivariate shared random effects approach offers valid results in cross-sectional data,
in longitudinal data they can be quite restrictive and hence, and they can lead to
misleading conclusions. In fact, the assumption that all the patients distance in the
same quantity in baseline and evolution from the overall population trend in all the
dimensions can be quite unrealistic. In order to avoid the this assumption, one may
consider a model with correlated random effects, where each dimension depends on
different random effects that are correlated among dimensions. The correlated ran-
dom effects model is much more flexible than the shared random effects approach,
however, when more than two dimensions are analysed, the approximation of the
marginal likelihood through the Laplace approximation becomes cumbersome. Most
of the PRO questionnaires provides more than two dimensions, and consequently,
the correlated random effects approach would not be useful due to dimensionality
problems. Fieuws and Verbeke (2006) proposed an inference strategy in order to
avoid the high dimensionality of the marginal likelihood of the model. Their pro-
posal was based on the idea that all parameters in the joint model can be estimated
by fitting all bivariate models implied in the multivariate model. More specifically,
for all
(
k
2
)
(Y l,Y s) dimension pairs, 1 ≤ l ≤ s ≤ k, they proposed to fit using MLE
the model defined by
f(yl,ys) =
∫ ∫
f(yl|ul)f(ys|us)duldus,
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where ul and us are random effects associated with Y l and Y s dimensions. Then,
they proposed to obtain the estimates of the correlated random effects model by
averaging over the results for the
(
k
2
)
pairwise model fits. Obviously, the resulting
estimates do not maximise the likelihood, hence inference does not follow from clas-
sical maximum likelihood theory. Instead, Fieuws and Verbeke (2006) showed that
pseudo-likelihood theory could be used to derive the asymptotic distribution of the
obtained estimates. Alternatively, the proposed estimation procedure based on the
replacement of the log-likelihood of the original model by a sum of implied marginal
or conditional log-likelihoods is also referred to as composite likelihood (Lindsay,
1988). However, the implementation of the pairwise estimation procedure for the
beta-binomial distribution goes beyond the scope of this thesis, and hence, it is left
as future work. On the other hand, in Chapter 3, we have shown the evolution
of patients with COPD adjusted by patients’ subtypes. Nowadays, we are working
with clinicians in order to incorporate covariates that can have both clinically and
statistically significant effect in the evolution of COPD patients.
Further work
The research that has been undertaken for this thesis has highlighted a number of
topics on which further research would be beneficial in the statistical analysis of
PROs. For instance:
1. The jointly modelling of the conditional mean and variance components in
hierarchical beta-binomial data.
An important issue that needs to be addressed when modelling hierarchical
data, is how to correctly account for both individual and group level vari-
ation that might be present in the data. The main focus in (generalised)
linear mixed effects models has been on modelling the mean structure of the
data while treating the variances/covariances as nuisance parameters. Taking
into account the structure but misspecifying or oversimplifying the covariance
structure can still have a serious impact on the efficiency of the mean param-
eters. In some circumstances, like the mean, the variance may depend on a
set of explanatory variables, McCullagh and Nelder (1989) proposed the joint
modelling of mean and dispersion in the GLM framework. However, the litera-
ture on joint modelling for generalised linear mixed models (GLMMs) is rather
limited. Pan and McKenzie (2007) proposed modelling the conditional vari-
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ance using the Cholesky Decomposition of the covariance matrix, for the linear
mixed model. Lee et al. (2006) proposed a joint mean–covariance modelling
for hierarchical data via HGLMs with structured dispersions and the so-called
double HGLMs Lee and Nelder (2006). Modelling dispersion and conditional
variance in the beta-binomial context would be of interest for further research.
2. Joint modelling of survival and longitudinal PROs.
In many longitudinal studies measurements also may include the time at which
an event of particular interest occurs (e.g. death, development of a disease or
drop out from the study). These outcomes are often separately analysed; how-
ever, in many instances, a joint modelling approach is either required or may
produce a better insight into the mechanisms that underlie the phenomenon
under study (see Tsiatis and Davidian, 2004, for a detailed overview). Usually,
the joint distribution of the event times and the longitudinal measurements
is modelled via a set of random effects that are assumed to account for the
associations between these two outcomes (see Hsieh et al., 2006; Rizopoulos
et al., 2009, for a review). Related to this topic, a joint modelling of PROs
and survival analysis of chronic disease patients will be of interest for further
research where the longitudinal modelling is based on the beta-binomial mixed
effects model developed in this thesis.
3. Testing for variance components in the beta-binomial mixed-effects model.
Testing zero variance components is one of the most challenging problems in
the context of linear mixed-effects models. The usual asymptotic Chi-square
distribution of the likelihood ratio and score statistics under this null hypoth-
esis is incorrect because the null is on the boundary of the parameter space.
Previous work by Greven et al. (2008) addressed this issue and provide Re-
stricted Likelihood Ratio Tests. Other authors introduce a simple test statistic
based on the variance least square estimator of variance components (Drik-
vandi et al., 2013). In this thesis, we did not explore this issue when testing
for the variance components in BBmm, although it would be an interesting
topic for further research.
4. Inclusion of non-linear covariate effects.
The real data applications presented in this thesis did not show evidence of
non-linear covariate effects. However, when the relationship between the re-
sponse variable and covariate effects are non-linear, the inclusion of non-linear
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effects in the BBmm under the modelling framework presented in this thesis is
straightforward by means of smooth effects with penalised splines reformulated
as a mixed-effects models (Ruppert et al., 2003; Wood, 2006). The estimation
of the variance components with the estimation procedure developed in this
thesis would be of great interest for researchers in PROs.
5. Incorporation of new features and efficient algorithms in PROreg R-package.
As part of the further research in the analysis of PROs, the incorporation of
new features and more efficient implementations of the BBreg and BBm func-
tions will be considered for further research.
Appendices
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APPENDIX A
RECODING PROCESS OF THE SHORT
FORM-36 HEALTH SURVEY
The SF-36 Health Survey recoding methodology is fully explained in Arostegui et al.
(2013) however, for the sake of clarity as it was mentioned in Section 1.2.1, we are
going to define more in detail the recoding process in this appendix. For simplicity
and brevity of exposition, we only show results for three of the eight health di-
mensions of the SF-36. The selected three dimensions (physical functioning, mental
health and role emotional) illustrate different distribution shapes as shown in Figure
1.1 and a wide range of number of possible values (see Table 1.1).
Table A.1 shows the possible values of the raw and standardized original scores,
as well as the sub-interval division of the 0-100 scale and the final recoded scores
for physical functioning, mental health and role emotional dimensions. Arostegui
et al. (2013) evaluated and validated the proposed method of recoding the scores
provided by the SF-36 Health Survey. They showed that the recoding has a natural
interpretation, not only for ordinal scores but also for questionnaires with many
dimensions and different profiles, where a common method of analysis is desired,
such as the SF-36. Briefly, let Y denote the original standardized score observed in
[0, 100] and Z the recoded ordinal score, from 0 to m, where Z ∼ Bin(m, p). Thus, Z
could be interpreted as grouped data for a dichotomous outcome that represents the
number of successes in m binomial trials and p represents the probability of success
in each trial. In the HRQoL context, Z is interpreted as the number of ‘points’ that
an individual has, p as the probability of obtaining one point more and m represents
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the maximum number of points that can be obtained.
Table A.1: Recoding methodology for role emotional, mental health and physical
functioning dimensions of the SF-36.
Role emotional Mental health
Raw Stdr. Inter. Recoded Raw Stdr. Inter. Recoded
3 0 [0, 16.67] 0 5 0 [0,2] 0
4 33.3 (16.67, 50] 1 6 4 (2,10] 1
5 66.7 (50, 83.33] 2 7 8
6 100 (83.33, 100] 3 8 12 (10,18] 2
9 16
10 20 (18, 26] 3
Physical functioning 11 24
Raw Stadr. Inter. Recoded 12 28 (26,34] 4
10 0 [0, 2.5] 0 13 32
11 5 (2.5, 7.5] 1 14 36 (34,42] 5
12 10 (7.5, 12.5] 2 15 40
13 15 (12.5, 17.5] 3 16 44 (42,50] 6
14 20 (17.5, 22.5] 4 17 48
15 25 (22.5, 27.5] 5 18 52 (50,58] 7
16 30 (27.5, 32.5] 6 19 56
17 35 (32.5, 37.5] 7 20 60 (58,66] 8
18 40 (37.5, 42.5] 8 21 64
19 45 (42.5, 47.5] 9 22 68 (66,74] 9
20 50 (47.5, 52.5] 10 23 72
21 55 (52.5, 57.5] 11 24 76 (74,82] 10
22 60 (57.5, 62.5] 12 25 80
23 65 (62.5, 67.5] 13 26 84 (82,90] 11
24 70 (67.5, 72.5] 14 27 88
25 75 (72.5, 77.5] 15 28 92 (90,98] 12
26 80 (77.5, 82.5] 16 29 96
27 85 (82.5, 87.5] 17 30 100 (98,100] 13
28 90 (87.5, 92.5] 18
29 95 (92.5, 97.5] 19
30 100 (97.5, 100] 20
Raw: Raw scores; Stdr.: Standardized original scores; Inter.: The subinterval division of the
0− 100 scale; Recoded: Recoding of the values. The decomposition in raw and original
standardized scores of the HRQoL dimensions is developed in Ware et al. (1993), while the
subinterval division and recoding process are explicitly explained in Arostegui et al. (2013).
APPENDIX B
ITERATIVE ESTIMATION
METHODOLOGIES
Numerical algorithms to find the maximum likelihood estimates and standard errors
are crucial for regression analysis including non-normal outcomes. In these cases, the
computation of the marginal likelihood has not a closed form, and hence, likelihood
approximations are needed. Moreover, even with approximated likelihoods, there is
no explicit formula to obtain both maximum likelihood estimations and standard
errors. It turns out that there is one general algorithms, called the iterative weighted
least squares (IWLS), that works reliably for exponential family distributions. Al-
though there are many ways to derive an IWLS procedure, we will focus on the
development of the methodology by the Newton-Raphson technique. Therefore, we
are going to, first, briefly introduce the well known Newton-Raphson procedure and
then, we are going to derive the IWLS algorithm
B.1 Newton-Raphson procedure
The Newton-Raphson procedure is a powerful technique for solving equations of the
form g(x) numerically. Although, it is widely used for finding out the root of a
function, it is simply based on the idea of a linear approximation.
Let define r as the root of the equation g(x) = 0. Assume that x0, the initial
value, is a good estimate for r, good in terms of distance. Hence, we have that
r = x0 + h, where h is not a large number. Since the true root is r and h = r − x0,
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the number h measures how far the estimate x0 is from the truth.
Considering that h is small we can use the linear or tangent approximation to
conclude that
0 = g(r) = g(x0 + h) ≈ g(x0) + hg′(x0)
and, therefore, unless g′(x0) is close to 0,
h ≈ − g(x0)
g′(x0)
and hence, we have that
r = x0 + h ≈ x0 − g(x0)
g′(x0)
Consequently, we get a new improved estimate x1 in the following way
x1 = x0 − g(x0)
g′(x0)
The repetition of the previous formula, getting new improved estimates for r,
results in the following iterative procedure: if xn is the current estimate, then the
next estimate xn+1 is define as
xn+1 = xn − g(xn)
g′(xn)
B.2 Iterative weighted least squares algorithm
Now we are going to extend the Newton-Raphson procedure to the GLM framework
(see Chapter 2 Section 2.1.1). First, we start with a log-likelihood contribution of
an observation yi of the exponential family form,
logL(θi, φ|yi) = yiθi −A(θi)
φ
+ c(yi, φ)
where θi is the so-called canonical parameter, φ is the dispersion parameter and c(·)
and A(·) are known functions. The exponential family distributions have very useful
characteristics, which make them very flexible for estimation procedures. The most
relevant feature of the exponential family distributions, compared with other more
rigid models, is that the variance is not closely defined by the mean,
µi = E[Yi] = A′(θi)
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Var[Yi] = φA′′(θi) = φ
∂
∂θi
E[Yi] = φv(µi)
Let us assume that we have n independent observations yi and consider that the
connection between the given covariates and the observed responses is defined as
h(µi) = x
′
iβ
where h(·) is called the link function. If we try to get the estimate of β, for a fixed
value of φ,we get the following score equation
S(β) =
∂
∂β
logL(θi|φ,y) = φ−1
n∑
i=1
∂θi
∂β
(yi −A′(θi))
while the Fisher information matrix is defined as
I(β) = φ−1
n∑
i=1
[
− ∂
2θi
∂β∂β′
(yi −A′(θi)) + ∂θi
∂β
∂θi
∂β′
A′′(θi)
]
which in general a very complex expression.
If we use the exponential family property, A′(θi) = µi, we have that
A′′(θi) = ∂µi/∂θi = vi
∂θi
∂β
=
∂θi
∂µi
∂µi
∂h
∂h
∂β
= v−1i
∂µi
∂h
xi
Hence, the second term of I(β) reduces to
U ≡
n∑
i=1
[( ∂h
∂µi
)2
φvi
]−1
xix
′
i
In the same way we have that,
S(β) =
n∑
i=1
[( ∂h
∂µi
)2
φvi
]−1
xi
∂h
∂µi
(yi − µi)
Furthermore, if we use a canonical link function in the model, i.e., if we use a link
function such as θi = h(µi) = x
′
iβ, we have that
∂θi
∂β
= xi
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∂2θi
∂β∂β′
= 0
and consequently, I(β) = U , from where we obtain a Newton-Raphson update equal
to
β1 = β0 +U−1S(β)
If we define X as the design matrix of the covariates and Σ as a diagonal matrix
with elements
Σii =
( ∂h
∂µi
)2
φvi (B.1)
we have that U = XΣ−1U and
S(β) = X ′Σ−1
∂h
∂µ
(y − µ)
where ∂h/∂µ(y − µ) is a vector that contains the elements ∂h/∂µi(yi − µi).
Finally, we can rewrite the β update formula as
β1 = β0 + (X ′Σ−1X)−1X ′Σ−1
∂h
∂µ
(y − µ)
= (X ′Σ−1X)−1X ′Σ−1
[
Xβ0 +
∂h
∂µ
(y − µ)
]
= (X ′Σ−1X)−1X ′Σ−1yw
where yw is called the working vector. Indeed, it is a vector with elements
ywi = x
′
iβ
0 +
∂h
∂µi
(yi − µi)
where all the unknown parameters are evaluated in their current values.
The updating formula can be connected to a quadratic approximation of the
log-likelihood. Indeed,
E[Yi] = x′iβ0
Var[Yi] = Var
[ ∂h
∂µi
yi
]
=
( ∂h
∂µi
)2
Var[yi] =
( ∂h
∂µi
)2
φvi = Σii
Indeed, starting with β0, the log-likelihood of any distribution of the exponential
family is approximated by
−1
2
log|Σ| − 1
2
(yw −Xβ)′Σ−1(Y −Xβ)
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with yw and Σ defined above.
At convergence, we can evaluate the standard errors for the estimates from the
inverse of
I(β) = X ′Σ−1X
where the variance matrix is evaluated using the estimates βˆ and φˆ.
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APPENDIX C
LAPLACE APPROXIMATION
Laplace method is a technique used to approximate integrals of the form,∫ b
a
eMf(x)dx
where f(x) is a twice-differentiable function, M is a large number and the integral
endpoints a and b could be possibly infinite.
Assume that the function f(x) has a unique global maximum at x0. Then, the
value f(x0) will be larger than other values f(x). If we multiply this function by a
large number M , the ratio between Mf(x0) and Mf(x) will stay the same, but it
will grow exponentially in the function exp(Mf(x)).
If we expand f(x) around x0 by Taylor’s theorem,
f(x) = f(x0) + f
′(x0)(x− x0) + 1
2
f(x0)(x− x0)2 +R (C.1)
where R = O (x− x0)3).
since f(·) has a global maximum at x0, and since x0 is not an endpoint, it is
a stationary point hence, the derivative of f(·) vanishes at x0. Consequently, the
second term in Equation (C.1) equals to zero and we get that
f(x) ≈ f(x0)− 1
2
∣∣f(x0)′∣∣ (x− x0)2
for x close to x0. Notice that the second derivative is negative at the global maxi-
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mum. The assumptions made ensure the accuracy of the approximation∫ b
a
eMf(x)dx ≈ eMf(x0)
∫ b
a
e−M |f
′′(x0)|(x−x0)2/2dx (C.2)
The integral in Equation (C.2) is a Gaussian integral if the limits of the integration
go from −∞ to ∞ (which can be assumed because the exponential decays very fast
away from x0), and thus it can be calculated. In fact, we find that
∫ b
a
eMf(x)dx ≈
√
2pi
M |f ′′(x0)|e
Mf(x0) as M −→∞. (C.3)
APPENDIX D
MATRIX DIFFERENTIATION
In this Appendix we collect some useful formulas of matrix calculus that appear
through the thesis.
D.1 Properties and definitions
Definition D.1. Through this work we are going to use the numerator notation for
the matrix derivatives. Hence, if y and x are scalars, yn×1 and xt×1 are vectors and
Y n×m and Xt×k are matrices, we define the derivatives in the following way:
By scalar:
∂y
∂x
∂y
∂x
=

∂y1
∂x
...
∂yn
∂x
 ∂Y∂x =

∂y11
∂x
· · · ∂y1m
∂x
...
. . .
...
∂yn1
∂x
· · · ∂ynm
∂x

By vector:
∂y
∂x
=
(
∂y
∂x1
· · · ∂y
∂xt
)
∂y
∂x
=

∂y1
∂x1
· · · ∂y1
∂xt
...
. . .
...
∂yn
∂x1
· · · ∂yn
∂xt

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By matrix:
y
∂X
=

∂y
∂x11
· · · ∂y
∂xt1
...
. . .
...
∂y
∂x1k
· · · ∂y
∂xtk

Property D.1. We present commonly used derivatives properties, which are not
difficult to prove. Assume that the scalar a, vector a and matrices A and B are not
functions of x or x.
• Derivatives of scalar, vector and matrix by scalar.
(SS1)
∂(u+ v)
∂x
=
∂u
∂x
+
∂v
∂x
(SS2)
∂uv
∂x
= u
∂v
∂x
+ v
∂u
∂x
(product rule)
(SS3)
∂g(u)
∂x
=
∂g(u)
∂u
∂u
∂x
(chain rule)
(VS1)
∂au
∂x
= a
∂u
∂x
(VS2)
Au
∂x
= A
∂u
∂x
(VS3)
∂u′
∂x
=
(
∂u
∂x
)′
(VS4)
∂(u+ v)
∂x
=
∂u
∂x
+
v
∂x
(VS5)
∂g(u)
∂x
=
∂g(u)
∂u
∂u
∂x
(chain rule)
(MS1)
aU
∂x
= a
∂U
∂x
(MS2)
AUB
∂x
= A
∂U
∂x
B
(MS3)
∂(U + V )
∂x
=
∂U
∂x
+
∂V
∂x
(MS4)
∂UV
∂x
= U
∂V
∂x
+
∂U
∂x
V
• Derivatives of scalar and vector by vector.
(SV1)
∂au
∂x
= a
∂u
∂x
(SV2)
∂(u+ v)
∂x
=
∂u
∂x
+
∂v
∂x
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(SV3)
∂uv
∂x
= u
∂v
∂x
+ v
∂u
∂x
(product rule)
(SV4)
∂g(u)
∂x
=
∂g(u)
∂u
∂u
∂x
(chain rule)
(SV5)
∂u′v
∂x
= u′
∂v
∂x
+ v′
∂u
∂x
(product rule)
(SV6)
∂a′x
∂x
=
∂x′a
∂x
= a′
(SV7)
∂x′x
∂x
= 2x′
(SV8)
∂x′Ax
∂x
= x′(A+A′)
(VV1)
∂au
∂x
= a
∂u
∂x
+ u
∂a
∂x
(product rule)
(VV2)
∂Au
∂x
= A
∂u
∂x
(VV3)
∂(u+ v)
∂x
=
∂u
∂x
+
∂v
∂x
(VV4)
∂g(u)
∂x
=
∂g(u)
∂u
∂u
∂x
(chain rule)
(VV5)
∂Ax
∂x
= A
(VV6)
x′A
∂x
= A′
• Derivatives of scalar by matrix.
(SM1)
∂au
∂X
= a
∂u
∂X
(SM2)
∂(u+ v)
∂X
=
∂u
∂X
+
∂v
∂X
(SM3)
∂uv
∂X
= v
∂u
∂X
+ u
∂v
∂X
(product rule)
(SM4)
∂g(u)
∂X
=
g(u)
∂u
∂u
∂X
(chain rule)
Property D.2 (Woodbury matrix identity).
(A−BD−1C)−1 = A−1 +A−1B (D −CA−1B)−1CA−1
for matrices A, B, C and D with appropriate dimensions and assuming A, C, D
and A−BD−1C are invertible.
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Alternative names for this formula are the matrix inversion lemma, Sherman–
Morrison–Woodbury formula or just Woodbury formula. The proof of the formula
can be found at Harville (1997) Theorem 19.2.8 in Equation (2.22).
Property D.3 (Jacobi’s formula).
∂det(H)
∂x
= trace
[
adj(H)
∂H
∂x
]
and, moreover, if H is nonsingular we have that
∂det(H)
∂x
= det(H)trace
(
H−1
∂H
∂x
)
.
The proof can be found at Harville (1997) Equation (8.5).
Property D.4. Let be H a nonsingular matrix, then
∂ log det(H)
∂x
= trace
(
H−1
∂H
∂x
)
The proof can be found at Harville (1997) Equation (8.6).
Property D.5.
∂H−1
∂x
= −H−1∂H
∂x
H−1
The proof can be found at Harville (1997) Equation (8.15).
Property D.6 (Inverse of a block matrix). If
Σ =
(
A B
C D
)
,
then
Σ−1 =
( (
A−BD−1C)−1 − (A−BD−1C)−1BD−1(
D −CA−1B)−1CA−1 (D −CA−1B)−1
)
.
The proof of the formula can be found at Harville (1997) Theorem 8.5.11 in
Equation (5.17a).
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D.2 Matrix differentiation of the proposed models
In this section we present all the matrix analysis of the BBreg and BBmm approaches
developed in Chapter 2 and Chapter 3 respectively.
BBreg approach
The log-likelihood contribution of the BBreg approach is given by (see Chapter 2,
Equation (2.5))
logL(p, φ|y) =
n∑
i=1
[
log
(
mi
yi
)
+
yi−1∑
k=0
log(pi+kφ)+
mi−yi−1∑
k=0
log(1−pi+kφ)−
mi∑
k=0
log(1+kφ)
]
.
Therefore, we present all the derivatives that are used in the estimation procedure
in Chapter 2, i.e.:
∂pi
∂βj
=
1
∂βj
(
exp(x′iβ)
1 + exp(x′iβ)
)
=
xij exp(−x′iβ)
(1 + exp(−x′iβ))2
= xijpi(1− pi),
∂p
∂β
=

∂p1
∂β1
· · · ∂p1
∂βp
...
. . .
...
∂pn
∂βp
· · · ∂pn
∂βp
 = SX,
(D.1)
where S = diag(p1(1− p1), . . . , pn(1− pn)).
∂ logL
∂pi
=
yi−1∑
k=0
1
pi + kφ
+
mi−yi−1∑
k=0
1
1− pi + kφ = ξi,
∂ logL
∂p
=
(
∂ logL
∂p1
· · · ∂ logL
∂pn
)
= ξ′,
(D.2)
where ξ = (ξ1, . . . , ξn)
′.
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∂2 logL
∂p∂p′
=
∂
∂p′
ξ′ =
(
∂ξ1
∂p′
· · · ∂ξn
∂p′
)
=

∂ξ1
∂p1
· · · ∂ξn
∂p1
...
. . .
...
∂ξ1
∂pn
· · · ∂ξn
∂pn
 = −V ,
vij = − ∂ξi
∂pj
=

0, if i 6= j
yi−1∑
k=0
1
(pi + kφ)2
+
m−yi−1∑
k=0
1
(1− pi + kφ)2 , if i = j.
.
(D.3)
∂ logL
∂φ
=
n∑
i=1
[
yi−1∑
k=0
k
pi + kφ
+
mi−yi−1∑
k=0
k
1− pi + kφ −
mi−1∑
k=0
k
1 + kφ
]
. (D.4)
BBmm approach
The approximated marginal likelihood of the model in Equation (3.25) is defined as
logL(β,θ|y) ≈ h(β,θ|y, u˜)− 1
2
log|M |
where
h(β,θ|y,u) =
h1︷ ︸︸ ︷
n∑
i=1
logfy|u(yi|β, φ,u) +
h2︷ ︸︸ ︷
logfu(u|λ)
h1 =
n∑
i=1
[
yi−1∑
k=0
log(pi + kφ) +
mi−yi−1∑
k=0
log(1− pi + kφ)−
mi−1∑
k=0
log(1 + kφ)
]
h2 = −1
2
log|D| − 1
2
u′D−1u,
and
M =
∂2h
∂u∂u′
∣∣∣
u=u˜
.
where u˜ is the solution of ∂h/∂u = 0.
Therefore, we present all the derivatives that are used in the estimation procedure
in Chapter 3, i.e.:
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∂pi
∂uj
=
1
∂uj
(
exp(x′iβ + z
′
iu)
1 + exp(x′iβ + z
′
iu)
)
= zijpi(1− pi)
∂p
∂u
=

∂p1
∂u1
· · · ∂p1
∂uq
...
. . .
...
∂pn
∂u1
· · · ∂pn
∂uq
 = SZ
(D.5)
where S = diag(p1(1− p1), . . . , pn(1− pn)).
∂pi
∂βj
=
1
∂βj
(
exp(x′iβ + z
′
iu)
1 + exp(x′iβ + z
′
iu)
)
= xijpi(1− pi)
∂p
∂β
=

∂p1
∂β1
· · · ∂p1
∂βp
...
. . .
...
∂pn
∂β1
· · · ∂pn
∂βp
 = SX
(D.6)
∂h1
∂pi
=
yi−1∑
k=0
1
pi + kφ
+
mi−yi−1∑
k=0
1
1− pi + kφ = ξi
∂h1
∂p
=
(
∂h1
∂p1
· · · ∂h1
∂pn
)
= ξ′
(D.7)
vij = − ∂ξi
∂pj
=

0, if i 6= j
yi−1∑
k=0
1
(pi + kφ)2
+
mi−yi−1∑
k=0
1
(1− pi + kφ)2 , if i = j.
∂2h1
∂p∂p′
=
∂
∂p′
ξ′ =

ξ1
∂p1
· · · ξn
∂p1
...
. . .
...
ξ1
∂pn
· · · ξn
∂pn
 =

−v11
. . .
−vnn
 = −V
(D.8)
By Property D.1 (SV8),
∂h2
∂u
=
1
2
u′(D−1 +D−1) = u′D−1 (D.9)
∂2h2
∂u∂u′
=
∂
∂u′
u′D−1 = D−1 (D.10)
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By Equations (D.7), (D.5), (D.7) and (D.10),
∂2h
∂u∂u′
=
∂2h1
∂u∂u′
− ∂
2h2
∂u∂u′
=
∂
∂u′
[
∂h1
∂p
∂p
∂u
]
−D−1
=
∂
∂u′
[
ξ′SZ
]−D−1 = ∂p
∂u′
∂
∂p
[
ξ′S
]
Z −D−1
= Z ′S

∂
∂p1
ξ1p1(1− p1) · · · ∂
∂pn
ξ1p1(1− p1)
...
. . .
...
∂
∂p1
ξnpn(1− pn) · · · ∂
∂pn
ξnpn(1− pn)
Z −D−1
= Z ′SWZ −D−1
(D.11)
where W = diag(w11, . . . , wnn) being
wij =
∂
∂pj
ξipi(1− pi) =
0, if i 6= j−vipi(1− pi) + ξi(1− 2pi), if i = j.
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